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ABSTRACT 
iii
CAMILLE LAMBE: Complementary and Alternative Therapy Use During Treatment of 
Breast Cancer 
(Under the direction of Dr. Barbara Germino) 
Complementary and alternative medicine (CAM) is used often by women having  
treatment for breast cancer and has been studied extensively in European American, 
educated, affluent women. However, it is poorly understood in poor, uneducated, rural and 
African American women.  Studies of folk medicine, spirituality and those few studies with 
ethnically diverse samples indicate that CAM is also used in these groups. The process by 
which women make decisions to use CAM during and after breast cancer treatment has not 
been clearly described. 
The aims of this study were to characterize CAM use during treatment for breast cancer 
in a sample of African American and Caucasian women; to examine precipitating and 
influential factors in Caucasian and African American women’s choices to use CAM during 
breast cancer treatment; to describe the process and timing of decisions to use CAM; and to 
clarify the use of CAM for treatment of breast cancer related issues as compared to the use of 
CAM for maintaining and improving health.  
This exploratory descriptive study used a cross sectional design and multiple methods 
including a card sort, individual interviews and quantitative measures.  A convenience 
sample of 19 African American and European American women participated, all of whom 
were CAM users and were receiving or recovering from breast cancer treatment.  The women 
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in the sample were generally educated beyond high school, were varied in age and income as 
well as type of residence (urban/rural).  
The results of this study indicate the importance of participant definitions of CAM.   
African American women in the sample reported higher use of CAM treatments than the 
European American women both for managing side effects of treatment and for their general 
health. The types of CAM treatments used by African American and Caucasian women were 
different.  Having breast cancer motivated all the women to engage in a type of life review to 
search for reasons for having breast cancer and to affect adoption of healthy lifestyle choices 
in the form of CAM. These women used a process of deciding about CAM use that was 
shaped by people they considered to be experts, a variety of other information sources, their 
health beliefs and their own personal experiences with the CAM treatment.  The decision to 
use CAM therapies involved weighing the pros and cons and trying out CAM therapies for 
their effectiveness. 
The importance of faith and spirituality, especially but not exclusively for African 
American breast cancer patients, was supported by these findings.  Prayer was the CAM 
therapy chosen most often by all of the women in the sample.  The study raises questions 
about literature indicating that women do not discuss CAM use with their health care 
providers.  In fact, the findings indicate the importance of providers as a resource for patients 
considering CAM during treatment of breast cancer and the need for study of precise doses 
of CAM and conventional treatment given concurrently.  
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Chapter I 
The Problem 
 The use of complementary and alternative medicine (CAM) is reported to be increasing in 
the United States (Eisenberg et al., 2001) and worldwide (Kimby, Launso, Henningsen, & 
Langgaard, 2003). There is no agreement in the scientific literature about how CAM is 
defined, however. The National Center for Complementary and Alternative Medicine 
(NCCAM), a center within the National Institutes of Health, has identified CAM as a group 
of diverse medical and health care systems, practices, and products that are not presently 
considered to be part of conventional medicine (National Center for Complementary and 
Alternative Medicine, 2004). Other definitions used in the literature include lists of selected 
treatments and therapies (Eisenberg, Kessler, & Foster, 1993) as defined by researchers; 
holistic approaches to health and illness (Montbriand, 1994); unconventional therapies 
provided by unlicensed practitioners (Druss & Rosenheck, 1999); licensed physicians’ 
integration of unconventional therapy with conventional care (Dalen, 1998); or any 
nontraditional therapy adopted by a person for relief of a particular problem, symptom, or 
concern (Low Dog, Riley, & Carter, 2001). All of these varied definitions complicate and 
limit knowledge about CAM use. According to available definitions, CAM may be 
prescribed by licensed or certified health care providers (Standish, Greene, Greenlee, Kim, & 
Grosshans, 2002) or by non-licensed practitioners of a particular kind of unconventional 
therapy (Mathews, 1992), or it may be self-initiated (Bushy, 1992).  Individuals may self-
prescribe CAM (Eisenberg et al., 2001) following information from the Internet (Satterlund, 
2McCaul, & Sandgren, 2003) or following influences from friends and family (Crocetti et al., 
1998) or fellow members of a support group (Henderson & Donatelle, 2004). Because 
control of care rests in part with the patient, all of these influences are important in the 
adoption of CAM treatments. A CAM treatment, for purposes of this study, is defined as any 
non-conventional, non-biomedical strategy that the patient initiates while receiving or 
recovering from conventional biomedical therapy for breast cancer, regardless of the source 
of information about CAM or the influencing persons or resources.  
 Cancer is a diagnosis that prompts patients not only to seek biomedical treatment but also 
to investigate CAM. Women have been found to be more likely than men to use CAM 
(Arcury, Preisser, Gesler, & Sherman, 2004). Newly diagnosed breast cancer patients are 
also more likely than other cancer patients to use CAM (VandeCreek, Rogers, & Lester, 
1999). Breast cancer patients are also more likely to adopt CAM after their diagnosis than 
other cancer patients (Boon, Brown, Gavin, Kennard, & Stewart, 1999). Survey data indicate 
that from 40 to 70% of women with breast cancer use CAM during treatment (Alferi, Antoni, 
Ironson, Kilborn, & Carver, 2001; Burstein, Gelber, Guadagnoli, & Weeks, 1999; Morris, 
Johnson, Homer, & Walts, 2000) 
 Breast cancer patients have been reported to use CAM from the time of diagnosis (Alferi 
et al., 2001), through treatment with chemotherapy (Shen et al., 2000) or radiation therapy 
(Kolcaba & Fox, 1999), and during advanced breast cancer (Mathews, Lannin, & Mitchell, 
1994). They report using CAM for well-being (Moschen et al., 2001), for relief of symptoms 
associated with their cancer (Rees et al., 2000), and for relief of side effects of treatments 
including surgery (Ashikaga, Bosompra, O'Brien, & Nelson, 2002), radiation therapy 
(Lengacher et al., 2002), chemotherapy (Maskarinec, Shumay, Kakai, & Gotay, 2000), and 
3hormonal therapy (Canales & Geller, 2003). Complementary therapy use increases among 
patients with breast cancer as treatment intensifies (Shen et al., 2002), which may increase 
the chances that the patient will experience interactions between their conventional treatment 
and the CAM they use (Izzo & Ernst, 2001). We know little about these interactions and their 
effects on cancer morbidity and mortality.  
 Although some authors advocate the beneficial effects of CAM during cancer 
chemotherapy (Bougnoux et al., 1999; Carlsson, Arman, Backman, & Hamrin, 2001; 
Conklin, 2000; Heggie et al., 2002; Messina & Loprinzi, 2001; National Center for 
Complementary and Alternative Medicine, 2004), others urge caution in its use (Boyle, 
1997). The conventional medical community has expressed major concerns about the use of 
CAM. Some authors are concerned that patients will use CAM rather than conventional 
biomedicine for cancer treatment. Others worry about drug interactions with CAM that may 
interfere with treatment effectiveness. Still others indicate that CAM use may intensify the 
toxicities of conventional treatment. Studies of CAM use during cancer show that only a 
small number of patients completely withdraw from all conventional biomedicine 
(Montbriand, 1998). Instead, most patients combine CAM with their biomedical regimen 
(VandeCreek et al., 1999), perpetuating provider concerns about interactions with 
conventional therapy.  
 Some forms of CAM, specifically antioxidants (Labriola & Livingston, 1999; Lamson & 
Brignall, 1999), St. John’s wort (Werneke et al., 2004), and essiac (Kumar et al., 2002), have 
been cited as having actions that interfere with the effectiveness of chemotherapy drugs. A 
larger body of literature, mostly case studies, includes reports of the additive effects of CAM 
to the complications of cancer treatment, including postoperative bleeding (Norred & 
4Finlayson, 2000), acute hepatitis (Whiting, Clouston, & Kerlin, 2002), and disruption of 
coagulation processes (Barone, Gurley, Ketel, & Abul-Ezz, 2001).  
 In several reviews of the literature about interactions between herbal medicines and 
prescribed drugs (Drew & Myers, 1997; Erlen, 1997; Izzo & Ernst, 2001; Mahady, Fabricant, 
Chadwick, & Dietz, 2002; Markman, 2002; Miller, 1998), the authors found cause for 
concern in mixing CAM with conventional biomedicine (Erlen, 1997; Vickers, 2004). These 
concerns included prolonged sedation from barbiturates, as in the case of valerian; bleeding, 
as in the case of ginkgo biloba combined with warfarin; and rejection of renal transplant, as 
in the case of St. John’s wort. In case study reports, kava, a natural anxiolytic, has induced 
fatal fulminant hepatic failure (Gow, Connelly, Hill, Crowley, & Angus, 2003), and black 
cohosh, an herb for hot flashes, has induced acute hepatic failure (Whiting et al., 2002). 
Although surveys of CAM use during chemotherapy have been done (Alferi et al., 2001; 
Chou, Horng, & Vargas, 2000; Lengacher et al., 2002; Meyer, Russo, & Talbot, 1995; 
O'Connor, 1980), there are few large, longitudinal studies of the effects and interactions of 
CAM with conventional breast cancer treatment. 
 Women with breast cancer who are most likely to combine CAM with biomedical 
treatment have traditionally been described as European Americans, educated, and affluent. 
This picture of CAM users is largely generated from the types of samples selected for study, 
which are dominated by patients with those characteristics. Since minority groups are rarely 
represented in the samples of published studies about breast cancer, little is known about the 
application of the traditions of CAM use within minority groups. Traditional medicine 
(Kakai, Maskarinec, Shumay, Tatsumura, & Tasaki, 2003), folk medicine (Fletcher, 2000), 
spirituality (Roberson, 1987), and herbal medicine (Mathews, 2000) have all been described 
5as being used by persons from a variety of cultures in the United States. Some authors have 
identified these therapies as CAM (Fletcher, 2000), and the patients they study seem to use 
them in a complementary manner (Cuellar, Aycock, Cahill, & Ford, 2003; Powers, 1982). 
Research with purposive samples of ethnically diverse groups (Chou et al., 2000; Mackenzie, 
Taylor, Bloom, & Hufford, 2003) has generated a more diverse picture of CAM users. A 
sample representative of European Americans, African Americans, Latinos, and Asian 
groups clearly shows that CAM use is prevalent in all of these groups, but the types of 
therapies used varies from group to group (Lee, Lin, Wrensch, Adler, & Eisenberg, 2000), 
perhaps based on cultural traditions. 
 The process by which breast cancer patients come to a decision about using CAM therapy 
is also unclear. Lack of diversity in study samples limits reports of decision-making about 
CAM use in breast cancer patients. Many of the studies sample mostly European Americans, 
well-educated women (Boon et al., 1999; Mathews, 2000; Rees & Bath, 2001; Seegers et al., 
1998; Truant & Bottorff, 1999), and few studies have focused on the decisions that women 
make during treatment (Matthews, Sellergren, Manfredi, & Williams, 2002) or how they are 
made.  
 Since adjuvant treatment is so vital to the potential success of biomedical therapy for 
breast cancer, adding another therapy that is unregulated is of particular concern. The role of 
complementary therapy, with its potential for drug toxicity, possible interactions with 
conventional therapies, and prevalence of use during toxic conventional biotherapy, makes 
the decisions women come to about CAM particularly important. Without insight into the 
processes women use to decide about CAM use, intervention and education for this group of 
women lack foundation (Moschen et al., 2001). The limitations of existing studies; the 
6potential for problems in interactions of conventional treatment and CAM; and the lack of 
systematic information about how and when women with breast cancer decide to use CAM 
all supported this study of a more diverse sample of women during adjuvant therapy for 
breast cancer as they decide whether or not to include complementary therapy in their 
treatment.  
 
The aims of this study were: 
1.To characterize CAM use during treatment for breast cancer in a sample of African 
American and European Americans women from both urban and rural settings in the South. 
2. To examine precipitating and influential factors in the choices of European Americans and 
African American women to use CAM during treatment for breast cancer. 
3. To describe the process and timing of decision making that women use in choosing CAM 
during breast cancer treatment. 
4. To clarify the use of CAM for treatment of breast cancer–related issues as compared to 
CAM use for self-care and healthy lifestyles. 
 
Chapter 2 
Review of Literature 
 The complementary and alternative therapy (CAM) movement has become pervasive in 
the United States, with CAM being added to conventional treatment regimes by patients with 
breast cancer (DiGianni, Garber, & Winer, 2002; Gray, Fitch, Goel, Franssen, & Labrecque, 
2003; Lengacher, Bennett, Kip, Berarducci, & Cox, 2003). Researchers demonstrates high 
CAM use in cancer patients (Vickers, 2004), in women in general (Patterson et al., 2002), 
and in breast cancer patients specifically (Maskarinec et al., 2000), but the variability in 
definitions of CAM makes the scope of CAM use unclear. Researchers have defined CAM as 
a list of treatments, a holistic philosophy, or as a series of domains. When authors use a list to 
define CAM therapies, treatments used by particular ages and ethnic groups may be 
inadvertently omitted. When researchers use a holistic definition of CAM, health 
maintenance behaviors are included in CAM definitions. Using a series of domains, 
particular treatments may be included in one domain for one report and in another domain in 
another report. 
 Decision-making is an important element in the use of CAM treatments because it 
provides an avenue for providers to intervene with patients. The decision-making process has 
been poorly described in the literature about CAM and breast cancer. The ways in which the 
elements of decision-making interact in women making the choice to use CAM or to reject 
CAM are unclear in women with breast cancer.  
8Descriptions of CAM use and decision-making that include African American women are 
largely absent in the breast cancer literature. Traditional medicine, folk medicine, and 
spirituality have been documented heavily in the literature about the African American 
community and the health care that they use (Abrums, 2000; Fields, 2001; Woodard & 
Sowell, 2001) but are absent in the literature about CAM in breast cancer. Forms of CAM 
used by African American women may be included in surveys of breast cancer patients, but 
often the sample surveyed includes few African American women. Authors who have studied 
multiethnic samples of breast cancer patients have found that European Americans and 
African American women both use CAM, but each group uses a different combination of 
therapies (Factor-Litvak, Cushman, Kronenberg, Wade, & Kalmus, 2001; Lee et al., 2000). 
 
Difficulties in Defining Complementary Therapy: Historical Background 
 The modern concept of CAM has its origins in the United States during the early 1960s. 
With the advent of the new age movement and self-help and wellness interest groups, 
patients became more involved with their medical care and their health. During this period 
("Unproven methods," 1967), cancer patients began hearing about cures and treatments for 
cancer from outside the United States (Seligmann, 1977b). The conventional medical 
establishment, however, voiced concern that cancer patients would forsake proven treatment 
for expensive unorthodox cures (Cramp, 1982). These unorthodox treatments and medicines 
included botanicals such as laetrile from South America (Seligmann, 1977a), treatments such 
as acupuncture from China (Reston, 1971), and practices such as yoga from India (Decker, 
1999). Users of CAM were portrayed by the medical community as dissatisfied, desperate 
patients with no hope left (American Cancer Society, 1982). Although the popular press 
9touted CAM as revolutionary and providing hope for patients with incurable illnesses 
(Reston, 1971;  Seligmann, 1977b), the conventional medical press was skeptical (Hubbard, 
1966). 
 In an early survey of CAM use in cancer treatment (Cassileth, Lusk, Strouse, & 
Bodenheimer, 1984), the authors described the prevalence of CAM use and presented a 
definition of CAM. They defined CAM as “treatments and methods deemed by established 
medicine to be unproven, unorthodox, ineffective, or fraudulent” (Cassileth, Lusk, Strouse, & 
Bodenheimer, 1984, 105). In their study, they interviewed 660 patients and found that 51% 
reported using CAM at the same time they used conventional cancer treatment. The authors 
collected information about CAM treatments from their respondents and created a list that 
they used to define CAM treatments. However, the sample they studied was narrowly drawn, 
including mainly European Americans, educated, and affluent women. Researchers have 
used the methods and therapies of this report in CAM definitions from that time to the 
present.  
 
Differences in CAM Definitions 
Use of a List to Define CAM 
 The most quoted survey of CAM use (Eisenberg et al., 1993) drew from a largely 
European Americans sample of 1,539 members of the public and was a phone survey. These 
authors found that 34% of their sample used CAM. They defined CAM with a list generated 
from their pilot work and simply asked the respondents if they did or did not use specific 
therapies. Essentially, the researchers defined CAM in this study by the therapies they asked 
about and by the people whom they questioned. These authors defined CAM as “a list of 16 
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commonly used interventions neither taught widely in U.S. medical schools nor generally 
available in U.S. hospitals” (Eisenberg et al., 1993, 246). These were therapies that were 
included in the earlier (Cassileth et al., 1984) list in addition to others. This list has become 
the standard definition for current research describing CAM use.  
 Other authors have utilized the author-defined list as a way to study CAM (Arcury et al., 
2004; Ashikaga et al., 2002; Consumer Reports, 2000; Cushman, Wade, Factor-Litvak, 
Kronenberg, & Firester, 1999). The problem with this method, however, is that the samples 
surveyed to create these lists have been narrowly drawn and do not include members of 
multiple cultures that also use CAM (Lengacher et al., 2002; Navo et al., 2004). Even when a 
list is provided to a set of subjects that includes multicultural modalities such as traditional 
and folk medicine, there has been low use reported when the sample was narrowly drawn 
(Eisenberg, 1998). That is, the study population in the original Eisenberg study was 82% 
European Americans, 9% Black, 6% Hispanic, 1% Asian, and 2% other. The researchers 
asked about some therapies that reflected cultural diversity, such as folk remedies and prayer, 
but because of the low proportion of respondents from minority groups, the authors came to 
the conclusion that CAM users are young, non-Black, highly educated, and affluent 
(Eisenberg et al., 1993). The findings of other studies dispute these conclusions (Frate, 
Croom, Frate, Juergens, & Meydrech, 1996; Richardson, Sanders, Palmer, Greisinger, & 
Singletary, 2000), concluding that African Americans and indigent patients were indeed 
frequent CAM users. The primary difference in these studies was the diversity in the 
samples.  
 In reports of an ethnically diverse sample of women from New York (Cushman et al., 
1999; Factor-Litvak et al., 2001), the authors asked about the use of CAM for women’s 
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health concerns.  The authors found unique types of CAM used by Hispanic and African 
American women (Cushman et al., 1999). The second study in this series (Factor-Litvak et 
al., 2001) combined the individual types of CAM for analysis. This report found no 
differences in the ethnic groups regarding CAM use. However, by grouping the individual 
modalities used by the women, the potential richness of CAM use information was lost. The 
authors’ conclusions failed to capture the unique systems of healing used by the women in 
their diverse sample. 
Use of Holistic Philosophy to Define CAM 
 Other researchers have defined CAM as a holistic approach to health (Montbriand, 1994, 
1995a, 1995b, 1998). Holism is a broad concept, encompassing both illness and health. It 
focuses on the interrelatedness of parts and emphasizes the organic or relation between parts 
and wholes (Merriam-Webster, 1967). In the context of holism, the experience of cancer is 
only a portion of the patient’s concern, and other body systems weigh equally in attention 
and importance. Prevention behaviors such as diet and exercise are included (Kinney, 
Rodgers, Nash, & Bray, 2003) in CAM lists when subjects are asked about the amounts of 
CAM they use. Another element in the holistic approach to health is the belief that there are 
things that are “good for you” and substances that are unhealthy. CAM users are more likely 
to maintain a low-fat diet and exercise more frequently (classified as CAM in some studies) 
than non-users (Politi, Rabin, & Pinto, 2006). Some breast cancer patients describe 
biomedical treatments for cancer as potential toxins (Downer et al., 1994) that may be 
harmful to their bodies (Montbriand, 1998). Many studies report that patients use CAM to 
detoxify their bodies from the effects of conventional cancer treatment (Cassileth et al., 1984; 
Gotay & Dumitriu, 2000; Marbella, Harris, & Diehr, 1998; Shen et al., 2002). 
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Distinguishing between therapies for general health and those aimed specifically at breast 
cancer (Alferi et al., 2001; Astin, Pelletier, Marie, & Haskell, 2000; Balneaves, Kristjanson, 
& Tataryn, 1999) is important because it gives clues about motivation for CAM use.  Many 
surveys of CAM utilization within the breast cancer literature include health promoting 
behaviors such as diet and exercise (Chou et al., 2000; Sparber et al., 2000; VandeCreek et 
al., 1999) as CAM. Often these approaches are seen as holistic healing and focus on the 
whole person rather than cancer and the side effects of its treatment. Although special diets 
and limited exercise have been advocated for some side effects of breast cancer treatment 
(Djuric et al., 1998; Schwartz, 2000), the distinctions made between CAM used for cancer 
and its side effects and those strategies used for general holistic health are important in the 
overall reporting of CAM use. Unless CAM definitions can be refined, measuring CAM use 
will continue to be based on imprecise definitions that are inconsistent across studies, 
threatening the validity of the construct. The belief that a healthy body is more or less likely 
to promote the growth of a cancer is beyond the scope of this study. 
 A survey by Barnes, Powel-Griner, McFann, and Nahin (2004) provides an example of 
making this distinction. The survey includes the element of prayer in the list of CAM 
treatments. However, the researchers specify that the prayer must be for cure of the cancer or 
the alleviation of one of its side effects (Barnes et al., 2004). This method is in contrast to a 
study by VandeCreek et al. (1999) that included prayer and exercise in the list of CAM 
treatments without any indication of the reasons for their use. The authors did not ask about 
the reasons for CAM use, and it is unclear from their results whether the CAM the women 
used was for routine health maintenance or if it represented an attempt by the breast cancer 
patients to deal with their cancer.  
13
Domains as a Way to Define CAM 
 The National Center for Complementary and Alternative Medicine (NCCAM) has also 
defined CAM. This center in the National Institutes of Health was established in 1991 to 
investigate the use and effects of CAM and to educate the public about it. The NCCAM 
identifies CAM as a group of diverse medical and health care systems, practices, and 
products not presently considered to be part of conventional medicine (National Center for 
Complementary and Alternative Medicine, 2004). Early studies outline therapies that were 
considered CAM (Hauser, 1991) because they were outside conventional medicine, but this 
list has changed as a variety of therapies have become more mainstream. Early reports define 
acupuncture and acupressure as unproven and unconventional (Reston, 1971), but current 
medical practice incorporates therapies such as acupuncture and massage (Bredin, 1999; 
Dibble, Chapman, Mack, & Shan, 2000; Harris, Hugi, Olivotto, & Levine, 2001; Rydholm, 
1999 ) as potential adjuncts to cancer care. As more and more conventional providers use 
CAM strategies (Standish et al., 2002), conventional medical schools are expanding to 
incorporate the principles of CAM into their curricula (Spiegel, Stroud, & Fyfe, 1998). The 
NCCAM provides definitions with examples to guide classification of CAM modalities (see 
Table 1). This series of domains is most useful in the analysis portion of a study and may be 
a useful way to organize disparate types of CAM. 
 Alternative medical systems. 
 The domain alternative medical systems reflects practices of ancient cultures such as 
traditional Chinese medicine (Simpson, 2003) or Ayurvedic medicine (Ashikaga et al., 
2002). These systems of healing became fashionable in the United States in the 1960s and 
were popularized in the new age and women’s movements (Boston Women's Health Book 
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Collective, 1984). They reflect the health beliefs of the culture of origin. An alternative 
medical system may employ treatments from several other domains.  Traditional Chinese 
medicine is an example of an alternative healing system that may include the biological 
therapy of herbs, the energy healing of acupuncture, and the mind-body therapy of 
meditation. A patient may subscribe to a particular modality from an alternative medical 
system without adopting the entire system of health beliefs. But many health beliefs are 
culturally derived, and the practices associated with them are quite prevalent (McCoy, 1997). 
 Traditional medicine (Hufford, 1997) and folk medicine (Mathews, 1987) are also 
examples of culturally based alternative medical systems. Each of these systems employs a 
series of therapies reflective of their culture of origin, but the literature seldom describes their 
uses as fully as other alternative systems. Some studies of minority populations have classed 
traditional and folk medicine as CAM (Bushy, 1992; Fletcher, 2000), and elements of these 
culturally based systems have been included in lists of CAM (Arcury et al., 2004; Gotay, 
Hara, Issell, & Maskarinec, 1999). Arcury et al. (2004) described an alternative healing 
system in North Carolina. They surveyed 1,059 rural mountain dwellers and reported the use 
of a system they classify as “honey-lemon-vinegar-whiskey.” This system includes home 
remedies used to deal with a wide variety of symptoms and complaints. Arcury et al. reported 
that this system was the form of CAM most frequently used by their subjects. This 
information is important because the patients reported blending these home remedies with 
conventional biomedicine. Work by Gotay et al. (1999) described a culturally distinct system 
used by Hawaiian cancer patients, including unique therapies not found in other studies of 
CAM such as seaweed, marijuana, and the Healing Mass, a native ceremony from Hawaii. A 
North Carolina study of women with breast cancer (Mathews et al., 1994) describes the 
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forms of CAM used by European Americans and African American women (including 
traditional medicine and Rootwork, a belief in the power of spells and potions) and the 
interaction between the women’s use of CAM and the conventional biomedical system they 
encounter as their cancer progresses. The report makes the distinction between the different 
systems of care and when each was used by breast cancer patients. This application of the 
alternative medical system, as outlined by the NCCAM, is useful because it shows the 
importance of a cultural system to decision-making and provides insight into the motivation 
of the women to adhere to their alternative medical system while using conventional 
biomedicine. 
 Mind-body interventions. 
 Mind-body interventions are based on the belief that the mind and body are linked and that 
each affects the other (Targ & Levine, 2002). Advocates of these interventions may be 
proponents of the stress theory of illness (Brown & Carney, 1996) and seek to improve health 
by stress reduction. Many surveys of CAM use report that patients believe cancer is caused 
by stress (Bowman, Deiming, Smerglia, Sage, & Kahana, 2003) and that the CAM they use 
is aimed at stress reduction (Truant & Bottorff, 1999). In like fashion, they may also believe 
that illness can be cured by the power of the mind (Cushman et al., 1999).  
 Shumay, Maskarinec, Gotay, Heiby, and Kakai (2002) found that 82% of their respondents 
had used mind-body interventions. They described this CAM domain as including religious 
healing, meditation, guided imagery or hypnosis, support groups, relaxation, and 
psychological counseling. This is consistent with the NCCAM definition (National Center for 
Complementary and Alternative Medicine, 2004). These authors classified support groups as 
a form of mind-body therapy. For the past 30 years the American Cancer Society (ACS) has 
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advocated support groups for breast cancer patients (McMillian, Tittle, & Hill, 1993; Smith, 
1998). Data support the beneficial effects of support group attendance for breast cancer 
survival (Davidson, Pennebaker, & Dickerson, 2000; Spiegel et al., 1998). The women who 
attend support groups and their conventional providers may or may not see their attendance 
as a type of complementary therapy. Reports of the prevalence of CAM use that include 
support group attendance (Alferi et al., 2001; Astin, 1998; Henderson & Donatelle, 2004) 
may be misleading about the frequency of use of CAM treatments unless this element is 
defined.  
Biologically based therapies. 
 Another NCCAM domain, biologically based therapies, encompasses a wide variety of 
treatments classified as “natural,” including vitamins, minerals, and other naturally occurring 
products such as shark cartilage and various herbal preparations. These may be ingested as 
extracts, pills, or injections; they may be inhaled, taken as enemas, or used topically. 
Biologically based therapies are not regulated by the Food and Drug Administration (FDA, 
2004) but are classified as nutritional supplements and are regulated by the Dietary 
Supplement and Health Education Act of 1994 (Ramsey, Ross, & Fischer, 2000). The lack of 
FDA regulation and the potential for harm have been criticisms of CAM by the conventional 
medical community (Jonas & Levin, 1999). An Australian study (Drew and Myers, 1997) 
described adverse effects related to regulation of some biologically based therapies. The 
extrinsic effects that they describe have concerned conventional providers for many years 
(Perharic et al., 1994) and can confuse and taint results of studies of CAM treatments. When 
an author describes an adverse effect of a biologic therapy, it may actually reflect the process 
used by the seller of the therapy rather than the intended CAM treatment itself. The CAM 
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treatment may not provide the anticipated outcome, but the result may have little to do with 
the proposed CAM treatment. Although investigation of CAM modalities is ongoing, beliefs 
that CAM treatments are impure may affect the patient’s decision-making and provider 
acceptance of CAM therapies. 
Table 1: 
Definitions and Examples of NCCAM Domains 
NCCAM Domain Definition Examples 
Alternative 
Medical Systems 
Therapies built on a complete system of 
theory and practice. 
Chinese Medicine, Ayurveda, 
Naturopathy, Folk Medicine,  
Traditional Medicine. 
Mind-Body 
Interventions 
Therapies use a variety of techniques to 
enhance the mind’s capacity to affect bodily 
functions. 
Meditation, Prayer, Mental 
healing, Faith healing, Art, 
Music.  
Biologically Based 
Therapies 
Therapies use substances found in nature. Herbs, foods, vitamins, 
dietary supplements, herbal 
products.  
Manipulative and 
Body-Based 
Methods 
Therapies based on manipulation and/or 
movement of one or more parts of the body. 
Chiropractic, Osteopathy, 
Massage. 
Energy Therapies Therapies use energy fields and include 
biofield therapies, of the human body, and 
Bioelectric-based therapies, involve the use 
of electromagnetic fields. 
Qi Gong, Reiki, Reflexology, 
Therapeutic Touch, Magnetic 
fields, Alternating current, or 
direct current fields. 
(National Center for Complementary and Alternative Medicine, 2004) 
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Manipulative and body-based methods. 
 Manipulative and body-based methods employ a wide variety of treatments to promote 
relief of symptoms or for a general state of wellness. They may include a variety of 
techniques like massage or spinal manipulation. Conventional biomedical providers have 
expressed concern about the practices in this domain because some practitioners lack formal 
preparation for practice and hold varieties of licensures and certifications (Richardson, 2000). 
At times, both the provider of the therapy and the CAM therapy provided may be unregulated 
by state or local agencies. Researchers have visited health food stores and been advised by 
clerks about CAM use and treatment (Gotay & Dumitriu, 2000; Mills, Ernst, Singh, Ross, & 
Wilson, 2003). Some CAM providers such as osteopaths are required to attend rigorous 
educational programs and pass licensing exams, but other CAM providers may be permitted 
to practice without regulation (Graedon & Graedon, 1999).  
 The practice of chiropractic is one of the most common forms of CAM (Consumer 
Reports, 2000) and is a good example of the preparation of many CAM practitioners. 
Chiropractors complete many years of education. They are licensed by the state in which 
they practice and are certified by the National Board of Chiropractic Examiners (Jonas & 
Levin, 1999). Many studies of CAM use in breast cancer patients demonstrate high use of 
massage (Alferi et al., 2001; Ashikaga et al., 2002; Balneaves, Kristjanson, & Tataryn, 1999; 
Boon et al., 1999). The education of the practitioner must be taken into account in the 
evaluation of the outcome of CAM therapies. The results of studies that teach patients to 
employ CAM therapies for themselves (Molassiotis, Yung, Yam, Chan, & Mok, 2002) must 
also be judged differently than studies with interventions provided by educated, certified, and 
licensed practitioners (Harris et al., 2001). Many authors do not define the specifics of the 
19
therapy provided in trials or the qualifications of the providers of manipulative and body-
based methods. 
 Energy therapies. 
 Energy therapies are aimed at the energy fields in the patient’s body (i.e., traditional 
Chinese medicine’s manipulation of Chi by acupressure) or at an energy field acting on the 
patient (i.e., magnetic field application to the patient). In evaluations of energy therapies, 
researchers had particular difficulty applying the randomized experimental controlled trial to 
these therapies. Some CAM Researchers with manipulations of energy has abandoned 
traditional tenets of research, losing credibility with conventional biomedical providers. 
There are numerous examples (Jacobson, Workman, & Kronenberg, 1999) of quality 
research in CAM treatments with energy therapies. Detailed explanations of the physiology 
involved in acupuncture (an energy therapy) summarize research about the therapy and 
explain the way in which it activates small nerve fibers that override pain sensations and 
promotes endorphins for pain relief (Stux & Hammerschlag, 2001). Energy therapy has 
demonstrated efficacy when used for side effects associated with breast cancer treatment 
(Dibble et al., 2000). 
 Stephenson, Weinrich, and Tavakolil (2000) reported a clinical trial of reflexology, 
another energy therapy, using established research principles to provide useful information 
for practice. In this study, the authors used the energy theory as the basis for their study and 
demonstrated that reflexology could be used to reorganize and re-circulate energy through 
blocked pathways to blocked organs. This study provided information about the actions of 
reflexology and documented the potential for pain relief in cancer patients.  This is an 
example of a study of a CAM treatment demonstrating efficacy and fulfilling the standards of 
20
rigor for research by providing reliable information about these tools for relief of cancer pain 
and anxiety. Similarly, a report on the use of yoga with breast cancer survivors showed that 
the intervention group who used yoga after treatment had more improvement in psychosocial 
variables that the treatment control group (Culos-Reed, Carlson, Daroux, & Hately-Aldous, 
2005). 
Summary of Definitional Issues 
 In studies that use a list to measure CAM use, the list provided to the subjects may be 
limited in scope and fail to measure wider use of CAM by specific cultural groups. In studies 
of CAM use in which the NCCAM domains were used as a basis for definitions of CAM 
(Barnes et al., 2004; Bennett & Lengacher, 1999; Shumay et al., 2002) the domains may 
provide structure for instrument development and discussions of findings, but they do not 
succeed in comprehensively defining CAM. Using the holistic approach to defining CAM 
may help to collect information about CAM treatments used for overall health rather than 
those aimed at complementing conventional biomedicine for breast cancer. The definition of 
CAM remains controversial and clouded in the literature. Surveys of CAM fail to take into 
account the cultural basis for complementary therapy, draw samples that are narrow, and 
generalize about CAM use. The study of CAM requires different methods than studies of 
conventional biomedicine (Ai et al., 2001; Fugh-Berman, 1997; Kronenberg & Fugh-
Berman, 2002; Tagliaferri, Cohen, & Tripathy, 2001). The definition of a particular CAM 
must be quantified with descriptions of its use and prevalence, especially as it applies to 
breast cancer patients in active therapy as doses are defined in conventional trials. The 
consequences of interactions between CAM and conventional biotherapy and the potential 
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benefits of using CAM therapies are too important to neglect precision in the study of CAM 
treatments. 
 
Complementary Therapy Use in Patients With Breast Cancer 
 Women with breast cancer are one of the largest groups of CAM users. Survey data show 
that women are more likely than men to use CAM (Norred, 2002); that breast cancer patients 
are more likely than other cancer patients to use CAM (Kimby et al., 2003); and that using 
CAM prior to a cancer diagnosis predisposes breast cancer patients to continue CAM use 
(Henderson & Donatelle, 2004). After a woman develops breast cancer, she is more likely to 
use CAM if her cancer or her treatment is toxic or she becomes sicker than other breast 
cancer patients with treatment and disease (McPhail & Smith, 2000). However, studies have 
mainly limited their inquiries to affluent, educated European Americans and have ignored 
minority patients with breast cancer who also use CAM. The reports of CAM use rarely link 
symptoms and side effects to particular CAM treatments for which they are used. The 
literature describes what forms of CAM some patients use but fails to describe specifically 
when and why they use particular therapies.  
Gender Differences in CAM Use 
 Women are more likely than men to use CAM. Eisenberg’s (1998) survey of 2,055 adults 
showed that 42% of the respondents used CAM and that more women than men used CAM. 
The author found that study participants made more total provider visits to CAM providers 
than to primary care physicians and estimated that 15 million adults, or 18.4% of all 
prescription drug users, combined prescription drugs with herbal remedies and/or high-dose 
vitamins (Eisenberg, 1998). Barnes et al. (2004) used data from the National Health 
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Interview Survey (NHIS) of 2002 to report the prevalence of CAM use. Their supplemental 
questionnaire asked about a list of 27 types of CAM and found that 75% of the total sample 
studied was using CAM. Women reported higher use of CAM therapies than men in this 
study, with the mind-body domain the most commonly used. A study of Native Americans 
from the Milwaukee Indian Health Center explored use of traditional healers, which the 
authors defined as CAM (Marbella et al., 1998). Older women were more likely to seek help 
from healers than were younger male patients.  The 150 respondents were interviewed about 
types of healers they had seen and also the ceremonies and rites in which they had 
participated. The results of this study showed how the women in this ethnic group combined 
their strong system of traditional medicine with conventional biomedicine. In a study of data 
from the 1995 National Comparative Survey of Minority Health Care of the Commonwealth 
Fund, again, more women than men used CAM (Mackenzie et al., 2003). The authors used a 
telephone survey conducted in six languages to study 3,789 persons’ CAM use. These 
authors found that 43% of the respondents had used CAM in the past year. CAM use differed 
across ethnic groups, with different groups using different CAM combinations. A study from 
rural South Carolina (Oldendick et al., 2000) also found women more likely to use CAM 
than men (55% vs. 49%). In this telephone survey, the investigators defined CAM as 23 
therapies that were generally considered complementary or alternative. This study provided 
valuable information about CAM use in rural residents of the South. The authors found that a 
high percentage of participants used self-help groups to treat “other” health problems, which 
the authors reported represented participation in cancer survivor groups. Arcury et al. (2004) 
used data from the Mountain Accessibility Project (MAP) to study 1,059 adults in 
Appalachian North Carolina. The investigators reported that more women than men used 
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CAM. The most widely used forms of CAM reported by this sample were home remedies 
(46%), most often the “honey-lemon-vinegar-whiskey” treatment. The women in this sample 
had developed home remedies to deal with a variety of health problems, but the authors do 
not explain this alternative medicinal system further. It is not clear what prompted the 
patients to use this form of CAM versus consulting a biomedical provider (Arcury et al., 
2004). In each of the studies cited, the authors found that women were more frequent users of 
CAM than men. The reports fail to distinguish the types of CAM used by women as 
compared to men and fail to identify the conditions that cause women to seek CAM.  
 In summary, according to surveys of the public, CAM is used more often by women than 
men (Barnes et al., 2004; Eisenberg et al., 1993; Eisenberg, 1998), by patients visiting 
outpatient clinics (Boutin, Buchwald, Robinson, & Collier, 2000), in ethnically diverse 
samples (Mackenzie et al., 2003; Marbella et al., 1998), and in rural populations (Arcury et 
al., 2004; Oldendick et al., 2000). With this predisposition to use CAM, it follows that when 
women develop cancer they may incorporate CAM into a treatment regime. 
Frequency of CAM Use by Breast Cancer Patients 
 Cassileth et al. (1984) interviewed 660 cancer inpatients and found that breast cancer 
patients were most likely to combine unorthodox and conventional therapy than other groups. 
This study was important in that it showed heavy CAM use by cancer patients in general and 
by breast cancer patients in particular. Nearly half of the patients reported combining CAM 
with conventional therapy. The sample was composed of European Americans, affluent 
patients. A more recent telephone interview study of men and women with breast, colon, and 
prostate cancer (Patterson et al., 2002) not only found a higher incidence of CAM use (70%) 
in women than in men but also found that breast cancer patients used alternative therapy 
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significantly (p<0.01) more often than those with colon and prostate cancer. Subjects in 
general used CAM largely for general health and well-being (a holistic approach); for 
treatment of their cancer; and for other diseases. Another important finding in this study was 
that the more types of conventional therapies the patients had received for their cancer, the 
more likely they were to use CAM. The patients reported that CAM improved their feelings 
of well-being. Other reports mirrored these results (Navo, et al., 2004; Sollner et al., 2000). 
Of 1,168 Hawaiian patients responding to a mail survey, one in four had used at least one 
form of CAM since the time of their diagnosis (Maskarinec et al., 2000). The women with 
breast cancer were twice as likely to use CAM as the men or women with the other cancers 
(gastrointestinal or prostate cancer). When a sample of older cancer patients with breast, 
lung, colorectal, or prostate cancer was studied, investigators found that breast cancer 
patients were more likely to use CAM than patients with the other diagnoses (p<0.05) 
(Wyatt, Friedman, Given, Given, & Beckrow, 1999). 
 Studies of CAM use by cancer patients consistently describe heavy use of CAM by breast 
cancer patients as compared to patients with other types of cancer. However, these studies 
fail to apply a consistent definition of CAM, survey mostly European Americans patients, 
and neglect to describe the reasons breast cancer patients report for using CAM. Many 
unanswered questions remain about the common use of CAM by women with breast cancer. 
For example, are there side effects of treatment or physical effects of breast cancer that are 
more amenable to CAM treatments than those that occur in other types of cancer? This study 
examines these issues to provide a clearer basis for future intervention and education. 
CAM Use Prior to Breast Cancer Treatment 
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A strong predictor of CAM use for breast cancer patients is prior use of CAM. Adler and 
Fosket (1999) found that CAM use before diagnosis continued after the patients found out 
that they had cancer. In this study, the main reason patients reported for CAM use was to 
treat their breast cancer. The authors followed the patients over time with interviews and 
found that CAM use varied with time, but the prior CAM users continued to use 
complementary therapy throughout treatment and afterward. Boon et al. (1999) also found 
that breast cancer survivors were more likely to have decided to use CAM during treatment if 
they had used CAM before their diagnosis. In this study, during participation in focus groups, 
women described searching for treatments that would enhance their chances of survival. 
CAM was seen as a safe and harmless method and a way of being proactive for their health. 
Prior CAM use also provided a basis for women’s decision-making (Truant & Bottorff, 
1999). In the initial period of deciding about treatment and supplemental therapy, the women 
in this study relied on the CAM they had used prior to their diagnosis. After conventional 
treatment had begun, the women reassessed their CAM choices and added more CAM or 
reduced the CAM they were using. These women constantly reassessed their CAM use and 
continued to use CAM after conventional treatment was completed. Prior CAM use may 
serve as a proven coping skill that women continue to use during diagnosis and treatment of 
breast cancer. The women who experience benefits of CAM use may also see CAM as a way 
to deal with new stresses of breast cancer. The studies cited reflect the way some women’s 
prior CAM use carries over to the time that they receive a cancer diagnosis. However, the 
samples from which these conclusions are drawn are mainly limited to European Americans 
women. Little information is available about how minority women who have strong 
traditions of faith (Ford, 2001), prayer (VandeCreek et al., 1999), and the use of herbal 
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medicines (Frate et al., 1996) deal with these stressors after they are diagnosed with breast 
cancer and whether they use CAM after their diagnosis.  
 International studies of patients with breast cancer also show CAM use during all phases 
of treatment. In a British study of patients with all stages of breast cancer, Rees et al. (2000) 
found that 31% of breast cancer patients had used CAM. An Italian study of 242 women 
from the Tuscan Cancer Registry found high CAM use in newly diagnosed breast cancer 
patients (Crocetti et al., 1998). Canadian breast cancer survivors (Boon et al., 2000) also 
reported high (67%) CAM use. In an Austrian study of 117 early stage (stages 0-2) breast 
cancer patients (Moschen et al., 2001), 47% of the sample reported CAM use. A German 
study followed women for 3 years after diagnosis and found that 36% of the women 
continued CAM use (Nagel, Hoyer, & Katenkamp, 2004). This European sample was 
referred to CAM practices most often by their physicians. Participants in the international 
studies used CAM to boost the immune system, increase quality of life, prevent cancer 
recurrence, and minimize treatment-related side effects. 
Use of CAM by Breast Cancer Patients Throughout Process of Illness 
 Studies of CAM use throughout the breast cancer experience document that women are 
likely to incorporate CAM into their care at the time of diagnosis, during treatment, at the 
time of recurrence, and during advanced cancer (Canales & Geller, 2003; Ganz et al., 2002; 
Shen et al., 2002). Some studies (Boon et al., 1999) have noted the role that CAM plays in 
the woman’s ability to cope during treatment, but the cues that cause her to select a particular 
CAM strategy at a particular time in the trajectory of her illness are poorly understood. 
 Breast cancer patients themselves report CAM use at all stages of their illness. In Burstein 
et al. (1999), 66% of the women used CAM. Many had used CAM before their diagnosis 
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while others added CAM after their breast cancer surgery. More than half of the CAM users 
had Stage I breast cancer and had undergone a lumpectomy rather than a mastectomy. 
Lengacher et al. (2002) found that two thirds of the patients reported using some form of 
CAM after their diagnosis. These patients were being treated with chemotherapy and 
radiation and were heavy users of CAM (vitamins, 53%; art therapy, 64%; music therapy, 
73%; and prayer 98%). Prior chemotherapy and radiation therapy predicted CAM use 
(p<0.1). Women undergoing stem cell transplant, a very toxic treatment, for advanced breast 
cancer also reported high use (73%) of CAM (Shen et al., 2002). They used CAM to boost 
their immune system and treat their cancer.  
 Ganz et al. (2002) studied the quality of life for long-term breast cancer survivors 5 to 10 
years from treatment and asked about CAM use. The authors found that the survivors used 
multiple forms of CAM, such as vitamins and herbs. Another survivor study found a majority 
of breast cancer survivors were still using CAM 3 years after their treatment was complete 
(Henderson and Donatelle, 2004). The reasons the survivors described for continued CAM 
use included to remain free of cancer, to enhance quality of life, to feel more in control, to 
reduce stress, and to strengthen their immune system. Boon et al. (2000) found that 67% of 
the survivors in their sample used CAM after being treated with surgery, radiation, and 
chemotherapy. Again, the most common reason given for using CAM was to boost the 
immune system, but the women also reported using CAM to improve quality of life, prevent 
cancer recurrence, feel in control, treat side effects of treatment, stabilize their current 
condition, and compensate for failed medical treatments.  
 Long-term survivors (2 to 28 years from diagnosis) have reported using CAM for long-
term treatment side effects such as lymphedema, pain, and menopausal symptoms (Ashikaga 
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et al., 2002; Canales & Geller, 2003). Survivors report using a variety of CAM modalities 
and gave a variety of reasons for their use: acupuncture for pain, dietary changes for 
reduction in fats, massage for lymphedema, and herbs for menopausal symptoms. A report of 
a study funded by the American Cancer Society found that breast cancer survivors believed 
that CAM use would prevent cancer recurrence (Hann, Baker, Denniston, & Entrekin, 2005). 
Reasons for CAM Use During Breast Cancer 
 A review of the biomedical literature between 1975 and 2002 found the main reasons 
given for CAM use were to boost the immune system, to improve quality of life, to prevent 
recurrence of cancer, to provide control over life, and to treat breast cancer and the side 
effects of treatment (Nahleh & Tabbara, 2003). As demonstrated in studies of women at 
various stages of breast cancer, women with breast cancer report various reasons for 
incorporating CAM into their self-care. Some reasons focused on health maintenance, while 
others dealt with specific symptoms of treatment. Yet another group saw CAM as a way to 
cure their cancer. A study by Boon et al. (1999) found that CAM was used mainly for 
survival and to be proactive in an attempt to prevent further illness. Curing cancer in these 
women’s view involved boosting the immune system to fight cancer. In a multiethnic sample 
of breast cancer patients from California, Adler and Fosket (1999) found many of the same 
results. They reported that a sample of women representing 7 ethnic groups used CAM for 
control of their cancer and to strengthen their antibodies. The majority of these patients used 
CAM before treatment, during treatment, and after treatment was complete.  
 Toxicity from treatment has been found to be a predictor of CAM use in studies of breast 
cancer patients. In a study by Chou et al. (2000) of a multiethnic sample of patients either 
being treated or in follow-up for breast cancer, 58% reported CAM use to improve health, 
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prevent cancer recurrences, and to deal with the side effects of cancer and its treatment. 
Receiving chemotherapy was the strongest predictor of CAM use in this study. Other authors 
have found that toxicities associated with chemotherapy administration and both acute and 
chronic side effects of treatment are strongly implicated as factors in women using CAM 
(Boon et al., 2000; Burstein et al., 1999; Lengacher et al., 2002; Whittemore & Grey, 2002).  
 
Use of complementary therapy within the African American community. 
 Few investigators have consciously sought samples representing diverse ethnic groups of 
women with breast cancer. Most of the groups studied are European Americans and tend to 
be educated and affluent, limiting the generalizability of information from these reports to the 
broader population of women with breast cancer. Evidence for this lack of generalizability is 
provided in the few studies with diverse samples where there are striking differences in the 
amount and types of CAM used by ethnicity.  
 Fletcher (2000) described a rich tradition of the use of folk medicine within the African 
American community. African slaves brought this tradition to the United States, and the 
African American community used folk medicine both to preserve their culture and to deal 
with day-to-day health problems. Modern-day folk healers enable African Americans to 
preserve cultural traditions and to reduce the costs of health care (Struthers & Nichols, 2004). 
Family and community leaders within this system of care are sources of health information 
and are seen as healers within the African American community. In a study of 
complementary therapy practices of breast cancer patients in New York City, Cushman et al. 
(1999) found that African American breast cancer patients continued to use the folk medicine 
practices they had learned from their grandmothers in the rural South. A study from rural 
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Mississippi (Frate et al., 1996) documented a high incidence of folk medicine use. The 
majority of the patients surveyed were African American (78%). These authors defined folk 
medicine as plant-derived and found heavy use of lemon, aloe, castor, turpentine, tobacco, 
and garlic. This list of therapies is important as it defines therapies included in the 
classification of folk medicine. A study from rural North Carolina (Arcury, Bernard, Jordan, 
& Cook, 1996; Arcury et al., 2004) also found high use of folk medicine such as turpentine-
kerosene-gasoline. Their list of therapies was similar to those defined in Mississippi, but their 
sample was composed of mostly rural European Americans.  
 A qualitative study of African American women with advanced breast cancer (Mathews et 
al., 1994) showed that spirituality in the form of prayer and attendance of church services 
was prominent in African Americans and an important aspect of the African American 
healing tradition. These authors described the way the women used their spirituality to blend 
the biomedical model with their concept of God as healer and protector. The women in the 
studies described above used folk remedies and spirituality as forms of complementary 
medicine. In these instances, folk remedies can be classified as biological treatments and 
spirituality as a mind-body therapy using the NCCAM classifications (NIH, 2001).  
 Cuellar et al. (2003) asked rural elders (143 European Americans and 40 African 
American) from Mississippi about CAM use. The authors of the study defined CAM 
therapies as reiki, chelation, hypnosis, and naturopathic medicine, and also included prayer 
and folk medicine. Because the authors included forms of CAM used by both African 
Americans and European Americans it is not surprising that the investigators found no 
difference in CAM use between the European Americans and the African Americans. Inquiry 
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into CAM use must include culturally relevant types of CAM to adequately describe the 
CAM experience. 
 Bethel Ann Powers (1982) used a case study to illustrate the influence of folk medicine in 
the African American community. Her description of the two systems complementing each 
other shows how members of the African American community blend conventional 
biomedicine with folk medicine. The patient in the case study, VJ, consults a conventional 
healer and a traditional healer, a root doctor. A root doctor is a healer who has received a gift 
of healing, passed down from family members or in mystical ways such as a miraculous birth 
or a distinctive birthmark (Mathews, 1987). Conventional biomedical providers may also be 
seen as healers (Mathews et al., 1994). The cultural influences of religion, traditional healers, 
and home remedies are important aspects of health within the African American culture and 
must be included in any inquiry about CAM use in this segment of breast cancer patients. 
 In studies of CAM use where samples of breast cancer patients have significant minority 
representation, authors have found high rates of CAM use in each ethnic group. Mackenzie et 
al. (2003) found all minority groups, which included African Americans, Latinos, Asians, 
and Native Americans, using CAM. Each group used different combinations of CAM 
treatments, but all used CAM therapy of some kind. Lee et al. (2000) reported similar results 
from a study of breast cancer patients. About half of the women in that study used CAM, but 
the types of CAM varied with their ethnic group. African Americans in the sample were most 
likely to use mind-body therapy in the form of spiritual healing, while European Americans 
were more likely to use biologic therapies or dietary therapies. When African Americans in 
surveys of CAM use were asked about the things they did to improve their health, they 
reported religion, home remedies, and traditional healers to be important. These modalities 
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must be included in inquiries about CAM, and a mixed ethnic sample is vital to generalize to 
the wider population of breast cancer patients. 
Decision-making for CAM 
 Although several models have been proposed to describe the decision to use CAM during 
breast cancer, they are difficult to apply over the course of breast cancer, through treatment 
to advanced disease, and are based primarily on data from the dominant cultural group in this 
country. Figure 1 represents the current state of the literature about CAM use in breast 
cancer. This alternative model is dynamic and can be applied over the entire breast cancer 
experience with women of varying cultural groups. 
 The literature documents that women with breast cancer use CAM from the time of 
diagnosis through terminal care. This model proposes that women with breast cancer engage 
in a process of personal appraisal before diagnosis, through treatment, and after treatment. 
This appraisal is influenced by their health beliefs (including culturally based beliefs), 
physical and emotional cues about the meaning of cancer, and the information that the 
woman gathers from her external environment.  
 
33
Figure 1.  
Model for Decision-making in CAM Therapy. 
Health beliefs and physical and emotional cues influence each other. For example, the patient 
with significant toxicity from treatment may have less confidence in the conventional 
biomedical provider who prescribed her chemotherapy than in the folk healer who provided a 
CAM therapy that relieved her symptoms. Once a woman appraises her situation and settles 
on a plan, she may choose to use CAM exclusively, to use CAM in combination with 
biomedicine, or not to use CAM at all. Women who use CAM exclusively make up a very 
small group of women (Montbriand, 1998). In addition, personal appraisal may influence 
women with breast cancer to become more vigilant about cancer and their health. Vigilance 
motivates the woman to seek additional information about her breast cancer and CAM and 
also triggers her personal appraisal to reevaluate her plan and perhaps modify it. She 
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modifies her plan as beliefs, cues, and information change through appraisal. Personal 
appraisal may either increase or decrease her level of vigilance and, in turn, CAM use. The 
more physical cues—either positive or negative—she has and the stronger health beliefs she 
has about the usefulness of CAM, the more likely her personal appraisal will increase 
vigilance and the need for information gathering about CAM. Personal appraisal is the 
process by which women choose to include or exclude CAM from their care.  Each woman’s 
plan is fluid and individual and is modified as her appraisal dictates.  
Information Gathering—Sources of Information  
 From the time of diagnosis of breast cancer, most women seek information to understand 
cancer and its treatment. In their qualitative study of decision-making over the life cycle, 
Brown, Carroll, Boon, and Marmoreo (2002) found that information seeking was essential 
for decision-making about the use of complementary medicine in breast cancer. They 
concluded that an overriding theme in studies of women’s decision-making was the need to 
find reliable and accurate information in order to make sense of the decision before them. 
This is a part of decision-making about CAM for women with breast cancer. Information 
gathering may be the first step in the process of deciding to use CAM. For some women, the 
lack of credible information about CAM determined that they would not use it (Boon et al., 
2000). So, although the woman seeks information, the information that she finds or fails to 
find and her appraisal of the quality or reliability of that information may affect her decision-
making about CAM use (Chou et al., 2000; Cushman et al., 1999; Paltiel et al., 2001). 
 Health professionals. 
 Patients frequently consult health care providers for information about CAM (Canales & 
Geller, 2003; Moschen et al., 2001). Breast cancer patients sometimes rely on their providers 
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as sources of conventional treatment information and also information about CAM (Edgar, 
Remmer, Rosberger, & Fournier, 2000; Shen et al., 2002). However, some patients reported 
that their reluctance to use CAM was due to negative reactions from their providers (Boon et 
al., 1999; Chou et al., 2000) and that some providers actively discouraged CAM use 
(Burstein et al., 1999). Other breast cancer patients reported using CAM because their 
experience with biomedicine had been negative (Montbriand, 1998).  
 Family and friends. 
 Family and friends influence decision-making by breast cancer patients. In a study by 
Crocetti et al. (1998), pressure from relatives was reported to be one of the most powerful 
reasons the women gave for choosing CAM. The women valued family and friends as 
information sources (Boon et al., 1999), sounding boards (Moschen et al., 2001), and systems 
of support (Rees & Bath, 2001). In the African American community, older female relatives 
give information about CAM to breast cancer patients and pass on traditional medicine 
practices (Cushman et al., 1999). Women in breast cancer support groups are also an 
important information source for breast cancer survivors (Canales & Geller, 2003; 
VandeCreek et al., 1999). In one study, attendance at a support group positively influenced 
the likelihood that a woman would choose CAM (Alferi et al., 2001).  
 Media. 
 Another source of information that breast cancer patients report using in their decision-
making is the media. Women actively look for information in the library (VandeCreek et al., 
1999) or on the Internet (Crocetti et al., 1998). Many women undertake a program of reading 
(Canales & Geller, 2003) and personal study to draw conclusions about CAM from the 
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information they find. When they find insufficient information to support a choice of CAM, 
they are less likely to adopt its use (Shumay et al., 2002). 
Demographic variables. 
 Demographic characteristics also have been demonstrated to have a positive relationship 
with CAM use. Their place in the model is unclear, but they seem to be part of the context 
within which women process information. Demographic characteristics that appear to 
predispose breast cancer patients to use CAM include young age (Adler & Fosket, 1999), 
more education (Ashikaga et al., 2002), higher income (Burstein et al., 1999), Christian 
religion (Alferi et al., 2001), being married (Downer et al., 1994), and having insurance (Lee 
et al., 2000). However, without more studies that sample a more heterogeneous group of 
CAM users, the role of these demographic characteristics remains unclear. For example, 
reports of information gathering in different ethnic groups (European Americans, Japanese, 
and non-Japanese cancer patients) found that the three groups sought different types of 
information from different sources (Kakai et al., 2003). 
Personal Appraisal 
 Personal appraisal is the process each woman with breast cancer uses to sort through the 
information she gathers. Influenced by her health beliefs, emotional and physical cues, 
experiences with biomedicine, history, culture, support systems, treatment, and information 
she gathers from resources, she will formulate a personal plan. Each woman has a distinct set 
of factors that influences her personal appraisal, influences that vary in importance to the 
woman during diagnosis, treatment, and follow-up. In a model described by Crocetti et al. 
(1998), women decided about CAM based on personal experience. They utilized information 
from family, friends, and practitioners, but the most important influence was their own 
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experience. Other authors (Balneaves & Long, 1999; Bowman et al., 2003) describe a similar 
process. Lazarus and Folkman’s (1984) theory of stress and coping first described appraisal. 
According to these authors, stress occurs when a situation (stressors) in the relationship 
between person and environment is determined by the person to be a threat or a challenge. 
Using cognitive appraisal, a person evaluates the significance of cancer stressors in terms of 
personal well-being (primary appraisal) and available resources for coping (secondary 
appraisal). The appraisal process is modified by the unique characteristics of the person or 
the environment (Folkman & Moskowitz, 2000). Coping is any attempt to mediate the cancer 
stressors by changing the meaning of the threat or changing the environment. Reappraisal 
involves reevaluation or change in an earlier appraisal of a stressor based on new information 
or effective coping strategies (Dowling, Hockenberry, & Gregory, 2006). In a focus group 
study by Canales and Geller (2003), the participants responded to the life-threatening illness 
of cancer by using appraisal, blending biomedicine with CAM to take care of themselves. 
Their beliefs about cancer as a life-changing event framed their adoption or rejection of 
CAM. Boon et al. (1999) described a process like appraisal in their model as an evaluation of 
the pros and cons of using CAM and building a treatment protocol, a highly individualized 
process. They found that the patient assumed responsibility for choosing from multiple 
options available to them. The work from which this model is drawn is based on a sample of 
affluent, European Americans women. It does not reflect the strong influence within the 
African American community of cultural health beliefs related to the meaning of physical 
symptoms (Mathews et al., 1994) or African American women’s distrust of information 
given to them by conventional biomedical practitioners (Phillips, Cohen, & Tarzian, 2001).  
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Truant and Bottorff (1999) described the process of settling on a plan as hand-picking 
complementary therapies that fit and getting a personal regimen in place. The appraisal phase 
either may conclude with incorporation of CAM into the plan or may increase the woman’s 
vigilance to prompt her to collect more information and reassess her plan. Regardless, these 
processes need to be clarified in samples that are more heterogeneous.  
 
Factors Affecting Personal Appraisal - Health beliefs and control needs. 
 Health beliefs and control needs are very influential in women’s decisions to choose CAM 
for breast cancer. A Canadian study found that CAM users feared recurrence and death from 
their breast cancer more than non-CAM users (Rakovitch et al., 2005). One of the strongest 
factors in determining CAM use during breast cancer treatment has been identified as prior 
CAM use (Burstein et al., 1999; Crocetti et al., 1998; Rees et al., 2000). Women who believe 
that CAM can benefit them and have used it successfully before their cancer diagnosis will 
continue CAM after diagnosis and add more CAM therapies (Adler, 1999) during treatment.  
 Women who use CAM report using it for beliefs directly related to their cancer, including 
faith in CAM to enhance survival (Downer et al., 1994), to detoxify from treatment (Shen et 
al., 2002), to aid conventional therapy (Moschen et al., 2001), to prevent recurrence (Alferi et 
al., 2001), and to boost their immune system (Boon et al., 2000). Indirect effects are more 
related to health maintenance, including beliefs that they have nothing to lose and that CAM 
is harmless (Boon et al., 1999), reduces stress (Truant & Bottorff, 1999), improves health 
(Patterson et al., 2002), increases quality of life (Paltiel et al., 2001), and makes them 
stronger (Astin et al., 2000).  
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Culture has a strong influence on health beliefs. Several studies with European Americans 
and African American samples note that the two cultures differ in their health beliefs about 
cancer (Ashing-Giwa, 1999; Barroso, McMillan, Casey, Gibson, & Kaminski, 2000; 
Champion & Scott, 1997), including the belief that cancer is a death sentence; the role of 
luck in cancer incidence; or women’s perceived susceptibility to breast cancer. Within the 
small number of samples of African American patients who have been studied, there was a 
strong belief in the benefit of CAM, in the form of herbal remedies and spiritual healing 
(Fletcher, 2000; Lannin, Mathews, Mitchell, & Swanson, 2002).  
 Women who use CAM exhibit the need for ultimate control of their plan. They also take 
part in decisions concerning conventional biomedicine treatment (Hack, Degner, & Dyck, 
1994) and report additions of CAM to optimize their overall health (Beaver et al., 1996). 
Balneaves, Kristjanson, and Tataryn (1999) found that women who used CAM were more 
likely to prefer an active or collaborative role in decision-making about their care. Adopting 
CAM provided the women with a feeling of control in other reports of CAM use (Boon et al., 
2000; Montbriand, 1995b).  
 Factors Affecting Personal Appraisal - Physical and emotional cues 
 The use of CAM seems to be influenced by emotional and physical cues. Women with 
more emotional distress in the form of anxiety (Downer et al., 1994), depression (Burstein et 
al., 1999), fear of recurrence (Edgar et al., 2000), and somatic complaints (VandeCreek et al., 
1999) are more likely to use CAM. The question of motivation is unclear. Do women use 
CAM because of these emotions or are women with these emotions more likely to use CAM? 
Previous investigators administered questionnaires or scales to measure these variables, and 
so the sequencing of the cue and the CAM use is unclear. Physical distress is also linked to 
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CAM use. Women with cytotoxic chemotherapy (Boon et al., 2000; Ganz et al., 2002), 
extensive surgery (Shen et al., 2002), treatment side effects (Ashikaga et al., 2002), and more 
advanced disease (Burstein et al., 1999) were more likely to use CAM. Having had more 
therapy leads to increased symptom burden (Ferrell, Grant, Funk, Otis-Green, & Garcia, 
1997; Ganz et al., 2002). In studies of CAM use, women taking Tamoxifen were less likely 
to use CAM than women whose disease required cytotoxic intravenous chemotherapy 
(Balneaves, Kristjanson, & Tataryn, 1999; Chou et al., 2000). If the woman’s breast cancer 
required an axillary dissection (Ashikaga et al., 2002), an indication of a more extensive 
cancer, or if the pathology showed positive lymph nodes (Alferi et al., 2001), another 
indication of extensive disease, she was more likely to use CAM.  
 Cytotoxic chemotherapy and extensive surgery are more likely to produce treatment side 
effects, and the women who reported treatment side effects were also more likely to use 
CAM. The sequence of side effects/CAM use is also unclear. The literature reflects that 
women who use CAM have more nausea and vomiting (Lee et al., 2000; Shumay et al., 
2002), swelling (Canales & Geller, 2003), pain (Alferi et al., 2001), physical distress 
(Crocetti et al., 1998), and limited physical functioning (Ashikaga et al., 2002). Women with 
more advanced breast cancer were also more likely to use CAM regardless of race (Burstein 
et al., 1999; Mathews et al., 1994; Paltiel et al., 2001; Patterson et al., 2002). The literature is 
clear that the more distressing physical cues the woman receives, the more likely she is to use 
CAM. The input in the process of personal appraisal by health beliefs and physical and 
emotional cues may affect the information gathering and the value given to that information. 
Vigilance 
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Vigilance is the heightened state of awareness that women develop in response to the 
things they learn, the things they believe, and the emotions and feelings they experience after 
their diagnosis with breast cancer. Vigilance also leads women to seek out new information 
about breast cancer or CAM. When the patient has increased vigilance, physical and 
emotional cues become more meaningful than when vigilance is lower. In a model for 
decision-making by Balneaves and Long (1999), the authors combine the stress and coping 
theory of Lazarus and Folkman (1984) with the conflict-theory model of Janis and Mann 
(1977) to describe decision-making in breast cancer. They examine the complexity of 
decision-making during breast cancer and emphasize the importance of embedding the 
conflict of deciding about treatments for breast cancer within the life stress of the total breast 
cancer experience. High-quality decision-making is defined by vigilant information 
processing utilizing behavioral and cognitive processes. Vigilance may be heightened in 
women with breast cancer for many reasons, such as experiencing physical symptoms, 
learning new information about breast cancer or CAM, losing confidence in the health care 
provider, or hearing or reading about a new biomedical advance being made in breast cancer. 
The woman appraises change as it applies to her and her personal preferences, and then she 
may reformulate her personal plan.  Vigilance is the impetus to seek assistance for 
symptoms.  Lack of vigilance causes the woman to minimize symptoms. It is alluded to in 
the model built inductively by McWilliam et al. (2000) that describes the way providers and 
patients communicate. They found that when patients felt vulnerable or out of control, they 
sought information to deal with their feelings of vulnerability.  Negative interactions with 
biomedical providers caused the women to seek information elsewhere: from CAM 
providers, family, and friends. The women in their study described their information seeking 
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as meeting a need to regain control over their body. Control is also a part of the proposed 
exploratory model and is instrumental in personal appraisal, feeding into the amount of 
vigilance. The higher the patient’s vigilance, the more likely they are to modify their personal 
plan because they are more attentive to cues, beliefs, and information.  
Summary 
The components of the model for decision-making about CAM in patients with breast 
cancer interact in a recursive fashion. The model is not static, and the elements of the model 
redefine themselves as the woman with breast cancer progresses from diagnosis through 
treatment to follow-up. She may be diagnosed, be treated, and live for many years without 
breast cancer. The CAM that she uses at the time of her diagnosis will be modified as her life 
progresses. If the patient’s breast cancer returns, she may incorporate different types of CAM 
in response to her personal appraisal, her level of distress, and the information she finds 
useful to her plan. The sources of information the breast cancer patient with recurrent disease 
uses may be different from the ones the woman who experiences a remission of her disease 
uses. As the cancer experience becomes more remote, the woman’s vigilance may diminish 
depending on her perceived risk of recurrence, which may be modified by her past history. 
The more frequently cues occur, the more heightened her vigilance. Personal appraisal is at 
the heart of the model. Through appraisal, the plan for CAM use is developed and modified. 
To do this, the woman receives information from the outside in light of her health beliefs, 
cultural influences, and personal cues. Personal appraisal is the black box within which 
outside influences are processed. The results of the woman’s personal appraisal are a plan to 
incorporate CAM or not and continual vigilance. Vigilance is the heightened state of 
awareness that women develop in response to the things they learn, their life experiences, the 
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things they believe, and the emotions and feelings they experience after their diagnosis of 
breast cancer. One woman in the Canales and Geller (2003) study said, “I learned to become 
my best advocate … I really learned that you have to trust yourself” (p. 16). The interplay 
between the elements of this model defines an experience of decision-making during breast 
cancer that acknowledges the cultural diversity of the breast cancer experience. 
 
Chapter 3 
Study Methods 
 CAM use was studied in a sample of European Americans and African American women 
receiving treatment for breast cancer. The investigation synthesized individual interviews and 
quantitative data from selected questionnaires to provide a rich description of women 
experiencing treatment for breast cancer who decided to use CAM, and the process of their 
decision-making. Although CAM use has been described in some populations of women with 
breast cancer, this study expands the scope of descriptions of CAM use to include African 
American and rural women. 
Design 
 This is an exploratory descriptive study that used a cross-sectional design, recruiting and 
collecting data at one point in time from women currently receiving breast cancer treatment. 
The study was designed to combine qualitative and quantitative data to elicit a rich 
description of the decision to use CAM during treatment for breast cancer and the factors that 
influenced that decision.  
Methods 
 The study used three methodological approaches, individual interviews, a card sort and 
selected quantitative instruments. A qualitative approach, using individual interviews, 
generated descriptions of CAM decisions by European Americans and African American 
women to provide in-depth information about CAM decision-making and a private forum to 
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explore unique forms of CAM use accounting for patient’s issues with disclosure. 
Quantitative data were generated from instruments measuring the particular types of CAM 
used; for treatment toxicities; and influences important to group members in the selection of 
CAM, as well as demographic and treatment information. 
 Individual interviews were used in this study to clarify the elements of decision-making 
about CAM, as they are useful to explore motivations in depth (Kerlinger, 1986). By 
conducting individual interviews, meanings can be clarified in a private, flexible atmosphere. 
Disclosure is an issue in the study of CAM use in breast cancer (Adler & Fosket, 1999), so, 
in the privacy of an interview, it may be more comfortable for women to discuss. An 
interview can delve into the types and motivations for CAM use more easily than other forms 
of data collection (Boon et al., 2000; Montbriand, 1999). Interviews have been used 
successfully to investigate CAM use (Brown & Carney, 1996; Crellin & Philpott, 1989; 
Shumay, Maskarinec, Kakai, & Gotay, 2001), CAM decision-making (Shen et al., 2002; 
Tasaki, Maskarinec, Shumay, Tatsumura, & Kakai, 2002), and with African American 
samples (Baldwin, 1996; Henderson & Donatelle, 2003). Therefore, the individual interviews 
provided a depth and richness to the information about CAM use and the forces that 
influenced women to adopt CAM. 
 
The Sample 
 The sample for the study was a convenience sample of European Americans and African 
American women who were currently receiving treatment for breast cancer. Other inclusion 
criteria were: 
• Aged 18 and above 
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• Stage II-IV breast cancer 
• Patients with breast cancer currently receiving or had received in the past 
chemotherapy, hormonal therapy, or radiation therapy 
• Able to speak and read English 
 Women were recruited from the population of breast cancer patients who had used CAM 
in the past or who expressed an interest in using CAM. Although less common, breast cancer 
may occur in young women. Several studies report that young age is a positive factor in 
CAM use (Ashikaga et al., 2002; Boon et al., 2000; Gray et al., 2003); however, older 
women have also been found to also use CAM (Astin et al., 2000; Navo et al., 2004; Wyatt et 
al., 1999). Therefore, women of any age above 18 years were included in the sample.  
 Women who have used CAM prior to their breast cancer diagnosis are more likely to 
continue CAM during treatment (Rees et al., 2000) and were a rich resource for study of 
CAM decision-making. Cancer treatments often have treatment-related side effects 
generating physical and emotional cues. These cues have been shown to increase the 
likelihood that women may choose to combine CAM with biomedicine (Adler & Fosket, 
1999; Alferi et al., 2001). African American women are more likely to present with a more 
advanced stage of breast cancer (Burri, Landry, Norton, & Davis, 2004; Du & Simon, 2005; 
Henson, Chu, & Levine, 2003; Li, Burton, & Glass, 2001; Mancino et al., 2001). In order to 
ensure that there would be an equal number of European American and African Americans in 
the study, breast cancer patients at all stages of disease were included. Women who 
expressed an interest in or were currently using CAM were included in the study.  
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The Setting 
 The study took place in three different locations around North Carolina in both urban and 
rural settings. The interviews took place in locations convenient to participants, including an 
oncology clinic, a wig and prosthesis shop, a public library, a school of nursing, and private 
homes.  
 Wake County participants were recruited from the Wake County area, as the principal 
investigator (PI) has extensive community contacts in this setting due to clinical practice in 
oncology nursing and experience with cancer patients as an American Cancer Society 
volunteer. African American subjects were recruited primarily from the clinic population of a 
community hospital serving a large African American and rural population and from an 
African American support group organized by a former patient of the PI. European 
Americans participants were recruited from wig and mastectomy supply businesses in the 
Wake County area.  
Procedures 
 
Pilot Study 
 After Institutional Review Board (IRB) review and approval, an expert panel was 
convened to review study materials for appropriateness of language of the quantitative 
instruments, the interview questions, and the feasibility of procedures for the individual 
interviews. As African American women had not often been included in recent research 
about CAM use in breast cancer treatment, the study materials were evaluated for content 
validity and relevance for this sample of women. The expert panel was made up of a CAM 
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provider; African American community members; a nurse researcher familiar with CAM use 
in breast cancer treatment; an oncology nurse; community contacts in Wake County; an 
African American faculty member from a historically Black university to provide input for 
recruitment and cultural issues; and an oncologist specializing in breast cancer treatment. The 
group was asked to review the procedures of the study for ease of participation by patients in 
active treatment; to assess the relevance, order, and wording of the interview questions; to 
comment on the language used in the quantitative measures; and to review the list of CAM 
treatments for completeness and redundancy. The panel was also asked to add additional 
items they had encountered in their experience to the working list of CAM therapies. 
Following review and input from the expert panel, procedures and questions were revised. 
Recruitment 
 Community contacts and key informants were enlisted to assist in identifying potential 
subjects for recruitment. Community contacts included oncologists, oncology nurses, breast 
cancer support group leaders, CAM therapy providers, and key informants in the African 
American community. They introduced the study to potential participants and provided a list 
of names and numbers for the PI to follow-up with by phone. The PI also visited clinics and 
shops to recruit participants and placed posters and fliers with the permission of the 
community contacts. Community contacts had proven to be important sources for patient 
recruitment in prior studies of CAM in breast cancer treatment (Gibson, 2000; Henderson & 
Donatelle, 2004; Navo et al., 2004;). Special attention was given to recruitment of African 
American subjects, as they are often resistant to participation in studies (Fields, 2001; 
Matthews, Sellergren, Manfredi, & Williams, 2002). Fliers and posters (Appendix A) were 
placed in oncology clinics, on African American radio station bulletin boards, and in 
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businesses selling CAM treatments, such as health food stores and wig and prostheses shops. 
If patients who saw these advertisements were interested in the study, they were asked to call 
the investigator on a toll-free number for more information. This number was linked to a 
mobile phone, which was carried by the PI and equipped with a voice messaging system. 
Snowballing and nominating recruitment were also utilized to increase study participation. In 
snowballing, subjects with breast cancer were asked to pass along information about the 
study to other patients with breast cancer whom they believed would like to participate. 
Nomination involved community contacts suggesting potential subjects for follow-up by the 
PI (Kruger & Casey, 2000). The PI recruited by telephone women who agreed to be 
contacted about the study. 
 When a woman agreed to participate in the study, she was sent an overview of the study 
and directions about the time and place of the interview. Each woman received a follow-up 
call on the day of the interview as a reminder of the meeting. At the beginning of each 
interview, the PI reviewed the consent form, answered questions about the study from the 
participant, and had her sign the consent form (Appendix B). Participants signed consent for 
the interview and also, if they agreed, signed consent for a follow-up interview. Each 
participant received a copy of the consent for her records. Interviews were arranged over the 
phone by the PI, at a time and location convenient to the participant.  
 The individual interviews lasted about 1½ hours each. Cash payment ($20 each) was 
provided to the participants as an incentive for participation. The PI conducted all interviews. 
The interviews were audio-taped with the permission of the participants and transcribed 
verbatim for analysis.  
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Individual Interview Procedure and Card Sort 
 After questions were concluded and the subject’s consent form was signed, the participant 
received a set of CAM cards and five blank cards (see Appendix C for CAM card list). The 
set of 81 cards listed 1 CAM therapy per card. The women sorted the cards using a card sort 
format to begin their discussion of their CAM use. For a card sort, between 30 and 100 cards 
have been found to be useful, as fewer numbers of cards do not allow for grouping of cards 
and more cards can be tiring and time consuming (Maurer & Warfel, 2004). The participants 
were asked to go through the card set and sort them into five categories: the forms of CAM 
they were currently using; the forms of CAM they had ever used but were not using at the 
time of the interview; those that they had considered but never used; those they had never 
used and were not considering; and those they had never heard of. Later in the session, the 
women were asked to separate the cards of the CAM therapies they were currently using into 
those they used for general health and those they used specifically for the breast cancer and 
its treatment. The blank cards were available for the participants to add CAM treatments not 
included in the card stack. This form of inquiry, a card sort, has been used successfully in 
past studies with breast cancer patients (Hack, Degner, & Dyck, 1994), and the results of the 
card sort have been analyzed using the theory of preferential choice. Bilodeau and Degner 
(1996) used preferential choice to examine treatment decision-making by breast cancer 
patients. Using the card sort was intended to both mirror a part of the patient’s decision to use 
CAM and to stimulate discussion about how decisions about CAM are made (Bilodeau & 
Degner, 1996). A paper and pencil tally reflecting the distribution of the CAM cards selected 
by each patient was totaled and recorded on the CAM Tally Sheet (Appendix D). Using the 
51
Interview Guide (Appendix E), patients were asked about how they had decided about the 
CAM therapies they were using and the factors that influenced them in their decision-
making. The questions in the guide explored the words they used to describe the 
complementary therapies they used to deal with their breast cancer and its treatment; their 
personal experiences with CAM; and the barriers and facilitators to their CAM use. With 
each modality the influences to use or not to use CAM (Boon et al., 1999) were explored, and 
the women described the ways they had come to use CAM. As more interviews took place, 
the Interview Guide was modified to clarify the themes identified in previous interviews.  
 At the end of each interview, the PI wrapped up the discussion by asking for the women to 
add thoughts and feelings about their experiences and decisions not covered by the interview 
guide. The women then completed the packet of quantitative instruments. The amount of 
time allotted for this was approximately 20 minutes. This packet included the Breast Cancer 
Chemotherapy Toxicity Questionnaire (Levine et al., 1988), the Sources of Information in 
Cancer (Mishel, Germino, Belyea, & Stewart, 2003), and the Demographic and Cancer 
Treatment Form (Lengacher et al., 2003). The PI was available to assist the women in 
completing the forms if there were questions or if the participants had difficulty reading 
them. On several occasions the PI read the forms to participants due to reading levels of the 
participants or physical difficulties in holding the paper and pen to complete the forms 
related to treatment toxicities. After completion of the forms, the cash payment was 
distributed. The women were offered the opportunity to receive summaries of the study 
results at the end of the investigation.  
 Each interview was audio-taped and transcribed verbatim for analysis. In addition, the PI 
made notes as necessary during the sessions or immediately following the interview. After 
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the interviews were transcribed, the PI and the dissertation chair reviewed the transcripts. 
Analysis began after the first interview was complete and transcribed (Strauss & Corbin, 
1990).  
Variables and Instruments 
 The elements of the women’s decision-making process—the patients’ level of vigilance, 
their personal plan, their personal appraisal, their information gathering, plus their health 
beliefs and personal cues—were assessed by individual interviews and with quantitative 
instruments. 
Quantitative Instruments 
 Quantitative measures attempt to assign objects to categories that represent the amount of 
a characteristic an object has (Waltz, Strickland, & Lenz, 1991). The influences on CAM 
decision-making have been measured using reliable quantitative measures. These influences 
included level of toxicity and information sources. Adding these measures to the descriptive 
data about the women who were interviewed helped to locate them in the population of 
breast cancer patients. How sick were these women? Whom did they consult about health 
care decisions? By providing validated measures of toxicity and sources of information about 
the women, this study was designed to add to information available about rural and African 
American women’s breast cancer experiences. 
Personal Cues  
 Personal cues are emotional and/or physical signals to women that they are having a 
problem that may be aided by adding CAM to their personal plan. Cues include somatic 
symptoms (VandeCreek et al., 1999) and/or emotional distress in the form of anxiety 
(Downer et al., 1994), depression (Burstein et al., 1999), or fear of recurrence (Edgar et al., 
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2000). They were operationalized as responses to the modified Breast Cancer Chemotherapy 
Questionnaire (BCQ) (Appendix F), a 30-item questionnaire with a 7-point Likert response 
scale (Levine et al., 1988). The BCQ focuses on physical and emotional cues and quality of 
life during treatment for breast cancer. Questions addressed physical, functional, sexual, and 
social aspects of quality of life. When the original BCQ was compared with other measures 
of the quality of life (correlation coefficients with Rand Emotional [0.58], Rand Physical 
[0.60], and Spitzer QL [0.62]), it proved a valid and responsive measure of treatment-related 
morbidity over time in patients receiving adjuvant chemotherapy for stage II breast cancer 
(Levine et al., 1988) measured at different times in the patients’ treatment cycles. The final 
score for the BCQ is expressed as the sum of the 30 questions, each on a 1-7 scale. Many 
studies of women who use CAM during breast cancer treatment report that emotional and 
physical distress increases the likelihood that they will use CAM (Ashing-Giwa, Ganz, & 
Peterson, 1999; Boon et al., 2000; Burstein et al., 1999; Crocetti et al., 1998; Gotay et al., 
1999). The BCQ has documented validity when used with other cancer samples in Eastern 
Cooperative Oncology Group and National Cancer Institute clinical trials (Gunnars, Nygren, 
& Glimelius, 2001). This instrument specifically includes items about hair loss, which is an 
important issue for African American women (Wilmoth & Sanders, 2001). The original BCQ 
was designed to be administered by an interviewer but was used in this study as a 
questionnaire with three possible responses: “All of the time (3),” “Some of the time (2),” 
and “None of the time (1).” As in the original instrument, the final score for the modified 
BCQ was expressed as the sum of the subject’s answers. Additional items were added to the 
BCQ by the investigator to reflect the current understanding of toxicity experienced by 
patients receiving treatment for breast cancer, cues that patients report lead them to use CAM 
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treatments (Ferrell et al., 1997), and neutropenia, a toxicity with a high incidence in African 
American cancer patients (Hershman et al., 2003). The resulting questionnaire had 35 items, 
including questions about fatigue, alopecia, feeling good about self, numbness in fingers, 
menopausal symptoms, depression, nausea, change in body image, positive feelings about the 
future, insomnia, worry, vaginal dryness, family support, alterations in smell, tearfulness, 
increased production of gas, low blood counts, optimism, constipation, feeling in control, 
mouth sores, and watery eyes. The revised BCQ was evaluated by the expert panel for 
content validity before the study began. Changes in format and minor content changes were 
made. The final questionnaire included 33 items in a modified Likert format with three 
possible responses: “All of the time (3),” “Some of the time (2),” and “None of the time (1).” 
An analysis of internal consistency was assessed when all data collection was complete by 
calculation of coefficient Cronbach’s alpha for the entire sample. The resulting Cronbach’s 
alpha was 0.827 for the 33-item Breast Cancer Treatment Toxicity Questionnaire (name for 
the modified BCQ). 
Sources of Information  
 Information sources are defined as individuals, institutions, and media that provide 
information for women in their process of deciding about using CAM during their treatment 
(Rees & Bath, 2001; Wallberg et al., 2000). They were assessed using the Sources of 
Information Checklist (Appendix G). This is an investigator-generated 22-item checklist of 
sources of information to be used by patients with breast cancer and includes sources like 
your surgeon, friends, television/radio, and herbalists. The checklist was modeled after a 
similar published checklist administered to a sample of African American and European 
Americans prostate cancer patients (Mishel et al., 2003) and was modified for use with breast 
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cancer patients by adding breast cancer appropriate items (Degner et al., 1997; Kakai et al., 
2003; Satterlund, McCaul, & Sandgren, 2003). This checklist was evaluated by the expert 
panel for content validity prior to use in the interviews, and modifications were incorporated 
to reflect their input. The Sources of Information Questionnaire was scored by totaling the 
number of checked items with higher scores reflecting use of more information sources. An 
analysis of internal consistency was assessed when all data collection was complete by 
calculation of coefficient alpha for the entire sample. The resulting Cronbach’s alpha was 
0.8964 for the 30-item Sources of Information Questionnaire  
Complementary and Alternative Therapy (CAM) 
 As the construct of complementary therapy is not consistently or clearly defined in the 
literature, individual interviews were used to explore its meaning for the women in the study. 
The motivation to use a therapy not prescribed by conventional biomedicine is central to the 
construct of CAM. A group of CAM therapies listed on 3 x 5 index cards was the basis for 
the working list of CAM treatments. The list was generated from studies of breast cancer 
patients (Lengacher et al., 2003), studies of CAM used by the public (Eisenberg et al., 2001), 
studies of ethnic samples (Cushman et al., 1999; Lee et al., 2000; Marbella et al., 1998), plus 
therapies used in traditional and folk medicines within the African American and rural 
communities (Bushy, 1992; Cuellar et al., 2003; Eisenberg, 1998; Fletcher, 2000; Lee et al., 
2000; Lengacher et al., 2003; Marbella et al., 1998). The compiled list was also reviewed by 
the expert panel, which made additions to the list to reflect current thought and practice in the 
clinical arena.  
 The Complementary Therapy Rating Scale (CTRS) by Lengacher et al. (2003) was used as 
the basis for the initial list. The CTRS was designed to be administered in an interview 
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setting, so it was modified to a card sort for ease of use by the interview participants. The 
CTRS list was based on the National Center for Complementary and Alternative Therapy 
domains of CAM treatment (Lengacher et al., 2002) and developed with input from patients, 
oncology nurses, oncologists, and administrators of oncology clinics.  
 The CTRS contains a demographic section that was separated out in this study and used to 
collect data from each participant on their age, race, education, stage of breast cancer, and 
current treatment. This form, Use of Complementary Therapy Survey for Breast Cancer—
Demographic and Cancer Treatment Form (Appendix H), was distributed to subjects at the 
end of the interview with the other quantitative instruments. The participants were given 
instructions, time, and any assistance needed to complete the forms. The original CTRS has 
been used with breast cancer patients and in rural populations and was found to be reliable 
with an alpha for the whole scale of 0.86 and for the instrument subscales, ranging from 0.67 
to 0.8 (Lengacher, Bennett, Kip, Berarducci, & Cox, 2003).  
Elements of Decision-Making 
 Decision-making was defined here as the process patients use to make decisions about 
using or not using CAM during treatment for breast cancer. The literature reflects partial 
definitions of the process of decision-making (Balneaves & Long, 1999; Canales & Geller, 
2003; Hack et al., 1994; Meyer, Russo, & Talbot, 1995; Hack et al., 1994; Meyer, Russo, & 
Talbot, 1995), and the interview questions were designed to produce data that was used to 
clarify the details of that process. Questions were based on the preliminary model for CAM 
decision-making, which was generated from the current literature. As the interviews 
progressed, the questions and probes were modified to better elucidate the decision-making 
process. A description of the process evolved as the women described their experiences and 
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decisions. Because of the limited amount of information about CAM decision-making during 
treatment, the interview questions were open-ended to provide more flexibility for 
information sharing (Morgan & Scannell, 1998).  
 
Analysis 
 Data entry and cleaning was continuous from the beginning of the study through final 
entry of all the data. Data sets were assessed using descriptive statistics, scatterplots, and 
histograms to detect coding errors using the Statistical Package for the Social Sciences 
(SPSS) (Belbase & Mason, 2004; Tabachnick & Fidell, 2001). The quantitative measures, the 
revised Breast Cancer Chemotherapy Toxicity Questionnaire and the revised Sources of 
Information Questionnaire, were psychometrically evaluated using Cronbach’s alpha as an 
index of internal consistency of the revised instruments (Waltz et al., 1991). The types of 
CAM used were assessed using the data gathered from the CAM Tally Sheets. Frequencies 
and descriptive statistics were calculated for by residence of the subjects, by racial groups, 
and for the total group. The individual interview transcripts and the quantitative data were 
analyzed separately and then synthesized to maximize the richness of the description. 
Aim 1: To characterize CAM use during treatment for breast cancer in a sample of 
African American and European Americans women from both urban and rural settings in the 
South. 
 Descriptive statistics were computed to describe the CAM treatments used by 
respondents, utilizing the results of the card sort procedures. These analyses were done by 
ethnicity, by urban/rural residence, and for the entire sample. Interview data furnished 
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information about when CAM was used and what physical, psychosocial, and emotional 
factors characterized CAM use.  
Aim 2: To clarify the use of CAM for treatment of breast cancer–related issues as 
compared to CAM use for self-care and healthy lifestyles. 
 The interview questions included requests for the women to explain the reasons for 
their CAM use, specifically in relation to treatment of breast cancer–related problems and 
self-care and healthy lifestyles. The themes from this discussion were coded and compared 
among the women, the ethnic groups, and the areas of residence. The card sort identified 
CAM therapies considered by the women related to their breast cancer and those they used 
for healthy lifestyles. Descriptive statistics were calculated on these differences. 
 Aim 3: To examine precipitating and influential factors in the choices of European 
Americans and African American women to use CAM during treatment for breast cancer. 
 Quantitative data about sources of information and treatment toxicities were 
combined with themes identified from individual interviews to validate that the elements of 
the decision-making model were indeed relevant to the women’s choices in the types of 
CAM selected and the extent or intensity of these factors associated with the decision to use 
CAM. The two ethnic groups were compared on personal cues.  
 Aim 4: To describe the process and timing of decision-making that women use in 
choosing CAM during breast cancer treatment. 
 The interview transcripts were analyzed to describe the timing of CAM decision-
making in relation to the breast cancer diagnosis and treatment as well as other factors such 
as specific toxicities of treatment. The women's accounts were examined for examples of 
CAM selection and rejection and the logic the women used to come to these decisions. These 
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data were compared to the elements of the preliminary model to determine the validity of the 
model elements and associations, and the model was revised to reflect and describe new, 
more relevant concepts and associations.  
 
Human Subjects Protection 
 Women participating in the interviews were in the midst of treatment with the possibility 
of experiencing treatment side effects such as nausea, fatigue, or low blood counts. At the 
time of recruitment, they were cautioned to cancel their interview if their provider had 
warned them to avoid crowds or infected individuals. There were no cancellations due to 
toxicities. Quantitative instruments were coded with subject numbers to identify the subjects. 
All study materials were stored in a secure location, and no subject was identified in any 
presentation of study findings.  
 
Chapter 4 
Results  
Description of the Sample 
 Since there are few studies of CAM use that include African American and rural women, 
the subjects for this study were a convenience sample of 19 European Americans and African 
American women who had received or were currently receiving treatment for breast cancer. 
The women in the sample self-identified as European American (10) or African American (9) 
women. They were interviewed from December 2005 until May 2006. All of the women 
indicated that they used CAM at the time of recruitment. Tables 2, 3 and 4 display 
descriptive statistics, socioeconomic factors, and disease characteristics for the sample. 
Although this sample is small, it is important to note that it is unique in several ways. The 
sample is equally balanced between European American and African American women, and 
the setting for this study is a geographic area including both rural and urban locations. The 
examination of CAM use by demographic characteristics, cited as important in prior 
literature, begins to elaborate a fuller understanding of CAM during breast cancer. 
Demographic Characteristics 
Much of the literature about CAM use reports that younger women are more likely to use 
CAM (Adler & Fosket, 1999; Buettner et al., 2006; Gerber, Scholz, Reimer, Briese, & Janni, 
2006; Hann et al., 2005). The women in this study ranged in age from 35 to 67 with a mean 
age of 51.16 (SD = 10.12). The African American women in the sample (M = 51.78, SD =
9.65) were slightly older than the European American women (M = 50.6, SD = 11.02), but 
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the difference was not statistically significant (t [17] = .247, p = 0.808). More of the sample 
reported that they lived in an urban setting than a rural setting (68% vs. 32%).   Table 2 
summarizes descriptive statistics for the study sample. 
Table 2 
Descriptive Statistics for the Sample 
Characteristic European Americans 
 (N = 10)
African Americans (N = 9) Total 
 (N = 19)
Age    
Mean (SD) 50.6 (11.2) 51.78 (9.65) 51.16 (10.12)
Median 49 51 51 
 Range 35-67 38-67 35-67 
Residence N (%)
Urban 8 (57.1)  5 (55.56)  13 (68.4)  
 Rural 2 (33.3)  4 (44.44)  6 (31.6)  
Work 
 Inability to work during treatment may be an indication of treatment-related toxicity 
during breast cancer and certainly affects the amount of disposable income available to 
purchase CAM. Eleven of the 19 women in the sample were not working at the time of the 
study. Of this group, 3 were unemployed, 3 were retired, and 5 were disabled.  Most of the 
women who were not working were in the midst of chemotherapy treatments that occurred 
either weekly or every three weeks. Several of the women reported that they had jobs that 
required them to be physically active and were unable to do those jobs since they started 
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treatment. Most of the women who were employed were European American (7), even 
though the European American women in the study reported more treatment-related toxicity 
(mean toxicity score: European Americans 83.30 vs. African Americans 74.78). Perhaps as a 
result of not working, half of the sample reported family incomes below $25,000/year, and 
only two of the women reported incomes over $75,000/year. The African American women 
in the sample had lower annual incomes than the European American women with 7 of the 9 
African Americans reporting incomes below $25,000/year. Most of the literature about CAM 
use during breast cancer is with samples of affluent women so, while small, the diversity of 
incomes for the women in this sample adds to our information about CAM use.  
 Education 
 CAM users are often identified as a more educated group than non-users (Nagel et al., 
2004). Education levels for this sample of women ranged from less than high school to one 
participant with an advanced college degree. The average number of years of education was 
13.84 (range 8-18 years, SD = 2.85). The women differed in education by race with the mean 
number of years of education for the European American women of 15.3 (SD = 1.77) years 
and the mean for the African American women of 12.22 (SD = 3.03) years.  
Religious affiliation 
 Faith and the role of spirituality are often associated with CAM use, and prayer is noted in 
many studies as an important CAM treatment (Ashing-Giwa & Ganz, 1997; Henderson, 
Fogel, & Edwards, 2003; Morgan et al., 2005). Although spirituality and faith were not 
measured directly, most of the women in this sample were members of Protestant or Roman 
Catholic Christian churches. Further information about the role of faith and spirituality will 
be discussed from the qualitative data. 
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Table 3 
Social/Economic Characteristics for the Sample 
Social/economic 
characteristic 
European 
Americans 
 N (%) 
African Americans 
N (%)  
Total 
N (%) 
Employment 
Full time 3 (30)  0 (0)  3 (16)  
 Part time  4 (40)  1 (11)  5 (26)  
 Unemployed 2 (20)  1 (11)  3 (16)  
 Retired 1 (10)  2 (22)  3 (16)  
 Disabled 0 (0)  5 (56)  5 (26)  
Education 
Less than high school 0 (0)  3 (33)  3 (16)  
 High school diploma 1 (10)  1 (11)  3 (11)  
Some college 3 (30)  4 (44)  7 (37)  
Four-year college degree 4 (40)  0 (0)  4 (21)  
College past four-year 
degree 
1 (10)  1 (11)  2 (11)  
Advanced college degree 1 (10)  0 (0)  1 (5)  
Income 
Under $25,000 3 (30)  7 (78)  10 (53)  
 $25,000-$75,000 4 (40)  1 (11)  5 (26)  
 Over $75,000 2 (20)  0 (0) 2 (11)  
 Missing data 1 (10)  1 (11)  2 (11)  
Religion    
 Protestant  7 (70)  7 (78)  14 (73)  
 Catholic 3 (30)  0 (0) 3 (16)  
 None 0 (0) 2 (22)  2 (11)  
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Time Since Cancer Diagnosis 
 The length of time since the women’s breast cancer diagnosis ranged from 2 months to 
132 months (M = 32.94, SD = 34.23). One woman who had been diagnosed 132 months ago 
was clearly an outlier. When descriptive statistics were recalculated with her data removed, 
the mean time since diagnosis was 27.44 months (SD = 25.13), and the range was 2-84 
months. Ten of the women had been diagnosed in the past year, and 8 had been diagnosed 
from 2 to 7 years. The European American women in the sample were more likely to be in 
their first year of treatment (n = 7 of 10), while the African American women were more 
likely to be more than 2 years from diagnosis (n = 5 of 9).  
Prior Treatment 
 The women had received a variety of surgical treatments ranging from biopsy to 
mastectomy. The most common surgical intervention was mastectomy, with 9 women having 
undergone this surgery and 2 of those completing reconstructive surgery at the time of the 
interviews. Seven women had lumpectomy and 3 of the women had only had a biopsy. 
Postponing surgical resection reflects the current practice of neo-adjuvant treatment. When 
women present with aggressive breast cancer, they often receive chemotherapy prior to 
surgical intervention, and therefore these 3 women faced surgical intervention in the future. 
Fourteen of the women in the sample had received or were receiving chemotherapy. Half of 
the sample had received radiation therapy.  
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Table 4 
Disease Characteristics for the Sample 
Characteristic European Americans 
 n =10 
N (%) 
African 
Americans n = 9
N (%) 
Total 
 n = 19
N (%) 
Time since diagnosis       
2-12 months 7 (70) 3 (33) 10 (53) 
 24-84 months 3 (30) 5 (55) 8 (42) 
 132 months 0 (0) 1 (11) 1 (5) 
Surgery type       
 Mastectomy 3 (30) 4 (44) 7 (37) 
 Lumpectomy 6 (60) 1 (11) 7 (37) 
 Biopsy 1 (10) 2 (22) 3 (16) 
 Reconstruction 0 (0) 2 (22) 2 (11) 
Past treatment       
 Chemotherapy 7 (70) 7 (77) 14 (74) 
 Radiation therapy 6 (60) 4 (44) 10 (50) 
 Hormonal therapy 4 (40) 3 (33) 6 (32) 
Current treatment       
 Chemotherapy 4 (44.4) 5 (55.6) 9 (47.4) 
 Radiation 0 (0) 0 (0) 0 (0) 
 Hormonal therapy 5 (62.55) 3 (37.5) 8 (42.1) 
 None 1 (50) 1 (50) 2 (10.5) 
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Current Treatment 
 At the time of the interview, all patients in the sample were receiving or had completed 
conventional treatment for breast cancer. Nine were receiving chemotherapy, and 8 were 
receiving hormonal therapies, and 2 had completed therapy. The women who were currently 
receiving chemotherapy had the lowest toxicity scores (M = 73.67, SD 9.54), while the 
women who had completed therapy had the highest toxicity scores (M = 88.50, SD 2.12). The 
patients who were receiving chemotherapy at the time of the interview were more likely to 
have been diagnosed less than a year and to be European American, while the patients 
receiving hormonal therapy were likely to be diagnosed between 2 and 7 years and to be 
African American. This also reflects the current practice of following cytotoxic 
chemotherapy with estrogen suppression for 5 years (National Cancer Institute, 2005). One 
of the participants had a prior cancer, a colon cancer for which she had been treated with 
surgery and chemotherapy. Of the 19 study participants, 8 had family members with breast 
cancer. The relationships of these family members to the subjects included father (1), mother 
(1), grandmother (3), aunts (2), and sister (1). European Americans (5 of 8) were more likely 
to have a family history of breast cancer.  
 
CAM Use for Breast Cancer 
 In this study CAM use was measured with a card sort to allow the women as much leeway 
as possible in identifying the CAM therapies they were using. They were given a deck of 81 
cards with 1 CAM therapy per card (see Appendix C for the list). The items on the cards 
were drawn from the CAM-use literature and with input from the expert panel. The women 
separated the cards into five stacks to identify the CAM they were currently using for their 
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breast cancer; CAM they were using to maintain or improve their health; CAM they had used 
in the past but were no longer using; and CAM treatments they did not plan to use. Each 
woman was also asked at the end of the card sort to identify therapies she was using that 
were not included in the 81 cards and to add these. The women in this study used a variety of 
CAM therapies not included in the card sort, such as Lutein, royal jelly, rice milk, flax seed, 
grape seed, Certo, Oxycise, and positive thinking (Peale, 1952). One woman used Papaw, an 
extract of Asimina triloba that belongs to the Custard Apple Family, during treatment. She 
began using this at the advice of her herb doctor. She described the Papaw:  
It’s a pill, and when I was going through my breast cancer I took it. It was just a general 
taker, I’d just take it with water . . . he [the herb doctor] said that once it get in my 
system, that ‘posed to knock the cancer, you know, out of your body. . . . I know that it 
helped me . . . it really did help me when I was going through all the things that I was 
going through.  
 
Frequencies of CAM Selection 
The women’s responses to the card sort were tabulated. In the card sort, the subjects 
selected only 53% (n = 43, M = 7.79, SD = 5.65) of the 81 therapies as therapies they were 
using for their breast cancer (see Appendix I). Nine therapies were selected frequently (by 6 
or more women), including prayer (used by 9 women), traditional medicine (8 women), 
special diet (8 women), antioxidants (7 women), exercise, meditation, special foods, support 
groups, and vitamin C (all used by 6 women). It is important to note that all the women in the 
interviews described traditional medicine as using conventional medical providers, their 
oncologists. They did not subscribe to the definition of traditional medicine delineated in the 
literature about CAM. In the literature, traditional medicine is a specific type of therapy that 
employs a holistic approach to health (Esper & Heidrich, 2005; Mathews, 1992; World 
Health Organization, 2003). In several other instances the women’s definitions of CAM 
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therapies differed from the definition of CAM therapies in the literature. The results reported 
here reflect these women’s descriptions of CAM use as defined by them, rather than 
definitions of CAM therapies from the literature. As an example, when the women reported 
using a special diet it might have meant a low-fat diet, a diet of organic vegetables, or a diet 
without junk food. All were tabulated as special diets. In another instance one woman 
described her family’s use of mistletoe. The herb mistletoe has been used in Europe and in 
this country to boost the immune system (Kienle, 1999; Kovacs, Hajto, & Hostanska, 1991). 
However, this woman was given it as a child as a tonic. She said:  
 I had an auntie who would take mistletoe, she would wash them real good. . . . She 
would take it and dice it up and put it over her greens. But she said it was for some kind 
of vitamins that would be in ‘em, but it didn’t taste right, o-o-h. No, ma’am, no, ma’am, it 
didn’t taste right.  It didn’t taste right cut up in nobody’s greens. 
 
Grouping of Therapies 
 The individual therapies selected by the women in the sample were grouped using the 
National Center for Complementary and Alternative Medicine (NCCAM) domains (NIH, 
2006). These domains were used to determine if there was one type of CAM treatment that 
was most frequently used by the women. NCCAM uses five domains to classify CAM 
treatments. One part of this general classification divides types of therapies into the way they 
are delivered. The method of delivery of a type of CAM is important to the way the women 
in this sample decided about CAM use (Mackenzie et al., 2003) because some women felt 
that a therapy that was not invasive was less potentially harmful.  Grouping the therapies 
made examination of the methods of administration more apparent. The NCCAM 
classifications include alternative medical systems, a collection of therapies built upon 
complete systems of theory and practice such as Chinese medicine; mind-body interventions,
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a variety of techniques designed to enhance the mind's capacity to affect bodily function and 
symptoms; biologically based therapies, which use substances found in nature, such as herbs, 
foods, and vitamins to alter body responses; manipulative and body-based methods, based on 
manipulation and/or movement of one or more parts of the body;  and energy therapies, the 
manipulation of energy biofields within the body by applying pressure and/or manipulating 
the body. The 81 therapies listed in the card sort were sorted using these categories 
(Appendix I). The women in the sample most frequently used  biologically based therapies, 
which includes vitamin C, special diet, antioxidants, and special foods. The mind-body 
domain was the second most frequently used CAM category. The most frequently used 
therapies in this domain were prayer,  support groups, and meditation. In the category of 
alternative medical systems, the main therapy used by the women was traditional medicine, 
defined by them as their medical oncologist. In the manipulative and body-based methods 
domain, the women in this sample used exercise and massage. Only 2 of the women in the 
sample used energy therapies. The women in this study selected more than half of the CAM 
therapies available in each of the five NCCAM domains. (See Table 5 below.) 
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Table 5 
CAM Therapies Used for Breast Cancer by NCCAM Domain 
 NCCAM Domains  
Alternative 
medical 
systems 
Mind-body 
interventions
Biologically 
based 
therapies 
Manipulative 
and body-
based 
methods 
Energy 
therapies
Total 
CAM 
therapies in 
the card sort 
 
6 15 49 5 6 81
% of therapies 
selected from 
available cards 
(n)
50 (3) 73 (11) 51 (25) 40 (2) 33 (2)  
Ethnic Groups 
 Although the study sample was small, it was so evenly balanced by race that exploring 
race as a variable was important, particularly since the current literature describes CAM use 
as mainly a European American practice. In contrast to current literature (Kessler et al., 
2001; Lee, 2004, 2005; Politi, 2006), the African American women in this sample used more 
types of CAM (76)  than the European American women (72) and averaged more therapies 
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per woman (M = 8.44, SD = 5.50 for African American women) than for European American 
women (M = 7.2, SD = 6.01). The African American women used prayer, spiritual healing, 
meditation, special diet, and exercise. European American women used traditional medicine, 
support groups, humor, special diet, and antioxidants. Although the ethnic groups shared 
some types of CAM, there were some differences by ethnicity (see Figure 2 below). 
Figure 2.  Frequently used types of CAM for cancer by Race 
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Amount of CAM Used 
 In comparison to subjects in published studies about CAM use in cancer (Struthers & 
Nichols, 2004), our results suggest that CAM use is not just a young, well-educated, 
European American, affluent women’s phenomenon.  This sample provides information 
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about CAM use in breast cancer patients from other demographic groups. Both ethnic groups 
in this sample used CAM, although the types of CAM they used were different. The amount 
of CAM that the women used was also examined. Heavy CAM users were compared to low 
CAM users to see if particular demographic or disease features would characterize CAM 
users.  The sample was divided into groups by the amount of CAM they used and then 
examined on these demographic variables. High CAM users were defined as women who 
used more than 10 types of CAM. This group included 2 European American women and 3 
African American women. The moderate CAM users (4-10 CAM therapies) included 4 
European American women and 4 African American women, and in the low CAM use group 
(0-3 CAM therapies), 2 subjects were African American and 4 were European American. 
The only person who did not use any CAM to manage her breast cancer was a European 
American woman. Table 6 below shows CAM use by demographic variables.  
 In this sample, high CAM users ranged in age from 38 to 58 while low CAM users ranged 
from 39 to 67. The educational level of the high CAM users was very similar to the low 
CAM users, and the most affluent women in the group were not in the high CAM use group. 
Many studies of CAM use sample women who are quite affluent compared to this sample. 
These results are important in that this sample of women, which is more balanced, shows that 
CAM may be more broadly distributed across demographic characteristics than prior 
literature indicates. 
 
73
Table 6 
Amounts of CAM Used for Breast Cancer by Demographic Variables 
Variables Low CAM use 
(0-3 therapies; 
N = 6)
Mod CAM use 
(4-10 therapies; 
N = 8) 
High CAM use 
(More than 10 
therapies; 
N = 5)
Race    
European American 4 4 2 
African American 2 4 3 
Age M = 55.50,  
SD = 11.34
Range = 39-67 
M = 50.63
SD = 10.06 
Range = 35-67 
M = 46.80
SD = 8.41
Range = 38-58 
Years of education M = 15.00,
SD = 1.10 
Range = 14-16 
M = 12.00,  
SD = 3.16 
Range = 8-17 
M = 15.40,
SD = 2.41
Range = 12-18 
Family income*    
Less than $25,000 3 5 2 
$25,000-$75,000 2 1 2 
Over $75,000 1 1 0 
Residence    
Urban 5 5 3 
Rural 1 3 2 
*Only 17 women reporting. 
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Residence 
 The rural or urban nature of the residences of this sample indicated that this may be 
another factor that characterizes the amount and type of CAM used. There were more than 
twice as many women in the sample who lived in cities and towns as in very rural areas. It is 
important to note that the size of the cities and towns ranged from large cities (population 
over 100,000) to very small towns (less than 5,000) (North Carolina State Data Center, 
2006). Ten of the women lived in cities with populations over 100,000 and 4 of the women 
lived in towns smaller than 5,000. The women living in the moderate size towns (between 
5,000 and 99,000) reported the least use of CAM (n = 5, M = 6.4, SD 5.4). The highest CAM 
use group by residence was the women who lived in the smallest towns (n = 4, M = 9.75, SD
= 6.65). The most frequent CAM strategies used by rural dwellers were prayer, meditation, 
ginger, herb tea, exercise, and spiritual healing. The most frequently used CAM strategies for 
the urban respondents were prayer, special diet, antioxidants, and traditional medicine. Since 
there were racial differences in CAM use as described earlier, the racial breakdown of the 
participants by residence is of interest. Half of the women in the rural group were African 
American; this may have affected the therapies reported by this group. Only 6 women self-
identified as living in a rural setting, even though 9 (4 European American, 5 African 
American) of the sample lived in towns of less than 99,000. Rural women shared 4 of the 
most commonly used forms of CAM (prayer, spiritual healing, meditation, and exercise) with 
the African American women and none with the women who described their residence as 
urban.  
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Past Treatment 
Another variable that has been implicated in CAM use is the characteristics of the breast 
cancer itself such as length of time since diagnosis and past and current treatment. The 
women in this study who used large amounts of CAM had been diagnosed more than three 
years (M = 39.40 months, SD 32.92), but the women in the moderate CAM use group (4-10 
therapies) had been diagnosed just over a year (M = 16.75 months, SD = 18.58). The women 
in the high CAM use group had received prior chemotherapy (5 out of 5), radiation therapy 
(4 out of 5), and hormonal therapy (4 out of 5). More invasive therapy has been identified in 
the literature to yield more toxicity (Badger, Braden, & Mishel, 2001). There is also some 
indication in the literature that prior treatment increases the likelihood of CAM use (Alferi et 
al., 2001; Kessler et al., 2001), perhaps due to the added toxicity of treatment or experiencing 
side effects with prior treatment that were not managed well. Although this study is limited 
by a small sample size, these findings indicate that further exploration is warranted. 
Current Treatment 
If current treatment provides cues in the form of toxicities that are associated with 
women’s choices to add CAM treatments to their regimen, then the treatment the women 
were receiving may be a relevant variable. Cytotoxic chemotherapy is implicated in more 
severe toxicities (Ganz et al., 2002; Weiger et al., 2002) than other cancer treatments, so it 
would be logical to hypothesize that women receiving chemotherapy might have higher 
CAM use. Table 7 displays this information in detail.  In evaluating the current treatments 
being received by subjects in this sample, 9 of the women were receiving chemotherapy and 
8 were receiving hormonal therapy. Of the 5 women in the high CAM use group, only 1 was 
receiving chemotherapy. The remaining 4 high CAM users were receiving hormonal 
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treatment, which may indicate that they had already completed their cytotoxic chemotherapy 
and that the CAM they used helped them to deal with cumulative side effects of their 
treatment or the side effects of their hormonal treatment. It is also possible that the women’s 
providers were adequately managing the toxicities that the women on chemotherapy were 
experiencing.  
Another concern in the literature has been the interaction between CAM treatments and 
conventional chemotherapy (Boyle, 1997; Rhodes-Kropf, Lantz, & American Association for 
Geriatric Psychiatry, 2001). Of the 9 women who were receiving chemotherapy, many used 
CAM treatments from the biological domain. This domain is especially important because 
these therapies are ingested for the most part and have a better chance of interacting with 
chemotherapy. The most frequently used CAM therapies in the biologic domain were health 
food supplements (5 women), special diet (5 women), vitamin B6 (5 women), vitamin E (5 
women), antioxidants (6 women), lemon (6 women), vitamin C  (7 women), and special 
foods (8 women). Vitamins and antioxidants have been implicated in reduced effectiveness 
of chemotherapy and the potential for bleeding through decreased platelet aggregation (Ernst 
& Cassieth, 1998; Kumar et al., 2002). Soy is another biologic that has been contraindicated 
for women with estrogen positive tumors and especially those women using Tamoxifen 
(Montbriand, 2005) because it mimics estrogen and may interfere with the action of 
Tamoxifen. The women in this study had heard the messages about soy, and only 3 of the 
subjects reported using soy; only 1 of the 3 was receiving Tamoxifen. 
CAM for Health 
In addition to using CAM to help manage the effects of their breast cancer and treatment, 
the women in this study were asked, during the card sort, to indicate the types of CAM they 
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were currently using, dividing these cards into CAM that they used for cancer and its side 
effects and CAM therapies they were using for their general health. Subjects reported using a 
wide variety of CAM treatments for their general health.  
Table 7 
Amount of CAM Used by Breast Cancer Characteristics 
Variables Low CAM use 
(0-3 therapies; 
N = 6)
Mod CAM use 
(4-10 therapies; 
N = 8)
High CAM use 
(more than 10 therapies; 
N = 5)
Type of surgery    
Mastectomy 3 3 3 
Lumpectomy 3 2 2 
Biopsy 0 3 0 
Current treatment    
Chemotherapy 2 6 1 
Hormonal 3 1 4 
No therapy 1 1 0 
Time since diagnosis    
2-12 months 2 6 2 
24-84 months 3 2 3 
More than 84 months 1 0 0 
In fact, they reported using more forms of CAM for managing their health than for their 
breast cancer (200 for health; 148 for breast). Of the 81 different types of CAM treatments in 
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the card sort (see Appendix I for list), this group of women used 48 (59.25%) of the therapies 
for their health.  
Frequencies of CAM Selection 
The average number of CAM therapies per woman used was 10.53 (SD 6.00), and the 
range was between 0 and 21 therapies.  The therapies were grouped to determine which 
CAM treatments were used most often. There were 18 therapies that were chosen frequently 
(between 5 and 11 times) for health. The most frequently used therapies were music, humor, 
exercise, and vitamin E. One to 4 participants selected 20 therapies. These included massage, 
zinc, “talking away” illness, meditation, counseling, soy, herbal supplements, support groups, 
spiritual healing, and art therapy. Thirty-three CAM treatments were not used by anyone (see 
Appendix I for the list). 
Grouping of Therapies 
 The NCCAM domains were again used to examine the types of CAM used for health (see 
Table 8). Of the NCCAM domains, the biologically based therapies were selected most 
frequently, with vitamin E, vitamin C, vitamin B6, and lemon being the most prevalent 
choices in this group. Many of the women reported taking a multivitamin as part of their 
daily practice. Few of the women reported vitamin use above the USDA standard daily 
requirements. Two exceptions were the increased use of vitamin C when they felt a cold 
coming on and the use of vitamin E oil on scars from mastectomies and biopsies. In these 
unique situations, the women reported increased doses of vitamins above USDA 
requirements.  As one woman said,  
 Vitamin C . . . I’ve always taken that a little bit here and there.  I used to just take it 
more for prevention of colds, like if I felt like I was getting a cold; I would just quickly 
take like 6,000 mg of Vitamin C. 
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The mind-body interventions were selected the next most often, specifically the therapies 
of music, humor, and prayer. In the manipulative and body-based therapies, 10 of the sample 
selected exercise for health. There were no therapies selected from the energy therapies for 
health.  
Table 8 
CAM Therapies Used for Health by NCCAM Domain 
 NCCAM Domains  
Alternative 
medical 
systems 
 
Mind-body 
interventions 
Biologically 
based 
therapies  
Manipulative 
and body-based 
methods 
Energy 
therapies 
Total 
CAM 
therapies in 
the card sort 
6 16 48 5 6 81 
CAM cards 
selected by 
patients 
(number of 
times each 
was used) 
5
(11) 
 
12 
(59) 
 
26
(109) 
4
(20) 
 
1
(1) 
49 
(200) 
Although the literature links prior CAM use to CAM use during breast cancer, these 
women used different kinds and different amounts of CAM  for the two purposes. While one 
woman used 20 different types of CAM for her breast cancer she only used 3 forms of CAM 
for health. Another participant used only 3 CAM treatments for breast cancer but used 21 
different types of CAM for health. In the interviews, the women said maintaining good health 
was important to tolerating treatment and preventing cancer recurrence. 
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Ethnic Groups 
Examination of CAM use for health by race revealed a different profile for European 
American and African American women (see Figure 3). The European American women 
were most likely to select prayer, relaxation techniques, and exercise (mostly mind-body 
therapies) for health, while the African American women selected humor, vitamin E, vitamin 
B6, and lemon, adding more biologic therapies to CAM for health. Both groups reported 
using music to stay healthy. The European American women reported in the interviews that 
they used the strategies for health to reduce stress and to fight recurrences. They tied stress to 
the occurrence of cancer and described using these forms of CAM as a preventative. One 
woman said,  
 I’ve tried to do it more (exercise) because I think that if I do more of it, that it’s going 
to help me to stay in shape, and to fight the cancer.  If my body’s in good shape, it’s 
going to be able to do a better job of fighting everything. 
 
Amount of CAM Used 
Looking at the ages of women who used various amounts of CAM in this sample, the high 
CAM users were older (M = 60.60, range 53-67 years), while the younger women (M =
46.42, range 35-58 years) were more likely to use fewer forms of CAM for health. 
Exploring CAM use for health by place of residence revealed that, for this sample, all the 
high CAM users for health lived in cities.  This may have been due to their close proximity to 
resources and services. Literature (Eisenberg et al., 1993; Henderson & Donatelle, 2004) 
indicates that CAM users are more affluent than non-users, and even though that was not 
found to be the case in this small sample, financial resources may well be linked to the 
number and type of CAM therapies used since some are very expensive.  
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Figure 3. 
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For the women reporting family income (n = 17), more than half had family incomes 
under $25,000. In this sample of CAM users, the 10 women in the lowest income group had 
the widest range of CAM use (0-21 therapies for health). The women in the moderate income 
group ($25,000-$75,000) had the highest mean CAM for health use (M = 11.80, SD = 5.54), 
and the women who did not report income had the lowest mean CAM use (7.5, SD = 6.36). In 
this sample, the most affluent women (income over $75,000 per year) used relaxation and 
massage, while the least affluent women (under $25,000) used lemon, vitamin E, music, 
exercise, and humor for health. 
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This was an educated sample, with more than half of the sample educated past high 
school. The years of education ranged from 8 to 18. The mean total specific CAM therapies 
for health for the women with less than a high school education was 2.5 (SD 2.54), while the 
mean in the group with college degrees was 14.00 (SD 2.83). As the women’s education level 
increased, the number of CAM treatments the women used for their health also increased. 
This is consistent with the literature about CAM users (Brown, Carroll, Boon, & Marmoreo, 
2002; Manne et al., 2004). 
Past and Current Treatment 
Several factors were examined related to the women’s breast cancer treatment in terms of 
their use of CAM for health, including type of surgery, past treatment, and current therapy. 
The women with a past history of the most invasive surgical intervention, a 
mastectomy/reconstruction, used only a moderate amount (5-15 types) of CAM for health. 
Only 3 of the women who used more than 15 CAM therapies for health had received 
chemotherapy or radiation in the past. Women who had received past treatment with 
chemotherapy were most likely to use moderate amounts of CAM for health, while the 
women with past history of radiation used low amounts of CAM for health and women with 
past hormonal therapy were more likely to use high amounts of CAM for health.  
 The amount of time since diagnosis may have influenced the women’s use of CAM for 
health. As they moved away from their acute cancer experience they might have been more 
focused on CAM to maintain their health. The range of time since diagnosis was 2-132 
months. However, the 5 heaviest CAM users (15-21 therapies for health) were spread over 
the entire sample with 3 of the 5 having been diagnosed within a year of the interview.  
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Examining the current treatment for cancer, the women who had the highest scores for 
using CAM for health (15-21) were receiving hormonal therapy (n = 2), chemotherapy (n =
1), or no therapy at all (n = 2). The women who reported the highest toxicity scores from the 
Breast Cancer Toxicity Questionnaire (range 84-95, study M = 79.21, SD = 9.30) also had the 
highest average use of CAM for health, averaging 13.75 forms. The women with the lowest 
toxicity scores (range 63-72) also had the lowest average use of CAM for health, averaging 
8.83 CAM forms.  Table 9 displays this information in detail. 
Table 9 
Number of CAM Treatments for Health by Type of Treatment Received 
Past treatment 
(number of women receiving) 
Current treatment 
(number of women receiving) 
Amount of 
CAM used 
Chemotherapy Radiation 
therapy 
Hormonal 
therapy 
Chemotherapy Radiation Hormonal No 
treatment
Low CAM 
use 
(0-7 
therapies) 
5 4 2 4 0 3 0
Mod CAM 
use 
(10-14 
therapies) 
6 3 2 4 3 0
High CAM 
use 
(15-21 
therapies) 
3 3 3 1 0 2 2
Total 14 10 7 9 0 8 2 
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Precipitating and Influential Factors in the Choices to Use CAM 
 Both quantitative and qualitative data were examined for factors that influenced the 
women to use CAM. The women used CAM either specifically because they had developed 
breast cancer or to tolerate treatment after their diagnosis. The women reported that the CAM 
they used for health was to restore health lost to breast cancer. 
Cancer as a Wake-Up Call 
 It just, you get such a jolt in life when you're going along and everything seems smooth 
and then suddenly your life’s turned upside down. You have cancer, and you say, how on 
earth did I get it? What am I going to do?  And it just makes you—it’s like a wake-up 
call. 
 
Many of the women in the study reported beginning the process of using CAM 
in reaction to receiving a cancer diagnosis, in the hope that using CAM would make 
them healthier and better able to tolerate treatment and prevent a cancer recurrence. 
They describe the cancer diagnosis as being out of balance. One woman said, “I kind 
of lost myself, and I think all that’s related to the cancer.” Being healthy was equated 
with not having cancer. After the women were diagnosed they reported a type of life 
review (Butler, 2002; Riessman, 1989) to determine the cause of their cancer. One 
woman said, “You go through this period of, you know, why?  And then my answer 
to that is why not?”   
Even women with strong family histories of cancer reported this search for the 
cause of their cancer. One woman said,  
 No one ever told me why I got cancer.  When I went in, it was what did your mother 
have [lung cancer], what did your sister [breast and ovarian cancer], what did your aunt 
[breast cancer], everything.  No ever said, what do you like, Julie?  What are your 
activities?  What is your lifestyle?  What are your eating habits?  No one ever asked me 
those questions, and I used to say to the doctor, “You’re asking all about everyone 
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outside of me, but no one knows me, nobody’s coming to know, what do you like? . . . So 
I decided that I was going to do that myself.   
 
Some women determined that their lifestyle could have been to blame for their 
cancer. They implicated poor lifestyle choices such as stress, poor diet, and not 
maintaining regular health checks.  
Poor lifestyle choices—stress 
 I could kick myself now because who knows what causes it, you know, I could have 
just done it to myself, and so I’m trying to be respectful of my body now, and hopefully 
it’s not too late. 
 
The women adopted a variety of CAM therapies to deal with what they saw as their 
negative lifestyle factors. They began behaviors to reduce stress, such as meditation, yoga, 
and diversions. One woman said, “I think stress contributes to breast cancer, any kind of 
cancer, so I try to avoid being stressed.” Many of the women described how fear and worry 
associated with their cancer diagnosis was a potential cause of stress and a detriment to their 
health that caused them to use CAM. Many of the mind-body therapies that they used, such 
as prayer, meditation, and music and art therapy, were aimed at reducing these fears and 
stresses.  
 Poor lifestyle choices—diet  
The women also attributed their cancer to poor diet or eating “junk” food. They became 
vegetarians, bought organic meats and vegetables, decreased fats, and increased their use of 
vitamins. Often the women described their dietary modifications as stopping foods and 
practices that are “bad for you” and increasing practices that are “good for you.” One woman 
said,  
 Special foods is I’m trying to do basically some cereal, some soy that I’m into, 
drinking more fruit juice, but like watching it doesn’t have a lot of ingredients in it, not 
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artificial fruit.  I’m going to cranberry juice, the real cranberry juice, orange juice, milk.  
I’m trying to stay away from a lot more sweets.  I was a big sweet eater, so by special 
foods I’m really trying to watch again what I eat, and not just eating junky food, eating 
chicken . . . I don’t want the skin on it.  I’m cooking healthier, and so those are a lot of 
my special foods. 
 
The women adopted CAM therapies to remove the things that they believed were bad for 
them. Few of the women used anything that contained alcohol. Other cancer populations 
have identified whiskey and rum-soaked raisins as CAM (Arcury, Preisser, Gesler, & 
Sherman, 2004; Frate, Croom, Frate, Juergens, & Meydrech, 1996), but not this group. A 
typical view was exemplified in the following: “Whiskey, I’m not going to drink no whiskey. 
It’s not good for you. It’ll mess up your liver in the long run.” The women viewed cancer 
treatment as poison and expressed the need to eliminate it after it had done its work. One 
woman expressed it this way: 
 And you know, to detox?  I really want to do more of this.  I think it’s very, very 
important to get out, I did some detoxing with juices and stuff like that I was putting into 
my body to take out some of those chemicals that got into it that I don’t like in it, like a 
lot of the radiation and stuff, so I’d like to learn, . . . how I can take out any of that stuff  
within me. 
 
In reaction to having cancer, the women tried to do things that were good for them, like 
following a healthy diet, exercising, and taking vitamins and supplements daily. They also 
tried to avoid things that were bad for them, like alcohol, fatty foods, processed foods, and 
high-stress situations. One woman said, “I try to be as organic as I can and not eat a lot of 
junk food that I’m not supposed to, and a lot of fruits and vegetables.”  The women also 
attribute their breast cancer to their diet. One woman said, 
 I think that I blame myself for getting this because I don’t think I really took care of 
my health the way I should have.  I’d never worried about what I put in my mouth, I 
didn’t worry about chemicals; I mean I thought somehow I was invincible, that it 
couldn’t happen to me, and I was really stupid, because I didn’t care really.   
 
87
Detoxification was also a part of the “good for you, bad for you” theme. The women 
described using CAM to detoxify from dietary indiscretions and to eliminate the toxic effects 
of treatment. One woman described her process and the indications she had that she needed 
to detoxify. She said,  
 Detoxification.  The way I would detoxify would be green teas and stuff like that that 
would help flush my system when I wasn’t feeling well or something like that. Yeah.  I 
still do. How do I know when I need it?  Uh, green tea? I have an upset stomach or, you 
know, not going to the bathroom as I ordinarily would do or something like that. 
 
Fasting was also part of detoxification. Some of the women used fasting as part of a religious 
observance while others fasted to eliminate impurities. In describing her religious fasting, a 
subject said, 
 Well, I think, well it’s good for both [health and breast cancer] because when you 
fasting and asking God, see, if you need a healing, and you asking God and you turn 
down your plate, he will come to your rescue. 
 
Another perspective was not at all related to religious faith: “The chiropractor prescribed 
detoxification, . . . and part of that is an enema, and I would do that, and the fasting?  I would 
do that, too.” 
 Poor lifestyle choices--lack of health maintained/information seeking 
Another reaction to having a cancer diagnosis was to become avid consumers of health 
information. One woman said, “I’ve just done a lot of reading through the breast cancer 
experience and found certain things that Researchers has shown have been helpful in 
preventing recurrence.” Literature reveals that CAM users seek more information sources 
than those who do not use CAM (Kakai et al., 2003), and the women in this study followed 
this trend. They completed a measure of the types of information sources they used, the 
Sources of Information Questionnaire (Appendix G). Out of the 30 possible choices, the 
mean number of information scores for the total group was 11.45 (SD = 6.86, range 1-25). 
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European American women consulted fewer sources of information (M = 9.20, SD = 7.13)
than African American women (M = 14.33, SD = 6.10). The most frequently consulted 
sources of information were the American Cancer Society (14), friends (14), the 
chemotherapy doctor (14), and their surgeon (14). The women also consulted pamphlets and 
fliers (12), chemotherapy nurses (12), family members (11), and the Internet (10). Every 
information source in the 30-item list was chosen at least once, but CAM providers (2), 
community centers (2), herbalists and root doctors (2), and patient advocates (1) were chosen 
the least. The number of CAM therapies that the women used increased with the number of 
information sources they consulted (see Figure 4 below). The women combined different 
types of information sources to increase their understanding. One woman said,  
 There’s also another thing that my friend [first information source] told me about, 
because my knees have been bothering me, and I looked it up on the Internet [second 
information source], this Certo. Yeah, I figured I might as well try it, you know, because 
she . . . when I went on the Internet and saw all these people [third information source], 
yeah, saw all these people who swore by it, I thought wow. Apparently there’s something 
to it. I just bought some yesterday [she used 3 types of information to come to decision].  
 
Often the women used the Internet to get information—much like using a library. When they 
had a question or they needed more information about a new CAM form, they used the 
Internet like a support group for a back-up information source. Two of the women who used 
breast cancer chat rooms for information called these groups their “cyber sisters.” Some of 
the women were cautious about Internet information. One said:  
 The Internet, only, you can’t believe half of it. You try to go to a site that you trust, 
like the American Cancer Society, or the Web M.D. [WebMD.com], anything that you 
trust.  You know, if you just put that in there, you don’t know what you’re going to come 
up with.  Science is scary stuff. 
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Figure 4 
Relationship of Number of Sources of Information to CAM Used for Breast Cancer 
_
Women also used other formal and informal support groups for information. Formal 
support groups included those founded by the American Cancer Society, such as Reach to 
Recovery, and Save Our Sisters within the African American community. When asked in the 
card sort, 9 of the women reported using support groups as a form of CAM treatment. 
Informal support groups included social clubs such as a group of retired women, cheerleaders 
competing in the Senior Olympics, and the fellow patients they saw weekly in the treatment 
room. These groups provided the women with information to help them decide about CAM 
use. 
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An exception was a subject who reported only one source of information. She was 
diagnosed with breast cancer during pregnancy, and her initial oncologist told her that she 
would need to terminate her pregnancy to save her own life. She found another oncologist 
through a series of chance occurrences and subsequently delivered a healthy baby. This 
subject’s only source of information from the 30-item list was her oncologist. She used 
several forms of CAM for health and reported several factors that influenced her decisions in 
her interview, but she relied on the oncologist as her ultimate information source.  
The expert 
Before starting a new CAM therapy and, at times to continue a past CAM treatment, the 
women consulted experts. Each woman had specific criteria that defined an expert. The most 
frequently noted people by the women in the sample were health care providers, either 
physicians or nurses. Friends and family ranked after health care providers. The women did 
not define who was an expert in the same way, but each woman had her own criteria. During 
the interviews, the women reported that it was important for a provider to cite published 
information from the literature to add credibility. In essence, they expected a provider to have 
digested print information and incorporated that into the discussion of treatment options and 
CAM. In describing her medical oncologist, one woman said,  
 He’s like a professor when he’s trying to explain things to you.   Of course, you know, 
75% of it goes right over your head because you don’t know what all these acronyms are, 
and all this, but he’s writing down all these notes and going over all this stuff. 
 
An important criterion for all the women was seeing information in print. This added 
credibility to the source. The women reported using several sources of print material from the 
Sources of Information questionnaire such as pamphlets (11), books from the library (5), and 
magazines (8). 
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Many of the women cited experts and qualified their endorsements by the detail that the 
expert had written a book or was quoted in a magazine. An association with noted cancer 
treatment hospitals also made a source more credible. One woman said,  
 One of the big things that people are promoting now, and that I do take is curcumin, 
which is a supplement. . . . Marisa W., she’s the physician who kind of runs that 
breastcancer.org . . . she has done a lot on that, and then you know that book . . . called 
Waking the Warrior about it. . . . So curcumin is one of the things that . . . but there are 
other studies.  There’s somebody at M. D. Andersen, I think, is who’s really promoting 
the curcumin. 
 
Being a licensed physician was also important to the qualifications of an expert. One 
woman knew root doctors who dealt with cancer, but she preferred to use her conventional 
provider because of this criterion. She said,  
 Yeah, it’s quite a few that goes to see ‘em [root doctors], but I see it like this.  Why 
would you spend your money out there messing with someone that doesn’t have the 
degrees sitting upon the wall?  If I’m going to spend some money like that, it will be with 
somebody that I know is a guarantee. 
 
Women in this study also reported trying CAM therapies that they were uncertain about on 
the strength of the recommendations from their provider. One woman reported using ginger 
tea at the recommendation of her chemotherapy nurse even though she said it tasted terrible:  
 Yeah. It doesn’t taste good. I don’t like it. But, it works. . . . When I start feeling 
nauseous and my stomach starts hurting and I just don’t want anything to eat. So then if I 
drink a cup of tea it’ll, um, settle my stomach. Then I can eat a little something and feel 
better. 
 
Several subjects in this study reported using a CAM therapy on the recommendation of a 
friend. For a friend to be considered an expert they needed to have tried the therapy and had 
good results. This type of endorsement was conditional, but if a friend or acquaintance, 
especially one who had had cancer, used a particular type of CAM, the women were likely to 
at least give the therapy a try. One woman started using the herb turmeric after reading about 
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it on the Internet and hearing about it from a friend. She describes the process that she went 
through to decide about using it:   
 Anyway, so after he [her friend with cancer] told me about these things that he’s been 
taking, I went to the Internet and looked them up, and sure enough they’ve researched 
how these things work, like one of them is turmeric, and it’s supposed to be a very good 
anti-inflammatory, and there’s a lot of studies going on about that. . . . I think that’s really 
what got me started thinking that there’s really something to supplements, you know, and 
then after doing a lot of reading and reading the cancer boards and seeing what people are 
doing, there were just certain things that are consistent, and then reading this book, that 
they tell you to do.   
 
This woman also points to another element of being considered to be an expert, 
involvement in research. Many of the women list a research base as a criterion for a therapy 
to have credibility. None of the women in the study had a research background, but often 
they said that seeing the research helped them decide about CAM use. Several of the women 
relied heavily on books written about breast cancer and CAM treatments. These books were 
authored either by cancer patients or by physicians involved with cancer patients.  
Health beliefs 
General health beliefs and beliefs about the benefits of certain kinds of therapies seemed 
to be another factor operating in the process of women deciding to use CAM therapies.  The 
belief that certain therapies were “good” or “bad” influenced these women when they 
decided about using CAM. The source of these beliefs was not clear in the interviews. They 
were likely to use CAM if they perceived a therapy as “good” and avoided a therapy if they 
perceived it as “bad.” When given the choice of CAM treatments, often they reported using 
one form or not using another because of how “good it was for you.” Several of the women 
reported not using home remedies containing turpentine that had been reported in other 
literature (Arcury et al., 2004) because they believed turpentine was for cleaning paint 
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brushes and “bad for you.” Other women reported not using whiskey or rum-soaked raisins 
because alcohol was “not good for you.”  
The women in this study saw some of the CAM therapies as “way out,” “goofy,” or too 
“new age.” One woman said, “Hypnosis, I think is hokey. . . . I don’t believe in it, and I have 
no reason for not believing in it other than I don’t believe in it.”  Another woman said, “I 
don’t want to do anything that I consider extreme, like putting certain chemicals or electricity 
or magnets in my body, because I don’t see that as balance.” The women used a variety of 
negative phrases to describe CAM treatments that they did not believe in, including “weird,” 
“freaky,” “loony,” and “new age.”  
One woman expressed the belief that CAM treatments employed the placebo effect. She 
said,  
 Some of them sound like, uh, they’re just going to enhance your, the placebo effect. 
And I want real results. I don’t want to just think I’m getting a result and, uh, I don’t want 
to fool myself and lie to myself and, act all beatnik and flaky. 
 
For the most part the women wanted to avoid these extreme measures. One woman said, 
“Hydrogen peroxide, I’ve heard of that quack [CAM provider who administers hydrogen 
peroxide therapy]. I like hydrogen peroxide for a lot of things, but not for a treatment, per 
se.” 
Although the women believed in CAM in general, they often didn’t use a certain form of 
CAM because of personal preference. This was difficult for the women to explain, but they 
were very clear that some therapies were just not for them.  An example was one woman’s 
views of biofeedback: “Biofeedback, I don’t think I need it, I just don’t see the usefulness for 
me, but I do think it’s a useful technique.” 
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Women did indicate that if their cancer came back or if things got worse, they might 
consider additional options. One woman said, “The Chinese medicine, if things got really 
bad, I’ve heard of Chinese medicine. I would consider—a last resort thing.” Another said, 
“Fasting?  Me fast?  If I were dying maybe, if they told me I would live, but that’s about it.” 
Still another reported,  
 Well, if it come down to really having to, take that, that it were going to help me with 
my health, benefit me, yes, I’ll go for it. But if it’s just something to keep my blood built 
up, you know, if it’s to keep my blood pressure down, yes, and keep me built up, yes, but 
just to take it because, you know, for energy and keep you spunky, I don’t need that. . . . 
If I had to, yeah, I would do it. 
 
Because of Cancer Treatment 
The women in the study also used CAM in reaction to actual and potential side effects of 
treatment. They started or continued forms of CAM because they experienced or anticipated 
side effects of treatment. If they had used CAM in the past and it was beneficial then, they 
would use it again for similar symptoms. One woman who used massage for her 
lymphedema said:  
 Massage, it helps a bunch. They [physical therapist] specialize in lymphedema; they’ve 
had the training, the Vader the German man, the Vader training.  I’m not presently going. 
But I would go back if my arm started hurting, or it started getting red, that happens 
sometimes, or it swelled up some—definitely!  
 
As indicated in the literature, past CAM use influenced many women’s choices to use 
CAM when they were diagnosed and treated for breast cancer (Mackenzie et al., 2003). The 
number of past CAM practices that the women reported using during the card sort ranged 
from 0 to 21 (mean 5.60 SD 5.61). The mean number of CAM therapies after their diagnosis 
increased to 8.2 (SD 5.8). Past CAM forms included chiropractic (7), DHEA (6), ginger (5), 
black cohosh (4), and fasting (4). Subjects reported changing or increasing their CAM 
practices after their cancer diagnosis.  
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According to previously published studies, CAM use increases as the level of toxicity 
rises (Shen et al., 2002), and so the women in this study completed a measure of toxicity, the 
Breast Cancer Toxicity Questionnaire.  For this sample the range of scores was 63-95 
(potential range 33-99) with a mean score of 79.6 (SD = 9.10). The European American 
women had higher total toxicity scores (M = 83.30, SD = 7.63) than the African American 
women (M = 75.9, SD = 9.29).  The toxicities that the women reported here were both 
physical and emotional toxicities associated with having treatment. The emotional toxicities 
included depression, irritability, worry, sadness, and hopelessness. The physical toxicities 
included fatigue, pain, sleep difficulties, taste alterations, menopausal symptoms, nausea, 
mouth sores, and watery eyes. The women in this study used CAM to deal with both 
emotional and physical toxicities.   
They told of using herbs to deal with irritability. One woman said,  
 And the ginseng?  I’m taking the ginseng to calm the menopausal symptoms but 
mostly the emotional stuff, and it has seemed to make a difference. I’ve been taking it 
once a day if I remember, and then some days I haven’t, I know this is making a 
difference because there’ve been days where I’ve forgotten, and I’ve gotten really 
irritable, have a hard time controlling my emotions, and then I’ll do it, and later it just 
will smooth out. 
 
Stress was implicated as a side effect of receiving a cancer diagnosis and of receiving 
cancer treatment. Psychological distress has been associated with CAM use (Cassileth et 
al., 1984), and the women in this study reported the belief that a stressful lifestyle can 
cause cancer (Rakovitch et al., 2005).  
They used many types of CAM therapies to deal with the stress they were feeling, 
including humor. One woman said, “I guess the humor, I’ve been using that all the while. 
I think I’ve used that all the while. I consider it very necessary for your health. Relieves 
stress.  That’s the biggest thing.” Another woman talked about the healing power of 
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humor. She said, “I’m sure humor helps heal. And I’ve heard a lot of people talk about 
that. That if you get sick, watch something funny.” Notice in this account that she cites an 
outside expert to justify her belief in humor.  
The women in this study were like other breast cancer patients (Boon et al., 1999; 
Montbriand, 1995a) who used CAM to increase their feelings of control. Several of the 
women described using guided imagery to control where their treatment went. One 
woman who was pregnant at the time of treatment described her experience with 
visualization. She said,  
 When I was getting my chemotherapy, I was picturing it . . . where it was going, what 
it was going to do, how it would stay away from her [her child], and how it would attack 
on cancer cells. It made me feel like I had some kind of control over what that poison was 
going to do, so I mean, I just . . . It made me feel like I had a say in what cells it would 
kill and maybe not kill.  I felt that if I tried hard enough, or concentrated hard enough, or 
visualized it enough that it would not [hurt the child]. . . . My biggest fear was harming 
her, of course, and so I just visualized it staying away from the placenta and just kind of 
attacking any cancer cells. 
 
The women also used CAM to deal with the physical side effects of treatment. They 
may have tried using conventional biomedicine for side effects but found it unsatisfactory 
to solve their problems. The women used herbal tea, ginger, and pickle juice for 
chemotherapy nausea, vitamins and herbs to maintain adequate blood counts, improved 
nutrition to decrease fatigue, and aromatherapy for increased energy. They also used 
herbs to deal with neutropenia from treatment. One woman used the herb Papaw for 
blood counts. There is literature to indicate that this herb may have some activity against 
breast cancer (Levine et al., 2005). She described the reason she took the herb: 
 Yeah, the chemo and even the radiation, ‘cause he [the herbalist] said so many times 
that will pull your commune [sic] system down, which it did, but every time I went and 
got my treatment. I was on that, and my commune system always was up… I didn’t have 
to miss nary a time. 
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Another woman reported using lemon juice for the vitamins to prevent treatment delays 
due to low European American blood cell counts. She said,  
 ‘Cause before the chemo you have to go for a blood test the day before at the hospital, 
and everything has to be good before they give you the next one [treatment]. They’ve 
been very good. Yeah. And I was determined I wasn’t going to miss a treatment. The 
lemon helped, yeah. It was the extra vitamin C.   
 
Another woman used ginger for chemotherapy nausea. She said,  
 And ginger? . . . Oh, my friends, one took me to like a Chinese-like health food store 
and got me ginger chewing gum, and they said that it would help settle your stomach, so 
sometimes if I felt sick, it did, it actually did work, sometimes if I felt like you know, it 
was sort of like creeping up on me, I would chew on the gum and it would help settle it. 
 
Keeping blood counts up was important to all the women in the study receiving 
chemotherapy, because low counts meant no treatment. Being able to receive their treatment 
was a source of pride and a validation of CAM’s effectiveness. One woman said,  
 They [the provider] told me to take a multivitamin. And, it keep my treatment, keep 
my blood built up, you know. ‘Cause some of the treatment make the blood go down. 
Have to—the body wants to build up . . . my blood’s been built up, staying up.  But I still 
get tired, and I figure that’s from the—probably from the treatment and stuff. They check 
my blood each week.  It’ll still be up. 
 
Women in this study reported using salves for radiation-induced skin irritation. Many of 
the women reported fatigue from treatment, and they used a variety of methods to deal with 
it—from vitamins to aromatherapy.  
Reasons Not to Use CAM 
Aversions 
Of the 81 therapies in the card sort, 29 were not selected by any subject as being used for 
either health or cancer. Of the remaining 52, 28 were selected by fewer than half of the 19 
women. Prayer was the only form of CAM that was selected by all the women for either 
cancer or health. Marijuana (16 women) was the CAM that the women selected most often 
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not to use, followed by turpentine (14 women), hypnosis (14 women), and colored light 
treatments (14 women).  The European American women selected black cohosh, fasting, 
mushroom extract, hypnosis, colored light treatments, and marijuana least often, while the 
African American women selected art therapy, whiskey, gingko, hypnosis, Rootwork, 
turpentine, and marijuana least often.  
 Often the women expressed interest in particular types of CAM treatments but reported not 
using them due to lack of information about a therapy. They required a certain level of 
information about a form of CAM before they used it. However, the African American 
women who declined to use Rootwork described the practice and had made a conscious 
effort not to use it. They had experience with Rootwork and had very firm health beliefs that 
prevented them from using it and for choosing other forms of CAM. They said that Rootwork 
was the work of the devil and that its use was making a deal with the devil. 
 Some of the women in the study reported aversions to some CAM therapies from their 
past experiences. A past negative experience with a particular therapy also meant that the 
subjects were less likely to use it. One woman expressed an aversion to enemas because of 
her past history. She said, 
 Enemas, my mother was insanely obsessed with enemas and gave us enemas every two 
seconds, every time something was wrong when we were kids, I would never have 
another enema as long as I lived.  That’s out. Yeah, totally out. 
 
Women were reluctant to use acupuncture because of needle phobias. Other women were 
averse to aromatherapy because the smells caused chemotherapy-associated nausea. One 
woman described it this way, “I can’t smell nothing [doesn’t want to smell anything].  Every 
time you smell something, it make you sick. It make you . . . throw up some more.” 
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Many women refused to consider hypnosis because they did not want another person to 
have control of their mind. One woman said, “Hypnosis?  Never!  I wouldn’t do it.  I won’t 
give my mind over to anybody else.” 
 Contraindications and co-morbid conditions 
There were also contraindications to some forms of CAM. Some women described past 
chemical dependencies that prevented them from using CAM forms such as whiskey and 
marijuana. One woman said, “Now I’m a recovering alcoholic and I am a former smoker, and 
I don’t [want] none of that stuff . . . near me, that’s right.” Several of the women were 
influenced either to adopt CAM or not to use CAM because of co-morbid conditions such as 
diabetes, cardiac disease requiring a pacemaker, hyperthyroidism, allergies, and 
hypertension. One woman said, “Milk Thistle?  Again, allergies.  When I say that, it makes 
me think weed, ragweed, and think that I was allergy [sic] to ‘em.” 
 Cost 
Cost of a CAM was also a reason not to use it. Many of the women reported they would 
love to use the CAM therapy of massage but could not afford it. Over 50% of the women 
were unemployed, and although they knew about CAM treatments they could only buy so 
much. These women had very little disposable income, so they often used CAM treatments 
that did not require money, such as therapies in the mind-body domain of CAM. The women 
with incomes below $25,000 used CAM forms such as music, exercise, and prayer. One 
woman said, “If I could afford this [Co-Enzyme Q10], this is something I’d definitely want 
to use.  I went the other day and it was $75 for just one bottle of Co-Enzyme Q10.” 
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Time 
As indicated in other literature (Lengacher et al., 2006), women report that one reason not 
to use CAM is that it takes too much time. The women in this study also reported this as a 
barrier to certain CAM therapies. Not only do the treatments themselves require time but the 
investigation of CAM is also time consuming. Several of the women reported that they did 
not have the time to investigate CAM forms even though they were interested in trying them. 
 Convenience 
Several of the women in the study reported that using certain types of CAM was 
inconvenient. Because the food and CAM practices were different than the normal family 
routine, these women found it difficult to adhere to a CAM regime due to family 
responsibilities. One woman said, “There again, shopping is limited and my teenage daughter 
would never concede to soy milk in the house.” Another woman said, “See, I don’t have the 
luxury, if I didn’t have to work and do everything I have to do, I would do this stuff every 
day, but I’m lucky if I can do it once every two weeks.” Sticking to a healthy diet was seen 
by some of the women as unpleasant. Another woman said,  
 I have to be able to be happy when I’m eating.  Like if somebody told me today, Julie, 
you know your chances of having a recurrence increase by 70% if you keep eating the 
foods you’re eating, it’s like well, keeping the foods I’m eating and be happy eating and 
maybe the cancer again or stick to this horrible diet that would make me unhappy every 
day of my life, and make me nasty and crabby, I’d probably try to do a little of both.  I 
wouldn’t be a fanatic about foods, never, even if they told me, you know, gave me all 
these reasons why I should do it, I’d still say, well, I’m still going to have my chocolate 
once in a while, I’m still going to drink my Pepsi once a day, and I’m not giving them up.   
 
Cultural relevance 
 One of the factors that the women used to decide about CAM forms was the cultural 
comfort and familiarity they felt with a particular CAM treatment. Several of the women did 
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not want to investigate Chinese medicine because, as one woman said, “Chinese medicine?  
I’m not a Chinese and I don’t think I need any Chinese medicine.” Other women were leery 
of folk remedies because they felt they were beneficial to others but not to them. One woman 
said:  
 Even though a lot of these folk medicines and stuff are probably a lot less harmful to 
my body than the candies that I eat or the French fries that I eat, it’s still not part of my 
culture, it’s not part of who I am, it’s not something I’m used to.  If I was born and grew 
up with this kind of stuff, then I’d probably keep doing it, just part of who I am in my 
history. 
 
Faith 
The role of faith for the African American women was unique in this study. Although the 
European American women reported religious affiliations and relying on their faith, their 
experience of faith was not as influential as it was for the African American women. Of the 
top five most commonly used forms of CAM for the African American women, three related 
to faith. They were prayer, spiritual healing, and meditation. These CAM forms played an 
integral role in the way the African American women dealt with the side effects of treatment. 
As the women described their experiences with dealing with cancer and the way they used 
faith, they used a combination of meditation, social support, and images to reinforce their 
faith experience. One woman described it this way. She said:  
 So my goddaughter, she came up and she brought me some angels [religious symbols], 
and every day I’d go through there and I’d look at and touch the little angels, and I 
thought well that just chilled [cheered] me up, you know.  And then I had scriptures all 
over my ‘frigerator [visual cues], all through my house, all scriptures in the Bible talking 
about healing, about breast cancer, so they had all of those scriptures, so I praise God for 
that.  And then my pastor and other people, missionaries and all of ‘em were just praying 
for me [social support].   
 
The women in this study reported using faith and support from God to deal with 
emotional and physical sequelae of their cancer. One woman described music that was 
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particularly meaningful because it was written during the “dark night of the soul,” which she 
likened to having breast cancer.  
Another woman described how she interacted with God. She said:  
 You know something make me angry, before I had got diagnosed with cancer, and I’d 
say well, Lord, you saw ‘em gitting on my nerves, didn’t you?  And you know, I just had 
a good time just laughing and talking with him, and after I had that talk, I was fine. The 
feeling goes away, and I be just as happy and jolly. Yes, because . . . seems like I really 
held on to him, and you know, after I found out.  Like I say, I was talking to him before, 
but after this, you know, it just made me just cling and hold on to him. It would just give 
me a good feeling, a good feeling, good feeling. 
 
The women called on faith to help them throughout their breast cancer experience. God 
was their partner, their social support, and their confidant. One woman described it this way,  
 From the beginning, you know, the Lord is not going to put any more on you than He 
feel like you can’t handle.  If you get to a point where you can’t handle it all by yourself, 
He’ll help you through it.  He gives you the strength some kind of way to get through it. I 
remember a time [before her diagnosis] when I would . . . I knew that I was not going 
through the first treatment, chemo treatment, when I was not doing that on my own.  It 
was like there was some other force there. I don’t know.  I never thought about Him not 
being there.   
 
Faith was also important in dealing with the day-to-day effects of treatment. One woman 
described her distress related to alopecia from chemotherapy, which is a particularly 
important side effect for African American women (Henderson, Gore, Davis, & Concon, 
2003; Long, 1993). As she was driving down the road she noticed her hair coming out more 
and more. She said: 
 I had been reading the book of Job. . . . God took me back to that scripture at the 
beginning when he loses everything, like his cattle and . . . his family and all of that, and 
he said, “The Lord giveth and the Lord taketh away, blessed be the name of the Lord.”  
And so that’s what I thought about with my hair, you know, that the Lord gave it and the 
Lord has taken away, blessed be the name of the Lord.  And then at the end of that, he 
was just like . . . always remember that at the end of Job there’s restoration, and so that 
really helped me.   
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None reported expecting God to prevent cancer recurrence, but their faith complemented 
and supported their tolerance of treatment. One woman described it this way:  
 It’s so funny because most people would think that you would pray, “Oh, God, heal 
me, oh, God, heal me,” and I recall only a few times that I actually prayed that.  Most of 
my prayers were “God, sustain me,” or “God, strength[en] me to get through this,” . . . 
And so, I mostly prayed for that.  I prayed that God would just help me to see the lesson, 
what I was to learn from the experience. 
 
Overview of the Process of Using CAM for Breast Cancer 
The process through which women in this study decided to use CAM involved 
continuous assessment and evaluation. They either began or continued CAM therapies in 
response to a need to improve their health and avoid cancer recurrence, or to deal with an 
actual or potential effect of their cancer and its treatment. They consulted experts perhaps in 
the form of their provider, a friend, or another cancer patient. Or they consulted a reference 
source such as the Internet or printed materials in the forms of pamphlets or books. In 
determining whether to use a CAM form, they balanced numerous factors, both pro and con, 
including the costs, their health beliefs about the therapy, and the therapy’s potential to harm 
them medically.  
Trying It Out 
The women also gave the CAM that they were using for the first time a trial run. One 
woman described this phase as “experimenting.” She said, “So I’m experimenting, you 
know, and I don’t know how long this kick is going to last, but you know, I’m just 
experimenting.” There was a time period during which they would use a CAM form before 
they decided to adopt it permanently. This time frame differed from woman to woman, from 
a one-time trial to several months. One woman said, “I would try it for a while, you know, 
make my own decision and I would check it out, I would you know, have blood tests done 
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again or just see how. . . . I would check in with myself, I do a lot of checking in with 
myself.” Another woman said:  
 Rum-soaked raisins?  They were having reports of Aromasin [her anti-estrogen 
medication] giving you more aches and pains, and I kind of ache sometimes, just my 
joints and all, hurt all over, so I tried this because I keep reading about in the People’s 
Pharmacy, they really supported it.  I couldn’t keep it up long enough, I was probably on 
it for a month, and I couldn’t keep it up long enough to tell. I think I’d probably have had 
to been on it for three months maybe at least to give it a fair trial. 
 
Defining the CAM Plan 
The main reason the women in this study reported for continuing a CAM therapy 
consistently was that it worked for them. This clear evidence of effect for the woman kept 
them using a form of CAM regardless of cost, aversions, and co-morbid conditions. When 
CAM therapies worked, the women reported sticking with them. CAM treatments that were 
taken for specific symptoms were evaluated in terms of their effects. One woman used 
vitamin C, Echinacea, and zinc to boost her immunity. She said:  
 I’ve always used zinc, Echinacea and vitamin C as a sort of like . . . immunity booster, 
something like that. . . . I usually take them probably starting around December, January 
and February.  Any other times of the year I only take them when I notice like symptoms, 
like, runny nose, if I’m feeling like achy, sneezing, and stuff like that. . . . I remember 
hearing something about it on the Today Show several years ago, so I thought that I 
would try it, and probably out of the seven years that I’ve used it, I haven’t had like a 
cold or anything. Yeah, I did it on a daily basis [during treatment], especially when I was 
going through the chemotherapy, the routine ones would be like Echinacea and vitamin 
C.  If I started to feel like my nose was running a little bit more, or if I was like on an 
airplane and people were sneezing, or if I were around like people who were sick and 
their immune system was already suppressed, then I would add the zinc.  
 
It is unclear from the interviews what motivated the women to continue health promotion 
behaviors. These seem to be lifestyle changes that have been incorporated and are evolving 
as the women continue their process of evaluation. They describe the CAM they use for 
health continuing past the acute time of their intensive treatment. The two women who had 
completed treatment continued to use CAM for health and for breast cancer symptoms. One 
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woman used meditation to reduce stress, and the other used massage to deal with persistent 
lymphedema.  
The women also report stopping CAM therapies for various reasons. Some of the women 
stopped treatments because there was an arbitrary number of CAM therapies they would 
tolerate. One woman said:  
 Now I’m not going to continue with all these.  I’m taking the turmeric with the 
bromelain, because the bromelain is supposed to increase the absorption of the turmeric, so 
I’ll probably continue with that.  The green tea extract I just started taking it because it 
was an antioxidant, but that one’s getting trashed, because I mean how many pills can I 
take? 
 
The women stopped CAM because after their CAM trial they determined it did not work 
for the prescribed symptom or that the symptom resolved. Another reason they stopped a 
treatment was medical advice. This was especially the case in relation to the use of soy by 
women whose cancer was estrogen receptor positive. Stopping a treatment did not 
necessarily mean that the women did not ever use a CAM form again. If a woman had a 
previous positive experience with a form of CAM she might use it if her symptoms returned 
or if she had similar symptoms. This was exemplified in a woman’s comments about 
Glucosamine:  
 Glucosamine, I took it for a couple of years, and I know it helped, but then all of a 
sudden I decided . . . I just quit taking all of my vitamins.  But, it’s just within the last 
couple of months that I decided to go back and start taking them again. I was just aching, 
my back was hurting me so bad, I think . . . [it is helping] a little bit.  I don’t think I’ve 
been on it long enough, probably one month.  I need to be on it a little while longer. 
 
This sample of women demonstrated that CAM is used by a more diverse group of 
women than those previously described in the literature.  By using the definition of 
complementary therapy as treatments not prescribed by a doctor or things that were helpful in 
managing the side effects of breast cancer or treatments or to stay healthy, these women 
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provided a fuller description of what CAM during breast cancer meant to them. These results 
showed that, even in this small sample, poor women used CAM, less educated women used 
CAM, and African American women used CAM. There are differences in the types and 
amounts of CAM used, but all the women used CAM. The process of deciding to use CAM 
that these women described is multifaceted. They used CAM to deal with the cancer and 
treatment-related effects, and a larger portion of their CAM use was aimed at staying healthy 
or becoming more healthy. Their CAM use was influenced by many factors, but the data 
from this small study emphasized the power and importance of providers in CAM decision-
making. This work indicates the importance of providers becoming more current in their 
understanding of CAM interactions with conventional therapy, evaluating benefits and 
hazards of CAM use for breast cancer survivors, and of ongoing dialogue with their patients 
about CAM use.  
 
Chapter 5 
Discussion 
This chapter will include a discussion of key study findings and how they relate to 
existing literature; an examination of the implications of the findings for research and 
practice; and a discussion of study limitations.  
The study had several significant findings. One finding was that both African American 
and poor women with breast cancer used CAM treatments. Another important finding was 
the differences and the similarities in the types of CAM treatments used by women of 
different ethnicities. The women in this study used CAM for both self-care and for health in 
the hope that they could correct past lifestyle indiscretions. They were motivated to adopt 
CAM by treatment-related side effects and by examination of lifestyle factors that they 
thought may have been relevant to their cancer. They engaged in a process of “trying it out” 
that was influenced by multiple environmental and personal factors related to their past 
history, their health beliefs, and prevailing health information, but they ultimately decided 
about CAM use after a trial period and personal evaluation.  
 
Limitations of the Study 
This was a small mixed methods study. Only 19 women were included in the sample. 
One of the key aims of the study was to compare CAM use in European American and 
African American women with breast cancer, but with the small sample, comparisons are 
clearly preliminary and suggestive rather than conclusive. However, combining the interview 
108
data with the data from the questionnaires provided multiple dimensions to the examination 
of CAM use by these women and allowed a beginning view of the reasons for and the 
process of choosing to use CAM therapies during the breast cancer experience. 
 This was a regional study. The women in this study all lived within a 50-mile radius of 
the study site, but they represent a variety of communities, from rural to urban. Comparisons 
of CAM use by type of community generate some interesting questions for future study of 
CAM use in context.  
The cross-sectional design and convenience sample of women who had received cancer 
treatment also provide some limitations. Although women were asked for retrospective 
information about their CAM use from the time of diagnosis, a prospective study with 
longitudinal data might have provided a fuller picture of CAM use specific to changes in 
toxicities of breast cancer treatment. All of the women in this study used CAM. When they 
were recruited, only women who reported using some kind of CAM were included. This 
limits conclusions about CAM use in general by breast cancer patients. Had all eligible 
women with breast cancer been included regardless of CAM use, decisions to avoid CAM 
use as well as to use CAM could have been examined. Although this sample provided 
information about the subjects’ reasons to use some CAM therapies and not others, including 
women who did not use any CAM could have enlarged the continuum of reasons for and 
against CAM use. A larger study guided by the findings of this study could further elaborate 
on CAM use for breast cancer patients. 
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Discussion of Findings 
CAM Use During Treatment for Breast Cancer in African American and European 
Americans Women in the Urban and Rural South 
In this study, the investigator used a card sort method to clarify the definition of CAM as 
it is used by women with breast cancer. CAM was defined for the women in this study as 
modalities they used to help them stay healthy during treatment or to tolerate treatment. The 
questionnaires and the interviews identified the therapies in the card sort as CAM. They had 
previously been identified by experts and in the literature as CAM.  
 
Methods for Studying CAM Use With Understudied Populations 
In the discussion of their systematic review of CAM use among cancer patients, Verhoef, 
Balneaves, Boon, and Vroegindewey (2005) note that the methods of studying CAM must 
include examination of the process by which patients decide to use CAM. To do this, these 
authors suggest that women should be allowed to tell their stories rather than be forced into 
choosing from preconceived categories that may not capture their personal meaning. The 
data presented here are meaningful to this issue because they are grounded in the women’s 
experiences rather than resulting from forced choices on checklists and questionnaires. Had 
there not been this open-ended approach to the research questions, information about new 
forms of CAM would not have been gained. By using the open-ended format of the card sort 
and the interview, each woman was able to convey her unique definition of CAM and to 
discuss the process by which she decided to use CAM therapies. This is of particular 
importance for the African American women in this study as little information is available 
concerning their CAM practices.  
110
What the women defined as complementary medicine was often different from the 
prevailing definition of CAM in the literature (Eisenberg et al., 1993; Lengacher et al., 2002; 
Montbriand, 1994). For example, all of the women in this sample defined the CAM therapy 
of traditional medicine as using the medication (chemotherapy or Tamoxifen) provided by 
their oncologist. Another exemplar was the inclusion of grocery products with claims to 
health promotion as CAM. One woman in this study used the breakfast drink Bright and 
Early as an energy boost instead of the aloe vera juice that she had previously used. She 
classified the drink as a health food supplement, based on advertised claims. This 
operationalization of a health food supplement is quite different from the types of health food 
supplements described by many authors in the literature (Berrino et al., 2001; Lesperance et 
al., 2002). The work by Lesperance et al. (2002) describes health food supplements as mega-
doses of both vitamins and minerals far surpassing the standard daily requirements. Lamson 
and Brignall (1999) discuss the benefits of using health food supplements in the form of 
antioxidants to augment cancer treatment but report studies with doses many times higher 
than would be contained in a daily glass of orange juice. There were other examples in the 
study findings. Without the open-ended format of the card sort and interview in this study, 
women’s particular definitions of CAM therapy that differed from the “official” definitions 
in the literature would have been missed.  
 
Characteristics of African American Women’s CAM Use: Similarities and Differences 
A major aim of this study was to build on and expand knowledge about CAM use by 
African American breast cancer patients. The current CAM literature contains reports that 
African American women do not use CAM, but inclusion of African American women as 
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study subjects has been limited. The literature reports that more European American women 
than African American women use CAM (Boon et al., 2000). The results of our exploratory  
study and a few others call that conclusion into question (Gray et al., 2003; Moschen et al., 
2001; Navo et al., 2004; Rees et al., 2000). Since African American women had been poorly 
represented in previous CAM studies, it was important to examine the conclusions of 
previous literature. 
This study sample, although small, was equally balanced between European Americans 
and African American women. African American women in this study used more forms of 
CAM both for their breast cancer and for their health than the European American women in 
the study. Of potential importance as well is the finding in this study that the African 
American women used different types and amounts of CAM than the European American 
women. This finding is similar to a few other reports of CAM use. The few studies that have 
included diverse samples have resulted in the finding that, given the same list of CAM 
treatments, African American and European Americans women choose some of the same 
CAM modalities as the European American women, but the number of women using them 
and the specific types they used were different (Alferi et al., 2001; Cushman et al., 1999; 
Factor-Litvak et al., 2001). A study by Alferi et al. (2001) that sampled 231 Black, Hispanic, 
and non-Hispanic European Americans found that 57% of the African American breast 
cancer patients used spiritual healing compared to only 18% of the non-Hispanic European 
Americans. In addition, they found that the African American women in their study were 
more likely to use herbal therapies (35%) than the non-Hispanic European Americans (12%). 
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Faith as a CAM 
 You just meditate on the Lord, . . . when I used to lay down at night, and I usually 
would just meditate on him day and night, and I would say, Lord, I know that you are 
the healer, I know that you’re my doctor, I know that you is my lawyer, I know that 
you is my everything, and Lord, I know that you will bring me out of this if you 
intend for me to come out, you will bring me out, and so he did. 
 
One noteworthy area of focus for the African American women was CAM practices 
associated with faith. They reported using spiritual healing, meditation, prayer, and music to 
craft a support system that centered on God and faith during the cancer experience. Other 
authors have identified these factors in African American women’s coping with breast cancer 
(Henderson, Gore, Davis, & Concon, 2003; Lackey, Gates, & Brown, 2001; Wilmoth & 
Sanders, 2001).  
The African American women in this study used faith, spirituality, and belief in God as 
complementary to their coping with having breast cancer and the side effects of treatment. 
Their stories about breast cancer experiences were interlaced with accounts of the ways their 
faith helped them to deal with their breast cancer diagnosis, to decide about treatment 
options, to tolerate treatment side effects, and to interact with providers. The importance of 
spirituality and faith for African Americans dealing with chronic illness has been well 
documented (Polzer & Miles, 2005; Tanyi & Werner, 2003; Westlake & Dracup, 2001; 
Woodard & Sowell, 2001). Faith has also been studied in a limited way with breast cancer 
patients (Lackey et al., 2001; Lythcott, Green, & Brown, 2003). In work by Henderson and 
Fogel (2003), spirituality was used as a form of social support and a way to cope throughout 
the breast cancer process. The essential importance of faith to African American women 
during breast cancer has also been documented (Ashing-Giwa et al., 2004). Prayer was the 
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most frequently cited form of CAM in this and other studies by Henderson (Henderson et al., 
2003).  
Spirituality and faith as described by the women in this study incorporated a system of 
several elements that could be considered alternative medicine, specifically an alternative 
healing system. The NCCAM defines an alternative healing system as, “a system based on 
the belief that one's body has the power to heal itself. Healing often involves marshalling 
multiple techniques that involve the mind, body, and spirit. Treatment is often individualized 
and dependent on the presenting symptoms” (National Center for Complementary and 
Alternative Medicine, 2004, p 2). Another definition of an alternative healing system is as 
follows: “Alternative medicine includes practices that incorporate spiritual, metaphysical, or 
religious underpinnings; non-European medical traditions, or newly developed approaches to 
healing” (Wikipedia contributors, 2006, p 1). The women studied by the investigator used 
their spirituality in the same ways that other types of alternative healing observances are 
used. They used religious symbols and Scripture in the same way that Eastern practices 
incorporate meditation and icons. They used fasting in the same fashion as do the 
practitioners of Ayurvedic medicine (Decker, 1999). They sought the support of their 
community for prayer and for healing rituals that gave them a sense of well-being and of 
peace. They related examples of anointing after their diagnosis. One woman described a 
anointing with oil by her pastor during a home visit, and several others reported anointing by 
the congregation of their church in corporate worship following disclosure of their breast 
cancer diagnosis. They told of group prayers prior to chemotherapy to give them strength to 
undergo treatment. They used prayer chains much like the remote prayers documented in the 
Mantra Project (Horrigan, 1999) with cardiovascular patients. These women also reported 
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that they held daily conversations with God much as they might seek help from members of a 
support group or a health care provider. Several of the women related that they had not been 
particularly religious prior to their diagnosis but that the cancer diagnosis deepened their 
relationship with God. Some of the women reported that their biologic and church families 
were remote during their treatment, so they developed a closer personal relationship with 
God. This may have reflected their feelings of isolation with their breast cancer diagnosis.  
In 1999, at the meeting of the Oncology Nursing Society, Dr. Janice Phillips (1999), in 
her keynote address, discussed the fear, fatalism, and silence associated with breast cancer in 
the African American community. The African American women in this study did not take 
part in support groups. It may be that what they describe as their deepened relationship 
through an ongoing interchange with God is a response to fear and isolation brought on by 
community silence. 
Several authors include prayer, meditation, and spiritual healing in their lists of CAM 
treatments (Barnes et al., 2004; Morgan et al., 2005; VandeCreek et al. 1999). The African 
American women in this study used these forms of CAM, and their interviews indicated that 
it was a powerful way of coping for them. The experiences that they described were different 
from those of the European American women, although some of the European American 
women also chose these forms of CAM.  
In a study by Bourjolly & Hirchman, 2001, the authors found that both European 
American and African American women sought social support during breast cancer but that 
the European American women used friends and family for support while the African 
American women relied on God. The women in our study reported this type of reliance on 
God; their church family also provided social support. The African American women were 
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not necessarily members of a church, but they had access to church-related individuals who 
provided emotional support in the form of prayer groups and instrumental support in the form 
of child care and supplemental food during treatments.  
It is interesting to note that, despite feeling closer to God, the women did not report that 
they expected God to intervene to prevent their cancer from returning. Lopez, Eng, Randall-
David, and Robinson noted this in their work with other women in North Carolina (2005). 
They reported that, for the African American women in their study, being healed or cured did 
not mean that their cancer would not recur but that God would take care of them regardless. 
The women believed this because of their own personal experiences and the experiences of 
others they knew. Several of the women told about friends and acquaintances who had great 
faith but still succumbed to their cancer.  
 
Use of CAM During Treatment 
Another important question for this study was which types of CAM were being used. 
This sample was varied in personal characteristics: some of the women were pre-menopausal 
and some were postmenopausal; some women were well educated while others had less 
education; some were new to breast cancer and some had lived with it for years; and some 
were currently being treated with chemotherapy or hormonal therapy while others had 
finished treatment. However, CAM use was ubiquitous to their breast cancer experience. The 
CAM therapies used most often were in the biological domain, which has tremendous 
implications for the potential of drug–CAM interactions. Montbriand (2004a, 2004b, 2004c, 
2005), in a series of articles for the Oncology Nursing Forum, reviewed the current reports of 
studies concerning the use of CAM and conventional biomedicine. Her review, as does other 
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literature, points up the continued controversy surrounding CAM use during cancer 
treatment. There is evidence that some CAM forms in specific doses can interfere with the 
effectiveness of both cytotoxic and hormonal chemotherapy. However, there is also evidence 
that other forms of CAM can decrease treatment-related toxicities and boost treatment 
effectiveness (Babu et al., 2000). Some authors have argued the evidence that biologicals 
offer a way to minimize the toxic effects of cancer treatment (Conklin, 2000; Thomson et al., 
2005; Weijl, Cleton, & Osanto, 1997) while others have advocated discontinuing all 
biologicals during treatment (Beyerstein, 2001; Meijerman, Beijnen, & Schellens, 2006). As 
evidence accumulates, the only consensus is that there needs to be more study (Lamson & 
Brignall, 1999; Weiger et al., 2002).  
In this study of CAM therapies, the women used mind-body treatments and treatments 
that they ingested. The therapies that were ingested have more potential to affect the way 
conventional therapies are tolerated and absorbed. This is relevant for all women receiving 
conventional therapy and for other breast cancer survivors with estrogen receptor positive 
tumors. As CAM therapies are studied more rigorously, more information will be gathered 
about drug/CAM interaction. The women in this study used vitamins, antioxidants, and 
minerals. Although there is still no definite evidence that the forms of CAM that these 
women use interfere with conventional therapy, numerous authors counsel practitioners to 
warn patients to avoid these forms of CAM (Boyle, 1997; Lamson & Brignall, 1999; Weiger 
et al., 2002) but have only small human studies or animal trials as a basis for their advice. As 
prevalent as the use of mind-body therapies was in our sample, it is important to make the 
distinction between these and the CAM treatments that are ingested because mind-body 
117
therapies provided the women in this study relief of treatment-related toxicities without 
chemically interacting with conventional therapy.  
In this study the women reported that the CAM they used for breast cancer and health 
improved their energy, and, important to the women receiving chemotherapy, they believed 
that the CAM they used enabled them to receive the curative therapy that they were 
prescribed on time. Often their providers recommended the vitamins and antioxidants they 
used. The women took great pride in avoiding treatment delays. So, in this regard, the CAM 
experience was positive and empowering. Concerns about receiving treatments on time are 
valid as prognosis is directly related to receiving the prescribed chemotherapy in a timely 
fashion (Bonadonna, Valagussa, Moliterni, Zambetti, & Brambilla, 1995). This study did not 
quantify the amount of biologic therapy that the women used, but these women often used 
CAM therapies that have been specifically discussed both positively and negatively in the 
literature.  
The women in our sample with the most toxicity had gone through acute treatment for 
their breast cancer (surgery, chemotherapy, and radiation) and were receiving anti-estrogen 
therapy with Tamoxifen. They did not stop CAM after their acute treatment was over. The 
CAM therapies they used were in several of the NCCAM domains, but many of them were 
ingested biological therapy. The use of Tamoxifen and other estrogen-modulating 
medications with CAM is not addressed extensively in the literature. Literature is emerging 
that reports on the negative effects of CAM treatments on the effectiveness of these estrogen-
modulating medications (Montbriand, 2004a). These anti-estrogen therapies are continued 
for many years (National Cancer Institute, 2005), but little work has been done to educate 
women about ongoing vigilance in dietary intake after acute cancer treatment is concluded. 
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Some studies in Europe have shown benefits of adding CAM when patients are receiving 
therapy with Tamoxifen. Munoz et al. (2003) found that black cohosh reduced hot flashes 
associated with estrogen suppression, and Babu et al. (2000) found that concomitant use of 
vitamin C and vitamin E reduced triglyceride elevations associated with Tamoxifen 
treatment.  
Women in this study who had been diagnosed longer were the heaviest users of CAM. 
Other work with long-term breast cancer survivors has also demonstrated that CAM use 
continues past the period of acute care (Hann et al., 2005). There is also some indication in 
the literature that prior treatment increases the likelihood of CAM use (Alferi et al., 2001; 
Kessler et al., 2001), perhaps due to the added toxicity of treatment or experiencing side 
effects with prior treatment that were not managed well. The concomitant use of 
conventional therapy with CAM in long-term survivors will become even more important as 
breast cancer becomes less an acute illness and more a chronic disease with chronic 
treatments and toxicities. Although this study is limited by a small sample size, these findings 
indicate that further exploration is warranted. 
Recommendations 
Future longitudinal study is needed to examine the exact doses of vitamins and 
antioxidants used by women being treated for breast cancer. Examination of CAM use and 
the conventional treatments given concurrently would begin to quantify the amounts of CAM 
and the actual benefits accrued by breast cancer patients. At present, clinical trials are under 
way within the NCCAM to assess the amounts of CAM used over time and the toxicities 
experienced by women who use them (National Cancer Institute, 2006). Also, providers need 
to become more educated about including exact amounts of CAM used during treatment and 
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current research about CAM–drug interactions. The reliance shown by these women on 
information from providers makes current knowledge about the effects of the use of 
biologicals during treatment even more vital.  
CAM Use for Treatment of Breast Cancer–Related Issues as Compared to CAM Use for 
Self-Care and Lifestyle Issues 
The literature differentiates between CAM that is used for cancer and CAM that is used 
for health (Astin et al., 2000; Balneaves et al., 1999). The women in this study had a difficult 
time differentiating one reason for CAM use from another because they said if they were 
healthy, they were less likely to have cancer. Cancer was a wake-up call for the women in 
this study. They adopted CAM as a reaction to breast cancer and the effects of treatment. 
They described two distinct roles for the CAM that they used during treatment. One group of 
CAM treatments was used for specific side effects of cancer treatment, including emotional 
and physical toxicities. The women ate specific foods for side effects of treatment, such as 
lemon for fatigue, and fruits and vegetables for neutropenia. These CAM treatments were 
very focused and were discontinued after the toxicity was past.  
Another group of CAM therapies was used to correct past lifestyle and dietary 
indiscretions that the patients identified through examination of their own lifestyles. Many of 
the women reported using therapies that would be considered elements of healthy living such 
as vitamins, exercise, and a healthy diet (American Cancer Society, 1996). They described 
using CAM to become more healthy so they could tolerate treatment and lessen the 
likelihood that their cancer would recur. This finding is similar to the results of Chou et al.’s 
study (2000) of Hispanics, African Americans, Asians, and European Americans, in which 
improving health and preventing further cancer were the main reasons women gave for using 
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CAM. Health-promoting behaviors such as diet and exercise are characterized as CAM 
(Chou et al., 2000), so they are normally included in lists of CAM therapies (Sparber et al., 
2000; VandeCreek et al., 1999). Some of the women in our sample modified their diet in an 
attempt to correct poor eating habits. Some ate a diet of fruits and vegetables and considered 
it a special diet because it lacked “junk food.” These women used special diets and exercise 
in much the same way as has been described in other literature (Djuric et al., 1998): to 
improve their body environment and to become more healthy during treatment (Schwartz, 
2000). Many of the therapies used by the women in this study were a direct reaction to 
receiving the diagnosis of breast cancer.  
The women in this study used CAM to enhance the way they felt during treatment and as 
a way to help themselves. Using CAM helped them feel as though they were active 
participants in their care. The concepts of health and cancer are very blended for these 
women. One woman said,  
 I don’t have a general well-being right now. It’s all breast cancer. That’s the thing 
with this sort of thing. . . . I never, ever could have imagined in my life how all-
consuming something like this is, and I don’t know how people get to a point where it 
isn’t that way anymore, where you just think about it, like even when I don’t think 
about it, it’s like I catch myself off-guard, and it’s like this little voice in the back of 
my head that says, You have breast cancer [whispered].  
 
Recommendations 
This study can provide insight for nurses caring for patients with breast cancer. In 
planning care, it is important to keep in mind the level of trauma experienced by the patient 
and help her normalize to a healthy lifestyle. Many of the CAM therapies used by these 
women did not require expenditure of time or money. More than half of this sample had a 
yearly income below $25,000, but they still used a variety of CAM treatments to deal with 
their cancer experience. They used movies (distraction) to relieve stress, walking (exercise) 
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to deal with nausea, the radio (music therapy) to calm anxiety, and quilting (art therapy) to 
increase their sense of well-being. Nurses involved in care for women with breast cancer can 
investigate the use of these simple and inexpensive CAM forms as the basis for breast cancer 
support groups. Two of the women in this study identified the exercise that they got as part of 
a seniors’ cheerleading squad as one of their forms of CAM. Both reported that they had tried 
traditional support groups but dropped out because the support groups were too depressing.  
 
Precipitating and Influential Factors in the Choices of Breast Cancer Patients to Use 
CAM  
Self-Blame and CAM Use 
Many of the women in this study reported that they believe they brought their cancer on 
themselves. The literature describes self-blame (Bennett, Compas, Beckjord, & Glinder, 
2005), cognitive appraisal (Lazarus & Folkman, 1984), and posttraumatic growth (Janoff-
Bulman, 2004; Tedeschi & Calhoun, 2004) in relation to stressful life events such as breast 
cancer. For some of these women, the stress and shock of a breast cancer diagnosis 
precipitated their adoption of CAM treatments. It motivated them to adopt numerous 
behaviors that are considered CAM, especially dietary and lifestyle changes. Throughout the 
interviews, the women reported a type of lifestyle review to search for factors that could have 
caused their cancer. Authors who describe breast cancer survivors who use CAM have 
described their distress as a negative aspect of their diagnosis (Burstein et al., 1999). In a 
study by Glinder and Compas (1999), the authors linked psychological distress with self-
blame and reported that persistent feelings of self-blame lead to long-term psychological 
distress. This was also seen in a study by Bennett et al. (2005), who found that persistent self-
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blame was related to symptoms of anxiety and depression. The women in our study used 
their distress to change their lifestyles and health habits, and used positive growth through 
CAM therapies to help themselves. This is similar to the posttraumatic growth described by 
Janoff-Bulman (2004) and Tedeschi et al. (2004). The authors describe positive growth after 
traumatic life events such as breast cancer diagnosis. Perhaps, for these women, adopting 
CAM was a way of effecting positive personal change. They reported choosing CAM 
because they viewed breast cancer as a double threat, in that conventional providers were 
unable to point to a specific cause for its occurrence and offered few effective systems to 
monitor potential recurrences (Smith et al., 1999). They also used information from medical 
experts (American Cancer Society, 1996; National Cancer Institute, 2005) and the popular 
press (Cool, 2006; Looking after your body, 2006) that advocated the use of numerous CAM 
treatments to prevent cancer.  
The Expert 
Experts influenced all of the women in this study in their CAM use. Often they relied on 
their oncologists and oncology nurses for information and recommendations about CAM. 
This refutes the idea that CAM use is a secret practice that must be hidden from providers. 
Considerable literature documents a lack of disclosure about CAM use in breast cancer 
patients. Adler and Fosket (1999) followed breast cancer patients for 5 years and investigated 
the amount of disclosure of CAM use. Their sample was a multiethnic group, 72% of whom 
used at least one form of CAM. Only 54% of this sample had disclosed to their provider that 
they used CAM. Reports by Eisenberg et al. (2001) and Patel (1987) also noted that patient 
nondisclosure of CAM use poses a danger in the setting of conventional medical treatment.  
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Our sample of women freely shared their CAM use with providers and used them to help 
decide about CAM use and CAM drug interactions. Several of the women reported that their 
providers were uninformed about CAM treatments, and so they did not spend a lot of time 
discussing CAM with them. In fact, the women’s providers often advocated adding CAM to 
reduce side effects of treatment. Several of the women had co-morbid conditions that caused 
them to be anxious about using CAM. These women in particular utilized their providers to 
determine if the CAM they planned to use would hurt the conventional treatment they were 
receiving for conditions such as diabetes, arthritis, or high blood pressure.  
Many of the CAM treatments not selected by the women in this study have proven 
efficacy for women with breast cancer including: massage (Bredin, 1999; MacDonald,  
March/April, 2000; Williams, 2000), reiki (Decker, 1999) and acupuncture (Dundee, Ghaly, 
& Fitzpatrick, 1989; National Institutes of Health, 1997). They were not used by the women 
in this sample at times because they lacked information about these therapies and often due 
to the expense involved in using them. More than half of this sample had a yearly income of 
less than $25,000 per year. The women in this group were not necessarily averse to these 
therapies but lacked the resources of time and money to take advantage of potentially 
beneficial CAM therapies. These women still used CAM treatments but they used modalities 
that did not require outlay of money such as music, exercise and prayer.  
Health beliefs strongly influenced CAM use for the women in this study. They had very 
definite ideas about the things that were good for them and those things that would harm their 
health. In a series of articles from Canada (Boon et al. 1999, 2000; Brown, Carroll, Boon, & 
Marmoreo, 2002; Verhoef et al., 2005), the authors found that health beliefs were very strong 
influences on the choices that breast cancer survivors made about using CAM. Not only did 
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the women in our study have specific ideas about things that were good for them, such as 
exercise, healthy diet, and daily vitamins, but they also had beliefs about things that were bad 
for them. Although the literature about home remedies in the South describes remedies such 
as turpentine (Frate et al., 1996), whiskey (Arcury et al., 2006), and Rootwork (Mathews, 
1987), this sample of women was very clear that they did not believe in the benefit of these 
therapies even though past family members had used them. There is some literature that 
indicates that family traditions and past CAM use will influence patients’ choices of CAM 
treatments. Our findings raise questions about assuming that groups of patients will 
necessarily use the therapies advocated by family and past traditions.  
The African American women in this study sought more sources of information than the 
European American women. The literature reflects that numerous barriers to information-
seeking exist for African American women with cancer, including historical mistrust of the 
medical community, stigma associated with cancer, and concerns about privacy (Matthews et 
al., 2002). This small study demonstrates that some African American women of various 
educational levels are using print and personal sources to gather information about CAM, 
which influences them to incorporate CAM into their personal treatment plan. This has 
implications for nurses and service agencies that provide information for patients. It is 
important to incorporate culturally relevant information in published materials. One woman 
in the sample was convinced that she had nausea and vomiting after her treatment because 
she had not peeled a strawberry that she ate after her treatment. Several of the women in the 
sample religiously followed the information in American Cancer Society and National 
Cancer Institute materials they had received from their oncology clinic.  
Recommendations 
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Nurses should review and modify materials to meet the needs of all their patients, not just 
the dominant ethnic group. Food choices and dietary modifications recommended in the 
literature should be tailored to methods of preparation used by African American women in 
the home. One woman reported that she was losing weight because the fried food she 
preferred was prohibited by the American Cancer Society publication she was following to 
avoid chemotherapy-induced nausea. Another woman who had worked in a college dining 
hall used her past understanding of nutrition to modify her diet to prevent problems with 
nausea. These types of inputs would be invaluable in adjusting recommendations in patient 
publications.  
 
The Process and Timing of Decision-Making by Breast Cancer Patients to Choose CAM 
Around the Time of Treatment 
Conceptual model revisited 
 In light of the findings in this study, the exploratory model, generated from the 
literature (Figure 1) was re-examined. Some of the relationships were reinforced such as the 
important roles of health beliefs, culture and physical and emotional characteristics of the 
individual women. However, the sequence that the women in this sample used these elements 
to decide about CAM use was different than previously described. These elements were 
precursors of the cancer diagnosis, so they colored the way the women coped with their 
cancer diagnosis and the types of CAM they chose. The diagnosis of cancer was a motivator 
to cause the women to seek information about CAM and later the effects of cancer and its 
treatments became motivators. The types of information used were similar to other Bilodeau 
& Degner, 1996) studies with breast cancer patients but these women described using experts 
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as sources who acted as authorities for many CAM decisions. The role of vigilance in the 
process of appraisal and re-appraisal was less important for this group of women than 
expected based on the literature. 
 These data emphasize the importance of the prior uses of CAM to women’s decision-
making. Often the women had prior experiences with CAM and that affected the ways they 
dealt with physical and emotional effects of having cancer. Many women had co-morbid 
conditions and all had personal health beliefs that influenced responses to their cancer 
diagnoses. Women brought these beliefs to the process of personal appraisal that was 
motivated by first receiving a cancer diagnosis and then by having emotional and physical 
side effects associated with breast cancer and its treatment. The women in this study gave 
added insights into the “black box of appraisal” and that portion of the model was further 
elucidated. The element of “trying it out” was important for these women and this sample 
gave more information about this process. They sorted through information about particular 
CAM treatments made judgments about using them then entered into their own personal trial 
of effectiveness. Often the sole reason for using a CAM strategy was that it worked for them. 
The process that the women in this small study used to decide on CAM involved 
continuous assessment of symptoms and trying out various CAM therapies. The therapies 
that they used for specific toxicities of treatment were adopted after they sought information 
from a variety of sources, including print materials, the Internet, friends and family, and their 
providers. At least one of the information sources women used was generally a person 
considered to be an expert. Even after the women decided that a CAM treatment might be 
useful to them, they had to make a personal commitment to purchase it. Often the women in 
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the study reported being interested in a CAM form and acknowledged the CAM therapy’s 
potential for them but had not taken the final step to buy it.  
However, after the CAM form was acquired or adopted, the women began the process 
of trying it out. The time frame for the process was variable. Some of the women would give 
a treatment just one try, while other women would use a treatment for months in order to give 
it a chance to work. This process applied to the use of CAM for specific symptoms. Women 
continued CAM treatments because they worked. If a CAM therapy worked, the women used 
it as long as the potential existed that the symptom might return. This was the case for 
neutropenia associated with chemotherapy. These women reported continuing the use of 
herbs, vitamins, and healthy foods as long as the threat of low blood counts and missed 
treatments loomed. The two women in the study who had completed chemotherapy still used 
CAM forms for persistent side effects of treatment. This has been documented in other 
literature about breast cancer survivors (Canales & Geller, 2003). When the threat of side 
effects passed, they were likely to stop the CAM treatments. 
This was not the case for the CAM treatments that the women used to maintain good 
health. They started them soon after their cancer diagnosis and continued them after 
treatment was done. The factors that influenced these women to stop health-related forms of 
CAM were not clear. Some data indicate that women continue these types of CAM to prevent 
cancer recurrence (Hann et al., 2005; Montbriand, 2004b).  
Recommendations 
It is important to further describe the process that women with recurrent breast cancer 
use to continue CAM treatments and to identify the role they see for CAM in their treatment 
plan. For instance, the relief of depression and anxiety by mind-body treatments such as 
128
prayer and art therapy provides important information for providers about alleviating the 
suffering associated with a cancer diagnosis without the risks associated with 
pharmacotherapeutics.  
 
Summary of the Study 
For the women in this study, CAM use supplemented the conventional medical 
treatment that they used to deal with their breast cancer. This small study raised questions 
about the reports that attribute CAM use only to European American, affluent women. The 
European American and African American women in this study used CAM often for specific 
effects of treatment and to improve their general health. The two ethnic groups differed in the 
types of CAM they used, but both groups used CAM. They went through a process that 
involved collecting information from experts and other sources as well as trial and error. 
Their health beliefs and other factors that affected their overall health influenced decisions to 
use CAM. Often they involved medical providers in their decision-making. This group was 
not reluctant to disclose CAM use to providers, as has been previously described (Adler et 
al., 1999; Astin et al., 2000; Boon et al., 2000; Tasaki et al., 2002), but sought medical input 
to prevent CAM–drug interactions. With the lower-income women in this sample it is 
important to note that the CAM used did not require financial outlays. This has implications 
for coping coaching by oncology nurses involved in treatment-related care. Even women 
with limited finances can benefit from CAM interventions they can practice at home. In 
addition, some CAM treatments, such as massage, music, and art therapy, could be provided 
by volunteers at cancer centers to patients who could not afford them.  
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This small study points up the importance of spirituality and faith, especially to 
African American women. Prayer was the CAM therapy chosen most frequently by all of the 
women in the sample. As the women were most likely to use their spirituality to cope, this 
aspect of their well-being should also be assessed. Religious practices were individual to 
each woman, but all appreciated acknowledgment of their faith and the role it played for 
them in sustaining them during breast cancer treatment. 
 
Recommendations for Future Study 
Allowing subjects to define CAM therapy is essential until such time as the definition 
is consistent and transparent to the lay public. Constraining participants to lists or categories 
of CAM as defined in the literature will result in an incomplete picture of CAM use that may 
not include common, everyday strategies women use to cope with breast cancer and its side 
effects. It is vital to clarify, in this and other populations of CAM users, their definitions of 
CAM and their perceptions of CAM use and to get detailed information about CAM use 
history in order to better describe the nature and extent of the larger problem--the potential 
for interaction and augmentation of conventional therapy by CAM treatments. 
Based on the results of this study and a few others, future research in this area needs 
to include larger, more diverse samples of breast cancer patients. Our data indicated that the 
study of CAM use during breast cancer must include ethnically diverse samples even though 
difficulties in recruitment continue to be an issue. Other characteristics of CAM users may 
influence CAM use, including age and education. In addition, prospective longitudinal 
studies of CAM use from the time of diagnosis into the survivorship period would add to 
information about the CAM decision-making process, including but not restricted to the use 
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of CAM for side effects of differing types of treatments. Women in this study reported using 
CAM, but their criteria for CAM were diverse and their reasons for using it extended to a 
variety of health promotion issues and were not limited to managing their cancer.  
The amounts of biologic therapy used by the women in this study who were actively 
engaged in treatment and with the knowledge of their providers merit further study to 
delineate the extent of this type of CAM use. Biologic therapies are of particular concern 
since so little information exists about the probability of CAM–drug interactions. As 
evidence accumulates, the only consensus is that there needs to be more study (Lamson et al., 
1999). Studies with patients who record doses of CAM and conventional treatments with the 
effects they experienced would help to further explain the actual experiences of the women 
who use CAM. 
This study points to the potential power of informed providers in guiding patients to 
CAM use to effectively augment conventional biomedical treatment. Intervention studies 
with providers to provide them with education about CAM, characteristics of CAM users, 
skills in obtaining CAM-use histories, and current evidence for the efficacy of particular 
CAM therapies could enhance the patient-provider dialogue about CAM use and potentially 
benefit both provider and patient. 
More research is needed to clarify what motivates women to continue CAM long past 
the time of treatment. Also, it is important to study long-term CAM users with recurrent 
disease to determine if they continue CAM after their disease has returned. Some literature 
notes that CAM use continues and increases in women with advanced breast cancer (Helyer 
et al., 2006; Shen et al., 2002). It is important to understand if CAM use changes when breast 
cancer returns and what toxicities women are targeting with their CAM therapy. 
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This study began with the idea of exploring CAM use, the process of deciding about 
using CAM during breast cancer, and including African American women in the sample 
studied. The results provide a beginning look at these questions and a clarification of some of 
the issues from the current literature. This small sample provides new insights into which 
types of CAM this group of southern breast cancer patients used and the influences they 
deemed important in choosing CAM forms. This work also echoes other Researchers that 
reports that women with breast cancer engage in self-blame about lifestyle factors that may 
have been related to their developing breast cancer. However, the women in this study made 
this process an empowering one by moving on to adopt positive health behaviors—changes 
to improve their health as well as to tolerate treatment and its side effects. The finding that 
women were using CAM with the knowledge and often the recommendations of their health 
care providers, and using their providers as expert resources for such decisions, affirms the 
potential importance of educating health care providers about the evidence base for the 
efficacy of CAM as well as the potential for CAM interactions with conventional treatment. 
In addition, the importance of dialogue with patients about their decisions concerning CAM 
use is supported.  
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Appendix A 
 
Fliers for patient recruitment 
 
133
Are you beiing tt reatted ffor Breastt Cancer?
Do you use tt reattmentts and actt iivii tt iies tto hellp
you manage tthe siide eff ffectts off your cancer
and ii tts tt reattmentt ll iike prayer,, home
remediies,, herbs,, exerciise or vii ttamiins?
If so, you may be eligible to participate in a research study about using 
home remedies and other complementary therapies (CAM) during 
breast cancer treatment. The study will involve a discussion group and 
private interviews about women’s practices during breast cancer 
treatment. 
You may qualify for this study if you are: 
18 years of age or older, 
Using home remedies or complementary therapy treatments, 
Receiving treatment for your breast cancer,  
Are either White or African American. 
Taking part is confidential 
Participants will be paid $20.00 for their time 
Call toll free:
1-877-625-3380
Appendix A1 
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Are you beiing tt reatted ffor Breastt
Cancer?
Do you use ttreattmentts and actt iivii tt iies tto hellp you manage
tthe siide eff ffectts off your cancer and ii tts tt reattmentt ll iike
prayer,, home remediies,, herbs,, exerciise or vii ttamiins?
If so, you may be eligible to participate in a research study about using 
home remedies and other complementary therapies (CAM) during breast 
cancer treatment. The study will involve a discussion group and private 
interviews about women’s practices during breast cancer treatment. 
You may qualify for this study if you are: 
18 years of age or older, 
Using home remedies or complementary therapy treatments, 
Receiving treatment for your breast cancer,  
Are either White or African American. 
Taking part is confidential 
Participants will be paid $20.00 for their time 
Call toll free:
1-877-625-3380
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Are you beiing tt reatted ffor Breastt Cancer?
Do you use ttreattmentts and actt iivii tt iies tto hellp
you manage tthe siide eff ffectts off your cancer
and ii tts tt reattmentt ll iike prayer,, home remediies,, herbs,,
exerciise or vii ttamiins?
If so, you may be eligible to participate in a research study about 
using home remedies and other complementary therapies (CAM) 
during breast cancer treatment. The study will involve a discussion 
group and private interviews about women’s practices during breast 
cancer treatment. 
You may qualify for this study if you are: 
18 years of age or older, 
Using home remedies or complementary therapy treatments, 
Receiving treatment for your breast cancer,  
Are either White or African American. 
Taking part is confidential 
Participants will be paid $20.00 for their time 
Call toll free:
1-877-625-3380
Appendix A3 
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Are you beiing tt reatted ffor Breastt Cancer?
Do you use tt reattmentts and actt iivii tt iies tto hellp
you manage tthe siide eff ffectts off your cancer
and ii tts tt reattmentt ll iike prayer,, home remediies,,
herbs,, exerciise or vii ttamiins?
If so, you may be eligible to participate in a research study about using 
home remedies and other complementary therapies (CAM) during 
breast cancer treatment. The study will involve a discussion group and 
private interviews about women’s practices during breast cancer 
treatment. 
You may qualify for this study if you are: 
18 years of age or older, 
Using home remedies or complementary therapy treatments, 
Receiving treatment for your breast cancer,  
Are either White or African American. 
Taking part is confidential 
Participants will be paid $20.00 for their time 
Call toll free:
1-877-625-3380
Appendix A4 
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Appendix B                                                
 
Complementary Therapy Use during Breast Cancer Treatment 
 
Consent 
 
You are being asked to take part in a research study being conducted by Camille Lambe, RN, 
MSN, AOCN, NP that will help nurses and doctors learn more about how women decide to 
use complementary therapy during treatment for breast cancer. Complementary therapy is a 
type of treatment not prescribed by a doctor that may be helpful to manage side effects of 
breast cancer or its treatments or to stay healthy. These therapies may include herbs, 
vitamins, meditation, prayer, exercise and other things. What they learn from this study may 
help other breast cancer patients when they receive treatment for cancer although this may 
not benefit you.  Being is this study is completely your choice.  
 
You were selected because you have breast cancer and are receiving additional treatment 
besides surgery for your cancer. You will be one of approximately 20 patients who will be 
asked to be in this study.  To be in the study you will be asked to take part in an interview 
about your use of complementary therapy since you have had breast cancer.  The interview 
will take about 1 ½ hours and you may be asked, if you are willing, to also have a follow-up 
interview lasting less than an hour.  Both interviews will be taped recorded and transcribed, a 
written word-by word account. Tapes of the meeting will be stored in a locked cabinet in the 
School of Nursing and destroyed after the study is complete.  You will also be asked to 
complete three short questionnaires about your cancer and yourself at the end of the 
interview. That should take less than 20 minutes to complete. 
 
Talking about your breast cancer experience and complementary therapy treatments may 
help you feel better, or it may be a little upsetting.  It is also possible that talking about these 
things will not affect you in any way.  If talking about them does upset you, you may talk 
about your feelings after you finish answering the questions, or you may stop answering 
questions at any time.  You will receive $20.00 as a token of appreciation for your 
participation in the individual interview and another $20.00 if you take part in a second 
interview. 
 
Nothing that you say will be shared with people other than the researcher’s faculty advisors. 
Results of interviews with all the women in the study may be grouped together and reported 
in professional meetings or in professional publications but without information that could 
identify you or any particular individual.  Although every effort will be taken to keep all the 
research records private, there may be times when federal or state law requires the disclosure 
of such records, including personal information.  This is very unlikely, but if disclosure is 
ever required, you can be assured that all steps allowable by law to protect the privacy of 
information will be taken.   
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You are free to participate or not to be in the study and you may drop out of the study at any 
time if you want to. If you do not participate or if you drop out, it will not affect your care in 
any way. 
 
You have been told about the reason for the study and about your part in it, and you have 
been able to ask questions.  If you are willing to be in this study, you will get a copy of this 
form. The signed forms will be kept in a locked cabinet in the School of Nursing for at least 5 
years.  
 
You understand that the study has been approved by the Nursing IRB.  You may contact this 
committee at 919-966-3113 any time during this study if you have any questions about your 
rights as a subject in this study.  You may also contact the researcher Camille Lambe, a 
doctoral student at 919-818-8747 or her dissertation advisor, Dr Barbara Germino at 919-
966-9209. 
 
I agree to take part in the individual 
interview. 
 
__________________________________
 
Signature of patient  Date 
 
I agree to a second follow-up interview. 
 
__________________________________
____ 
Signature of patient   Date 
 
______________________________
 __________ 
Signature of person obtaining consent
 Date 
 
Convenient phone number and time to call 
to arrange an interview. 
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Appendix C  
 
CAM Card List 
 
Antioxidants 
Acupuncture/Acupressure 
Aloe vera juice 
Aromatherapy 
Art Therapy 
Biofeedback 
Black Cohosh 
Cannabis, Marijuana 
Chelation 
Chinese medicine 
Chiropractic 
Coenzyme Q10 
Colored light treatments 
Counseling 
Detoxification 
DHEA 
Echinacea 
Electro-stimulation 
Enemas 
Exercise 
Fasting 
Folk medicine 
Ginger 
Gingko 
Ginseng 
Glucosamine/Condroitin 
Guided Imagery 
Health food supplements. 
Herb tea 
Herbal supplements. 
Home remedies 
Homeopathy 
Honey 
Humor 
Hydrogen peroxide therapy 
Hypnosis 
Lemon 
Magnetic Therapy 
Massage 
Meditation 
 
Metabolic therapy 
Milk Thistle 
Mineral supplements 
Mistletoe 
Mullen 
Mushroom Extract 
Music 
Natural medicine 
Naturopathy 
Noni 
Ozone Therapy 
Pickle juice 
Polarity 
Prayer 
Red clay 
Red Clover 
Reflexology 
Reiki 
Relaxation techniques 
Remifemin 
Rootwork 
Rum soaked raisins 
Salves 
Selenium 
Soy 
Special diet 
Special foods 
Spiritual healing 
Support group 
Talking away illness 
Therapeutic Touch 
Traditional medicine 
Turpentine 
Vinegar 
Vitamin B6 
Vitamin C 
Vitamin E 
Vitex 
Whiskey 
Yoga 
Zinc
 
I. D. # ___________________ 
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Appendix D 
 
CAM Tally Sheet 
Patient ID Are using 
for breast 
cancer 
Are 
using for 
health 
Have 
used in 
the past 
Are 
considering 
Would 
not use 
Antioxidants      
Acupuncture/Acupressure      
Aloe vera juice      
Aromatherapy      
Art Therapy      
Biofeedback      
Black Cohosh      
Cannabis, Marijuana      
Chelation      
Chinese medicine      
Chiropractic      
Coenzyme Q10      
Colored light treatments      
Counseling      
Detoxification      
DHEA      
Echinacea      
Electro-stimulation      
Enemas      
Exercise      
Fasting      
Folk medicine      
Ginger      
Gingko      
Ginseng      
Glucosamine/Condroitin      
Guided Imagery      
Health food supplements.      
Herb tea      
Herbal supplements.      
Home remedies      
Homeopathy      
Honey      
Humor      
Hydrogen peroxide 
therapy 
 
Hypnosis      
Lemon      
I. D. # ___________________ 
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Magnetic Therapy      
Massage      
Meditation      
Metabolic therapy      
Milk Thistle      
Mineral supplements      
Mistletoe      
Mullen      
Mushroom Extract      
Music      
Natural medicine      
Naturopathy      
Noni      
Ozone Therapy      
Pickle juice      
Polarity      
Prayer      
Red clay      
Red Clover      
Reflexology      
Reiki      
Relaxation techniques      
Remifemin      
Rootwork      
Rum soaked raisins      
Salves      
Selenium      
Soy      
Special diet      
Special foods      
Spiritual healing      
Support group      
Talking away illness      
Therapeutic Touch      
Traditional medicine      
Turpentine      
Vinegar      
Vitamin B6      
Vitamin C      
Vitamin E      
Vitex      
Whiskey      
Yoga      
Zinc      
I. D. # ___________________ 
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Appendix E 
 
Interview Questions 
 
• Introduction of the PI  
• Answer questions about the study. Have participant sign consent. Provide them with 
copy of consent. 
 
• Would you describe your breast cancer experience and talk about your treatment and 
any side effects you have had? 
 
• This study is about Complementary Therapy that women use during breast cancer. 
Complementary therapy treatments are not prescribed by a doctor but are any of the 
things you have found helpful to you in managing the side effects of breast cancer or 
treatments or to stay healthy. They may include herbs, vitamins, meditation, prayer, 
exercise or other things.   
 
• On these cards are things that other women have used to help them during breast 
cancer treatment. What I would like you to do is to take some time to divide the cards 
into piles.  
 
• Divide the cards into the things you are using now and the things you are not using.  
If you don’t know what something is, we can discard those cards. 
I also have blank cards to write any other things that you have done to help yourself 
since you found out about your breast cancer. Deleted last sentence 
 
When the woman is finished: 
 
I. (Addressing the appropriate pile): For the things you are using, let’s divide those into the 
ones you use for breast cancer and  treatment side effects and those you use for your general 
health?. 
 
a. About the things you use for the breast cancer: 
Tell me about using these. (Probes:  Tell me how you decided to use this to help yourself? 
How do you use them?  When do you use them?  How do they help you?  How can you tell 
that it’s helping?).  
 
How did you find out about these things? (Probes:  Did someone suggest it?  Did something 
happen to make you think it might help you?  Did you read something, find something on the 
internet or other? Did you talk with anyone about using this?) 
 
Have you talked to your doctor about the things you are using for your breast cancer? Why or 
why not? 
 
b. About the things you use for your general health:
I. D. # ___________________ 
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Were you using this before your breast cancer? How does it help your health? (Probes: When 
did you start using this?  What made you start using it at that time?) 
 
II. Let’s look at the things you put in this pile—the things you are NOT using: Divide these 
into things you have used in the past, things you are considering using and things you would 
definitely not use?  
 
a. Let’s go through these things, the ones you have used in the past. [Ask for each:] 
Why did you stop them? Could you tell me more about that decision? (Probes: 
Can you tell me about stopping them?  What made you decide to stop? Would 
there be a time that you might consider restarting them?  What might make you 
reconsider? Have you had a bad experience with them?) 
 
b. Now let’s go through the things you are considering. [Ask for each:] (Probes: 
Why have you not started these? What concerns do you have about them? Are 
you still thinking that you might use them?  What would make you decide?)  
 
c. Now tell me about the things you would not use. [Ask for each:] Is there a special 
reason why? (Probes: How did you find out about these things?  Have you talked 
to anyone about them?  Has that been a factor in deciding not to use them?) 
 
Is there anything else that’s important for me to understand about your decision to use 
Complementary Therapy? 
 
Thanks—this has been really helpful.   
 
The last thing is filling out these three short questionnaires about you, the information 
sources you use about CAM and the effect cancer and its treatment have had on you. 
 
After collecting these, hand out the honorarium and thank the 
participant again for her time. Mention that you may be contacting 
her for a brief follow up and why. 
 
I. D. # ___________________ 
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Appendix F 
 
Breast Cancer Treatment Toxicity Questionnaire 
 
This questionnaire is for women receiving treatment for breast cancer. We are 
interested in how you have been feeling, physically and emotionally during the last 2 
weeks. The questions focus on some of the problems and feelings reported by women 
who have received treatment for breast cancer. Check the one box in each line that best 
applies to you. 
 
All of 
the time
Some of   
the time
None of
the time
How often during the past 2 weeks, have you felt 
that:  
 
You were positive or optimistic regarding the future?  
Your fingers were numb or felt like they were “asleep”?  
You were having trouble remembering things?  
You were low in energy?    
You were tearful or down in the dumps?    
You were troubled or upset because of feeling 
unattractive? 
 
You were uncomfortable or embarrassed because of 
changes in your skin or nails? 
 
You were irritable?    
You were worried or tense?    
You were uncomfortable or embarrassed because of 
thinning or loss of your hair? 
 
You were sad or tearful because of losing your breast?  
You were feeling good about yourself?    
You were having pain?    
The future looked hopeful and promising?  
You were troubled by weight loss?    
You were drowsy or sleepy during the day?    
You had an upset stomach?  
You had trouble getting a good night’s sleep?    
I. D. # ___________________ 
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You had a runny nose?    
You had a loss of appetite?    
All of 
the time
Some of   
the time
None of
the time
How often during the past 2 weeks have you felt that:  
You had the feeling that you smelled of chemicals?  
You had a change in the way your food tastes.  
You had problems with fatigue or tiredness that 
interfered with your housework? 
 
You had more than the usual amount of gas?  
You had menopause symptoms?  
You had constipation?    
You had burning, watery, or sore eyes? 
 
A great 
deal 
Some None 
How much time during the last 2 weeks would you say 
that your family has been worried about you and about 
your health? 
 
How much time during the past 2 weeks have you had 
problems with fatigue or tiredness which limited your 
social activities? 
 
How much help and support have you received from 
people outside your family during the past 2 weeks? 
 
How much trouble have you had in the past 2 weeks 
because of feeling nauseated or sick to your stomach? 
 
How much trouble or inconvenience have you had 
during the past 4 weeks because of low blood counts? 
 
How much trouble or distress have you had because of 
pain, soreness, or sores in your mouth during the past 2 
weeks? 
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Appendix G 
SOURCES OF INFORMATION 
When you are looking for information about cancer, its treatment, and complementary 
therapies which of the following sources influence you the most? Check all that apply. 
 
__________ American Cancer Society 
__________ Audiotapes, Videotapes or 
CDs 
__________ Books from the Public 
Library 
__________ CAM provider 
__________ Cancer Information 
Groups (like, Reach for 
Recovery) 
__________ Church or Spiritual leader 
__________ Community Center  
__________ Family members  
__________ Friends  
__________ Health Food Store 
assistant/clerk 
__________ Herbalist or root worker 
__________ Home Health Nurse 
__________ Hospital Cancer Center 
__________ The Internet 
__________ Magazines  
__________ Medical Library, or 
Bookstore  
__________ National Cancer Institute 
Cancer Information Line 
__________ Newspapers 
__________ Pamphlets and Fliers 
__________ Patient Advocate 
__________ Pharmacist 
__________ Primary Care Provider 
__________ Television/Radio 
__________ Therapist or counselor  
__________ Your chemotherapy 
doctor 
__________ Your chemotherapy nurses 
__________    Your nurse practitioner/ 
physician assistant 
__________    Your surgeon 
__________ Your radiation therapy 
doctor 
__________ Other
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Appendix H 
Use of Complementary Therapy Survey for Breast Cancer 
Demographic and Cancer Treatment Form 
Modified from (Lengacher et al., 2002)   
1. Age ________________ 
2. Education (check all that apply): 
Less than High School _____ High School Diploma _____ Some College _____ Four-
Year College Degree _____ 
College past Four-Year degree ____ Advanced College degree _______________ 
3. Work: 
Full time _____ Part time _____          Unemployed _____          Retired _____
 Disabled _____  
Other (please describe) _________________ 
4. Ethnicity: 
African American _____ American Indian _____ Asian _____  Caucasian 
_____   Hispanic _____  
Pacific Islander _____ 
Other __________________________________________ 
5. Area where you live: 
City Residence ______________  Rural Residence ______________ 
6. Approximate family income: 
Under $25,000 _________ $25,000 - $75,000 __________ Over $75, 000 ______ 
7. Religion: Fill in the name of faith and church or circle NONE. 
__________________________________________________________ NONE 
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8. How long have you known that you have breast cancer?  
__________ Years, __________ Months.  Have you had other cancers? 
________________. If so what type? _________________ 
9. Family history of cancer? 
Breast cancer? _____Yes ______No If yes for breast cancer, list the family 
member’s relation to you. ______________________ 
Other cancer in your family 
_____________________________________________________________________
____________ 
10. Treatments you have received (check all that apply): 
Surgery ___    Biopsy ___    Lumpectomy ___    Mastectomy ___    Reconstruction 
______ Chemotherapy ________  
Radiation __________ Hormonal therapy ___________ 
Other, please describe 
_______________________________________________________ 
What treatment are you receiving now (please describe)? 
_____________________________________________________________________
____ 
Reference List 
 
Lengacher, C., Bennett, M., Kip, K., LaVance, M., Smith, L., & Cox, C. (2002). Frequency of 
use of complementary and alternative medicine in women with breast cancer. 
Oncology Nursing Forum, 29(10), 1445-1452. 
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Appendix I 
 
CAM used for Health and for Cancer by Race and NCCAM Domain 
 
CAM for Cancer CAM for Health 
NCCAM 
Domain 
 White African  
American
Total White African  
American 
Total 
1 Chinese medicine 0 0 0 0 0 0 
1 Folk medicine 0 0 0 1 0 1 
1 Naturopathy 0 0 0 1 0 1 
1 Home remedies 1 2 3 1 1 2 
1 Natural medicine 2 2 4 1 1 2 
1 Traditional medicine 6 2 8 2 3 5 
2 Biofeedback 1 0 1 0 0 0 
2 Colored light treatments 0 0 0 0 0 0 
2 Hypnosis 0 0 0 0 0 0 
2 Rootwork 0 0 0 0 0 0 
2 Guided Imagery 1 0 1 1 0 1 
2 Support group 4 2 6 1 1 2 
2 Art Therapy 3 0 3 2 1 3 
2 Spiritual healing 1 4 5 2 1 3 
2 Meditation 2 4 6 3 1 4 
2 Relaxation techniques 2 3 5 6 1 7 
2 Counseling 1 0 1 2 2 4 
2 Talking away illness 0 0 0 2 2 4 
2 Prayer 2 7 9 7 2 9 
2 Music 2 3 5 6 5 11 
2 Humor 4 1 5 5 6 11 
3 Aloe vera juice 0 0 0 0 0 0 
3 Black Cohosh 0 0 0 0 0 0 
3 Cannabis, Marijuana 0 0 0 0 0 0 
3 Chelation 0 0 0 0 0 0 
3 Coenzyme Q10 1 2 3 0 0 0 
3 DHEA 0 0 0 0 0 0 
3 Gingko 0 0 0 0 0 0 
3 Homeopathy 0 1 1 0 0 0 
3 Hydrogen peroxide therapy 0 0 0 0 0 0
3 Metabolic therapy 0 0 0 0 0 0 
3 Milk Thistle 0 0 0 0 0 0 
3 Mullen 0 0 0 0 0 0 
3 Noni 0 0 0 0 0 0 
3 Ozone Therapy 0 0 0 0 0 0 
3 Pickle juice 0 1 1 0 0 0 
3 Red clay 0 0 0 0 0 0 
3 Red Clover 0 0 0 0 0 0 
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3 Remifemin 0 0 0 0 0 0 
3 Rum soaked raisins 0 0 0 0 0 0 
3 Selenium 0 0 0 0 0 0 
3 Turpentine 0 0 0 0 0 0 
3 Vitex 0 0 0 0 0 0 
3 Detoxification 0 1 1 1 0 1 
3 Herbal supplements. 2 3 5 3 0 3 
3 Enemas 1 1 2 0 1 1 
3 Fasting 0 1 1 0 1 1 
3 Mistletoe 0 0 0 0 1 1 
3 Mushroom Extract 0 0 0 0 1 1 
3 Whiskey 0 0 0 0 1 1 
3 Ginger 1 2 3 1 1 2 
3 Glucosamine/Condroitin 1 0 1 1 1 2 
3 Vinegar 0 0 0 1 1 2 
3 Soy 0 0 0 2 1 3 
3 Echinacea 0 1 1 0 2 2 
3 Ginseng 1 0 1 0 2 2 
3 Salves 2 1 3 0 2 2 
3 Special diet 4 4 8 2 2 4 
3 Health food supplements. 2 3 5 3 2 5 
3 Antioxidants 4 3 7 4 2 6 
3 Zinc 1 0 1 1 3 4 
3 Aromatherapy 1 0 1 2 3 5 
3 Honey 1 0 1 3 3 6 
3 Mineral supplements 2 1 3 4 3 7 
3 Special foods 3 3 6 4 3 7 
3 Herb tea 2 2 4 3 4 7 
3 Vitamin C 3 3 6 4 4 8 
3 Vitamin B6 2 1 3 3 5 8 
3 Lemon 1 2 3 4 5 9 
3 Vitamin E 1 2 3 3 6 9 
4 Chiropractic 0 0 0 0 0 0 
4 Massage 1 3 4 4 0 4 
4 Reflexology 0 0 0 0 1 1 
4 Yoga 0 0 0 2 3 5 
4 Exercise 2 4 6 6 4 10 
5 Acupuncture/Acupressure 0 0 0 0 0 0 
5 Electro-stimulation 0 0 0 0 0 0 
5 Magnetic Therapy 1 0 1 0 0 0 
5 Polarity 0 0 0 0 0 0 
5 Reiki 0 0 0 0 0 0 
5 Therapeutic Touch 0 1 1 1 0 1 
72 76 148 105 95 200 
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